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SUMMARY
Barrett’s oesophagus is a pre-malignant condition, the incidence of which is steadily 
increasing. The exact cause of this condition is not known although it is strongly 
associated with reflux of gastric and duodenal contents. The early part of this study deals 
with the development of an in-vitro model of Barrett’s cell culture to better understand 
the mechanism involved in neoplastic progression. Despite limited success our study 
shows that long term culture of Barrett’s cells is extremely difficult, labor intensive and 
not easily reproducible. Cytogenetic evaluation of cultured cells using Fluorescent In-situ 
Hybridisation showed that amplification of chromosome four and eight in early stages of 
Barrett’s. It is difficult to draw a conclusion from this study owing to the small number of 
samples analyzed. The latter part of the study deals with the evaluation of cytotoxic and 
genotoxic effect of bile acids on oesophageal cell lines using the cytokinesis-blocked 
micronucleus assay, a multi end point assay. Bile has been increasingly implicated in the 
pathogenesis of Barrett’s although evidence regarding genotoxic and cytotoxic effect of 
various bile acids on oeophageal cell lines is limited. Our study clearly shows that all bile 
acids induce a significant cytotoxicity at concentrations which are significantly relevant 
in patients with Barrett’s. However all bile acids except DC A lacked significant 
genotoxic effect in-vitro. Bile salts and acid together had a synergistic effect on cell 
toxicity. DCA induced significant DNA damage and apoptosis at concentrations as low as 
100-200 |imo 1/1 iter. Further evaluation of the mechanism of DNA damage by DCA 
showed that it was predominantly a clastogen in nature. This study provides more 
evidence to show that DCA can cause DNA damage and apoptosis in oesophageal cell 
lines. We therefore conclude that un-conjugated bile acids (DCA) at neutral pH could
play an important role in the development of Barrett’s metaplasia and its progression to 
oesophageal adneocarcinoma.
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1CHAPTER ONE
1.1 INTRODUCTION
The incidence of adenocarcinoma of the oesophagus has been steadily increasing over the 
last three decades in the Western world (Blot et al, 1991; Pera et ah, 1993). In fact the 
increase has been more rapid than that of any other malignant neoplasm (Haggitt 1994). 
Oesophageal adenocarcinoma (OADC) is a lethal malignancy and most patients present 
with advanced disease at the time of diagnosis. The prognosis is poor with a very low five 
year survival rate(Clark et al, 1996; Spechler 1996). Though a few moderately strong 
risk factors have been identified, the exact reasons for the rising incidences are unknown 
(Kim et al, 1997). Virtually all adenocarcinomas arise from pre-existing Barrett’s 
metaplastic tissue, as does at least 40% of the adenocarcinoma of the gastro-oesophageal 
junction (Pera et al, 1993; Clark et al, 1994). The increasing incidence of oesophageal 
adenocarcinoma could be a reflection of an increasing incidence of its precursor lesion 
Barrett’s oesophagus (known as BE) (Prach et al, 1997; DeVault 2000).
1.2 BARRETT’S OESOPHAGUS
1.21 DEFINITION
Barrett’s oesophagus is defined as a condition in which the normal stratified squamous 
epithelium of the distal oesophagus is replaced by metaplastic columnar epithelium 
containing goblet cells (Haggitt 1994).
21.22 HISTORY
The earliest description of columnar lined oesophagus was by Tileston, a pathologist, 
who reported several patients who had “peptic ulcer of the oesophagus. He noted the 
close resemblance of the mucous membrane about the ulcer to that normally found in the 
stomach (Tileston W 1906). A number of other investigators described a similar kind of 
lesion in the subsequent years. Most of these investigators, including Norman Barrett, 
who described this lesion in 1950, believed that the columnar lined organ was not 
oesophagus at all, but rather a tubular segment of the stomach that had been tethered 
within the chest by a congenitally short oesophagus (Barrett NR 1950). In 1953 Allison 
and Johnstone proved that this columnar lined intra-thoracic structure was indeed 
oesophagus and not stomach (Allison et al., 1953). They suggested that the ulceration in 
columnar lined oesophagus should be called “Barretts ulcers” . In the early 1970’s there 
was considerable disagreement between investigators as to whether the columnar lined 
epithelium of Barrett's oesophagus was gastric or intestinal type. This confusion was 
clarified by the work published by Pauli et al in 1976 (Pauli et al., 1976). These 
investigators found that three types of columnar epithelium could be present in Barrett's 
oesophagus.
• Specialised columnar epithelium also called specialised intestinal metaplasia 
(SIM)
• Gastric fundic type epithelium with oxyntic glands containing chief and parietal cells, 
and
• Junctional type epithelium comprised exclusively of mucus secreting cells.
3The latter two epithelial types can be indistinguishable from those normally found in the 
gastric fundus and cardia. The specialised intestinal metaplasia is clearly abnormal and 
can progress to dysplasia.
1.23 PATHOGENESIS AND SIGNIFICANCE OF BARRETT’S OESOPHAGUS
The prevalence of BE is increasing and so are its sequel (Prach et al, 1997). BE is found 
in 0.8-2% of patients undergoing upper endoscopy and in 6-15% of patients who undergo 
endoscopy for symptoms of gastroesophageal reflux. The prevalence in the general 
population is not precisely known but some studies suggest a prevalence of 5-9% in a 
general population aged more than 50 years (Cameron et al., 1990; Hirota et al, 1999). 
Based on prospective studies, the incidence of adenocarcinoma developing from Barrett's 
oesophagus is approximately 1 per 100 patient-years (Drewitz et al., 1997). This 
represents a 30- to 125-fold increased risk over the general population. Thus, Barrett's 
oesophagus is a relatively common lesion that has significant malignant potential. 
Approximately 5%-10% of patients diagnosed with Barrett’s oesophagus are thought to 
be at risk of developing oesophageal adenocarcinoma (Spechler et al, 1984; Cameron et 
al, 1985). The risk of malignancy is lower in short segment BE than in long segment 
Barrett’s oesophagus (Rudolph et al, 2000).
Barrett's Oesophagus develops as a result of chronic duodeno-gastro-oesophageal reflux 
(DGER). It is believed that the chronicity of symptoms is more important than their 
severity in predicting Barrett's oesophagus. Barrett’s mucosa by itself is usually 
asymptomatic and in-fact the metaplastic oesophageal mucosa may be less pain sensitive 
than the native squamous mucosa (Iascone et al, 1983; Loffeld 2001).
4Although chronic DGER is the most significant risk factor, the exact role of continuous 
or intermittent acid reflux, bile or other duodenal contents still remains to be elucidated. 
Apart from gastroesophageal reflux, genetic factors appear to be involved in the 
development of Barrett’s oesophagus as indicated by reports of high prevalence rates of 
BE in certain families (Everhart et al, 1983; Crabb et al, 1985) and by the fact that BE 
is rare among ethnic minorities (Smith et al, 1984).
There are other risk factors which are of less significance like white race, male gender, 
obesity and affluent society. Helicobacter pylori infection (especially cagA gene positive 
strains) which is strongly associated with the development of intestinal metaplasia and 
cancer in the stomach (Stemmermann 1994; Asaka et al, 1997) does not seem to have a 
positive association with BE or oesophageal adenocarcinoma (Talley et al, 1988; 
O'Connor et al, 1994; Abbas et al, 1995; Liston et al, 1996). In fact recent reports 
suggest that H.pylori infection may actually protect the oesophagus from cancer by 
preventing the development of reflux oesophagitis and Barrett’s oesophagus (Labenz et 
al, 1997; Werdmuller et al, 1997; Weston AP 1998). It is proposed that H.pylori 
infection can cause pangastritis decreasing gastric secretion and hence preventing gastro- 
oesophageal reflux (Graham et al, 1998) A number of physiological abnormalities 
predispose to Barrett’s oesophagus (Spechler 2000). The proposed abnormalities are (see 
figure 1.1):
• Extreme lower oesophageal sphincter hypotension that predisposes to the reflux 
of gastric contents, which may be caustic due to high concentration of acid and 
refluxed bile
• Gastric acid hyper-secretion
FIGURE 1.1. 
SCHEMATIC REPRESENTATION OF MECHANISMS LEADING 
TO GASTRO-OESOPHAGEAL REFLUX AND BARRETT'S OESOPHAGUS
Adapted from Spechler et al., 2000
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6• Duodenogastric reflux
• Poor oesophageal contractility delays the clearance of the noxious refluxed 
material
• Diminished oesophageal pain sensitivity leads to loss of symptoms which 
otherwise would have warned the patient of oesophageal injury.
• Decreased secretion of epidermal growth factor in the saliva delays the healing of 
the reflux- damaged oesophagus.
Adenocarcinoma in BE does not arise de novo but appears to develop through a multi- 
step process with progressive worsening of a precursor lesion. This stepwise progression 
is recognised histologically as a metaplasia-dysplasia-carcinoma sequence (Reid et al., 
1992). The precursor lesion of adenocarcinoma is called dysplasia. Dysplasia can develop 
in short segment or long segment Barrett’s but its prevalence is higher in long segment 
Barrett’s (Weston et al., 1997). Dysplasia is a morphological term, which etymologically 
means “malformation”. It is derived from classic Greek and composed of ‘dys’ which 
means bad and ‘plasis’ which means form. It is defined as an unequivocal, non-invasive 
neoplastic transformation of the epithelium excluding all reactive changes.
The sequence of metaplasia-dysplasia-carcinoma is a multistep process and is associated 
with several changes in the gene structure, gene expression and protein structure 
(Jankowski et al., 1999). Barrett’s epithelium and its progression to adenocarcinoma is 
associated with a wide variety of cellular and molecular abnormalities. These include 
aneuploidy, chromosomal deletions and trisomy, microsatellite instability, single-gene 
alterations, in-appropriate production and response to growth factors, and alterations in
FIGURE 1.2 SCHEMATIC REPRESENTATION OF THE METAPLASIA 
DYSPLASIA CARCINOMA SEQUENCE (Adapted from Aldulaimi et a l , 1999)
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8cellular adhesion molecules. These changes are mirrored by histologic progression 
through the metaplasia-dysplasia-carcinoma sequence (see figure 1.2).
The process by which squamous epithelium is replaced by specialized intestinal 
metaplasia is poorly understood. Prolonged reflux oesophagitis is associated with 
inflammation and cell death. Responses to the cell death and inflammation include an 
increase in the height of the zone of proliferation and length of basal papillae. This is 
accompanied by increased folding of the oesophageal epithelium, leading to stem cells at 
the tip of papillae becoming more superficial. These superficial stem cells may then be 
exposed to increased amounts of potentially noxious gastro-duodenal refluxate and 
oesophageal luminal contents. Such an environment may lead to stem cells dying or 
being damaged or selected if expressing the glandular phenotype of Barrett’s epithelium 
(Jankowski et al, 1999). Activation of specific oncogenes (especially epidermal growth 
factor receptor, c-erbB-2, H-ras and myc) and inhibition of specific tumour suppressor 
genes (especially p53 and p i6) play an important role. One of the earliest events is thus 
the selection and propagation of the metaplastic clones with specialized intestinal 
metaplasia. Subsequently, altered expression of growth factors and genomic alterations of 
cell cycle-associated genes are noted.
1.231 ROLE OF ACIDS
Acid and pepsin play an important role in the oesophageal damage in patients with 
GERD. There is strong experimental and clinical evidence to support the role of acid and 
pepsin in the development of oesophageal injury. Studies have shown that reflux of acid 
with pepsin is more important in the induction of oesophageal damage than reflux of acid 
alone. It has been demonstrated that patients with GERD and BE have increased
9frequency and duration of acid reflux (Hennessy 1985; Zamost et al., 1987; Gillen et al., 
1988; Stein et al, 1992; Stein et al, 1993) and that the severity of oesophageal injury is 
proportional to the degree of acid and pepsin reflux. In vitro studies have shown that acid 
can effect the proliferation and differentiation of the cells depending on the pattern of 
exposure. While prolonged exposure can lead to differentiation of BE cells, intermittent 
exposure can lead to proliferation of the cells (Fitzgerald et al, 1996). The role of pepsin 
alone in the pathogenesis of BE has not been explored extensively in Barrett oesophagus. 
In fact it is difficult to separate the role of pepsin alone as activation of pepsin needs a pH 
of less than 3. Development of BE cannot be attributed to acid reflux alone. Studies have 
shown that the degree of oesophageal injury does not always correlate with the degree 
and frequency of acid reflux. BE is probably the consequence of a complex interaction 
between acid reflux, genetic susceptibility, environmental factors, and DGER. The fact 
that acid suppression does not prevent or reverse BE goes against the theory that acid 
could be the sole primary factor in the development of BE.
1.232 ROLE OF BILE ACIDS
There is increasing evidence that bile plays an important role in the development of BE 
(vide chapter 4 sec 4.15 for detailed discussion on bile acids). Studies have shown that 
patients with BE have increased bile reflux compared to patients with uncomplicated 
GERD. The fact that patients develop recurrent or progressive disease despite maximal 
acid suppressive therapy suggests that there must be other factors involved in the 
development of BE (Sontag 1992; Champion et al., 1994; Jankowski et al, 2000).
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Complete regression or reversal of BE following acid suppression therapy has not been 
reported (Neumann et al., 1995).
Oesophagitis has been seen in achlorhydric patients with pernicious anaemia (patients 
with lack of hydrochloric acid in gastric juice) (Palmer 1960; Orlando et al., 1973). It has 
also been documented in patients with gastrectomy and oesophago-jejunostomy 
(anastomosis or joining of the oesophagus with the small bowel after removal of the 
stomach) (Nakayama 1956; Helsingen 1961; Meyer et al., 1979). Neoplastic progression 
of BE has been seen in patients who had bile reflux without any pathological acid reflux 
(Jankowski et al, 2000). Bile acids are also involved in the promotion of goblet cell 
metaplasia in other gastrointestinal epithelium such as stomach, duodenum, intestine and 
bile ducts (Jankowski et al., 2000). All these factors suggest that bile acids alone could be 
highly important in the pathogenesis of BE and its complications. The role of bile in the 
pathogenesis of BE is discussed in detail in chapter four which deals with evaluation of 
the cytotoxicity and genotoxicity of the bile acids.
1.24 MANAGEMENT OF BARRETT’S OESOPHAGUS
The management of BE is controversial. The goals of treatment in patients with Barrett’s 
oesophagus are to eliminate symptoms of gastroesophageal reflux disease (GERD), heal 
erosive oesophagitis, reverse the metaplastic mucosa, prevent complications and detect 
dysplasia at an early stage. The final goal is to reduce the risk of progression to 
adenocarcinoma. These goals can be achieved by active management of gastro- 
oesophageal reflux and surveillance for malignancy. Patients with BE are known to have 
more reflux as compared to patients with uncomplicated GERD. Aggressive medical
11
management (i.e. pharmacological acid suppression) and possibly surgical fundoplication 
(surgical procedure which involves the wrapping of the upper part of the stomach around 
the lower end of the oesophagus to prevent reflux) are important components of the 
overall treatment of patients with Barrett’s oesophagus.
1.241 MEDICAL MANAGEMENT
Medical treatment involves the use of histamine-2 receptor blockers and proton pump 
inhibitors (PPI). The pharmacological agents do not prevent reflux but suppress gastric 
acid production and thereby reduce the volume and frequency of reflux. The goal of the 
treatment is to raise the intra-gastric pH above 4 during the periods of the day when 
reflux occurs (Hunt 1999). H2  blockers work by blocking the histamine stimulation of 
parietal cells, thereby reducing basal and, to a minor degree, postprandial acid 
production. The doses of H2 blockers required to control GERD symptoms and heal 
oesophagitis are two to three times higher than those needed for the treatment of peptic 
ulcer disease. The H2 blockers are found to be about 50% effective in healing and 
controlling the symptoms (Sabesin et al, 1991; Sabesin SM 1991). Various PPIs like 
esomeprazole magnesium, lansoprazole, omeprazole, pantoprazole sodium, and 
rabeprazole sodium have been used in the management of GERD. The PPIs irreversibly 
bind and inhibit the H+, K+-Adenine Triphosphatase (ATPase) in the canalicular 
membrane of the parietal cells. The H+, K+ Adenine Triphosphatase (ATPase) proton 
pump is the final common pathway through which most stimuli act to induce the 
secretion of the gastric acid. At the recommended doses they are all found to have similar 
pharmacologic activity (Sachs 1997). Large controlled studies, have shown that one of 
the newer PPI, esomeprazole has significantly higher healing rates and symptom relief in
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patients with erosive oesophagitis, compared with omeprazole, lansoprazole and 
pantoprazole (Labenz et al, 1997). The PPIs are found to be more effective in treatment 
of oesophagitis with faster healing rates compared to the H2-blockers (11.5% per week 
versus 6.4% per week for H2 blockers) (Klinkenberg-Knol et ah, 1994; Chiba 1997). 
Maintenance therapy with PPIs is often required at the same dosage as used for 
oesophageal healing in order to prevent recurrence (Vigneri et al, 1995). Use of these 
pharmacological agents has been shown to be effective in relieving symptoms and 
healing oesophagitis (Hallerback et al., 1994; Sampliner 1994). Studies conducted by 
Sampliner have shown that patients can still have abnormal 24hr pH in spite of treatment 
with high doses of PPI (Sampliner 1994). Studies have shown that long term treatment 
with PPIs can cause partial regression of BE (Peters et al., 1999; Weston et al., 2000). 
Complete regression of BE following long-term medical treatment is very rare and has 
not shown to alter the risk of progression to BE (Cooper 1982; Sharma et al., 1997; 
Wilkinson et al., 1999).
A number of prokinetic agents (bethanechol, metoclopramide, and cisapride) have also 
been used in the treatment of GERD. These agents act by either increasing lower 
oesophageal sphincter pressure, enhancing gastric emptying or by improving the 
peristalsis. One of these agents, cisapride, has been found to have similar efficacy to H2 
blockers in the treatment of mild oesophagitis when used as the primary agent and some 
facilitating effect when used in conjunction with these drugs (Galmiche et al., 1988; 
Richter 1989; Hatlebakk et al., 1997). More recently NSAIDS (COX-2 inhibitors) have 
been used in the treatment and chemoprevention of BE. The use of NSAIDS is based on 
the evidence that COX-2 is over-expressed in patients with BE and OADC. Studies have
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demonstrated that use of a COX-2 inhibitor normalizes not only proliferation in vitro and 
in vivo, but COX-2 over expression is normalized as well (Buttar et al, 2000; Kaur BS 
2002). It has been shown that specific COX-2 inhibitors can decrease the incidence of 
cancer in animal models (Buttar et al, 2002). Studies have shown that use of NSAID’s 
can bring about 38%-90% reduction in the relative cancer risk (Thun et al, 1993; 
Funkhouser et al, 1995; Farrow et al, 1998; Langman et al, 2000). Better designed 
studies are required to prove the effectiveness of the COX-2 inhibitors.
1.242 SURGICAL MANAGEMENT
Unlike medical management which aims at reducing the gastric acid secretion surgical 
management aims at restoration of the lower oesophageal sphincter. Surgical 
management consists mainly of fundoplication and can be performed either 
laproscopically or as an open procedure. The surgical procedures aim at providing an 
appropriate length of intra-abdominal oesophagus, repairing the hiatal defect, and 
creating a loose, “floppy” fundoplication. Current experience with anti-reflux surgery 
suggests that there is no one best operation for all patients. Factors such as the degree of 
oesophageal shortening, disturbances of oesophageal motility, prior operations, and 
surgeon’s skill decide the type of operation. Studies have shown that surgical procedures 
tend to offer a superior control of reflux compared to medical management (DeMeester et 
al, 1986; Spechler 1992; Peracchia et al, 1995). Correctly performed anti-reflux surgery 
early during the course of GERD prevents the development of BE (DeMeester 2002). 
Although there are considerably more reports of regression following anti-reflux surgery, 
regression is rarely complete and occurs in only 10-44% of patients (Caygill et al, 2004).
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Although surgical therapy has been found to have slightly better results than medical 
therapy, neither of them has shown to have a major impact on the progression of BE to 
adenocarcinoma. While some people ((Low et al, 1999; Hofstetter et al, 2001; Oberg et 
al, 2001) believe that fundoplication causes regression of Barrett’s there are others 
who believe that fundoplication has no effect on the reversal of Barrett’s (Cheu et al, 
1992; McDonald et al, 1996; Csendes et al, 1998; Gutschow et al, 2002). Some people 
believe that the refractory nature of the disease could be due to ongoing reflux, especially 
bile reflux, which may contribute to metaplastic changes (DeMeester 2002). There are 
reports of high grade dysplasia and adenocarcinoma after surgery and evidence that there 
is an increased rate of failure of anti-reflux surgery in patients with BE compared to 
patients with uncomplicated GERD (Williamson et al, 1990; Little 1994; Csendes et al, 
1998). This could probably be due to the contribution of other agents such as bile acids in 
the pathogenesis of BE. Owing to this Csendes et al have tried more aggressive antireflux 
procedures such as duodenal switch operation (Csendes et al, 1998). More recently 
Csendes et al, (Csendes et al, 2002) found that surgery of acid suppression and bile 
diversion (i.e. truncal vagotomy with anterectomy and Roux-en-Y gastrojejunostomy 
with fundoplication) had the best results in patients with recurrent reflux after surgery.
1.243 NEWER TECHNIQUES FOR ERADICATION OF BARRETT’S
A number of new endoscopic reversal techniques have been used for the reversal and 
eradication of BE. These methods involve selective and complete ablation of BE leaving 
the underlying layers intact whilst trying to keep the pH above 4 by the simultaneous use 
of PPI’s or by anti-reflux surgery (Barbezat 2000; Sharma 2001). Various ablation
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techniques include thermal coagulation (multipolar electrocoagulation, bipolar 
electrocoagulation, heater probe, argon beam plasma coagulation) lasers (Nd:YAG and 
KTP), photodynamic therapy and endoscopic resection (Lim et al, 1999). Regression of 
BE has been shown with ablation techniques with squamous re-growth. However 
evidence of metaplastic islands buried underneath the squamous undergrowth was found 
by some of the investigators (Berenson et al., 1993; Barham et al, 1997). The endoscopic 
techniques include photodynamic therapy (PDT), laser photocoagulation, argon plasma 
coagulation electrocoagulation and cryotherapy.
Photodynamic therapy is a non-thermal chemical ablation method which is based on the 
action of visible light on a previously administered photosensitizer which has been taken 
up by the tissue. The photo sensitizers used in Barrett’s include hematoporphyrin 
derivative (HpD) or Photofrin (porfimer sodium) and 5-amonolevulinic acid (ALA). ALA 
has been found to be ideal in Barrett’s metaplasia because its intermediate compound 
protoporphyrin IX (PpIX) which is a photoactive compound is selectively produced by 
oesophageal mucosa (Gossner et al, 1998). ALA can be given orally and produces 
superficial damage with minimal scarring and subsequent stricture formation. Lasers are 
the most commonly used light source in the PDT. This is normally delivered by fiber 
placed endoscopically in the lumen of the oesophagus. Varying degrees of eradication of 
BE with re-epithelialisation has been reported with PDT. Studies have shown islands of 
buried columnar glands in patients with re-epithelialisation (Kelty et al, 2002). Owing to 
the short follow-up periods these results have to be viewed with caution.
Endoscopic mucosal resection has been used in the staging and treatment of patients with 
Barrett’s oesophagus (Soehendra et al, 1997; Ell 2000). This has been used in
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management of early localised cancers. Further studies and long-term follow up are 
required before any conclusive remarks can be made about this technique.
Most of the mucosal ablative methods are in experimental stage and none of them have 
been shown to reduce or eliminate the cancer risk.
1.244 ENDOSCOPIC SURVEILLANCE OF BARRETT’S
Endoscopic surveillance forms one of the main components of management of patients 
with Barrett’s metaplasia. It is based on the assumption that BE adversely affects survival 
and that surveillance can detect early and curable cancers. These assumptions are 
controversial with a lack of strong evidence to support them. Though surveillance can 
detect early cancers its reliability and efficacy in improving survival from oesophageal 
cancer remains unclear (Spechler 2000). Sampling error is one of the factors which 
adversely affect endoscopic surveillance. The sensitivity of endoscopy could be increased 
by using the protocol of taking four quadrant biopsies at 2 cm interval with a jumbo 
biopsy forceps (Cameron et al, 1997). A number of newer techniques such as 
chromoendoscopy, endosonography and fluorescent techniques have been used to detect 
BE in-spite of which sampling error still remains a problem. Another factor which 
adversely affects surveillance is the fact that the prevalence of symptomatic GERD is 
high in the general population while the prevalence of BE is very low in patients with 
symptomatic GERD. Hence only a very small percentage of patients (5%) with BE in the 
general population are detected by endoscopy whilst vast majority of patients with BE 
(95%) remain undetected due to asymptomatic GERD (Sontag 2001). Surveillance aims 
at reducing morbidity and mortality by treatment and early detection of BE and treatment 
of high grade dysplasia and oesophageal adenocarcinoma. . The current BSG guideline
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recommends that when surveillance of nondysplastic CLO (columnar line epithelium) is 
considered appropriate, it should be performed every 2 years (BSG Guidelines in 
Gastroenterology, Aug 2005). Patients with LGD are managed by extensive acid 
suppression for 8-12 weeks followed by extensive re-biopsy. If the changes persists 
surveillance should be carried six monthly. Persistent HGD may be associated with 
invasive adenocarcinoma in 30-40% of the patients. If the diagnosis is confirmed by two 
pathologists and the patient is fit oesophagectomy is recommended. In those unfit for 
surgery endoscopic ablation or mucosal resection should be considered (BSG Guidelines 
in Gastroenterology, Aug 2005).
1.3 GENETIC CHANGES IN BARRETT’S
Below is a brief overview of the cell cycle followed by summary of the main candidate 
genes implicated in cancer development in patients with BE.
1.31 CELL CYCLE AN OVERVIEW
Knowledge of the cell cycle and its control is central to the understanding of most 
carcinogenic processes. A brief overview of the cell cycle and its control and the various 
stages affected in Barrett’s oesophagus is given below. The cell cycle is the process 
through which the cells grow and duplicate themselves. This involves the accurate 
duplication of DNA and their faithful distribution to the two daughter cells. The 
Mammalian Cell Cycle consists of four discrete phases namely Gl, S, G2 and M phase 
(see figure 1.3).
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G1 Phase (Gap-1):
G1 phase is characterised by cell growth and protein synthesis. This is the only part of the 
cell cycle regulated by external stimuli (growth factors and mitogens).
S Phase (synthesis phase):
This is the phase of DNA replication. After completion of DNA replication the cell enters 
the G2 phase.
G2 phase:
During this phase the cell undergoes growth and protein synthesis.
M Phase:
Mitosis is characterised by the following stages (see figure 1.4): - 
Prophase:
During prophase the chromosomes condense and become visibly distinct. Prophase ends 
when the nuclear envelope breaks down, abolishing the distinction between nucleus and 
cytoplasm. By late prophase the two chromatids move towards the poles and form a 
mitotic spindle.
Metaphase:
The discrete chromatid pair takes places in the centre of the mitotic spindle. The 
chromatids are tightly coiled and discrete.
Anaphase:
During this phase the sister chromatids separate and move to the opposite poles.
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Telophase:
Telophase is characterized by reconstruction of the nuclear membrane around each 
daughter nucleus. This is followed by cytokinesis which is the division of the 
cytoplasmic part of the cell. In rapidly replicating human cells the full cycle lasts about 
24 hours, with G1 9 hours; the S phase 10 hours; G2 phase 4.5 hours and mitosis about 
30 minutes (Lodish et al, 2000).
1.32 CANCER AND CONTROL OF CELL CYCLE
Cancer cells arise from normal cells by progressive acquisition of mutations over a period 
of time. These multiple genetic alterations can involve genes that control various aspects 
of cell proliferation, differentiation and apoptosis [reviewed by (Bertram 2000; Bell et al, 
2005). Mutations can lead to activation of genes which stimulate cell proliferation or 
inhibit apoptosis (Oncogenes) or inactivation of genes which normally inhibit cell 
proliferation (tumor suppressor genes). Uncontrolled cell proliferation is the hallmark of 
cancer. Loss of cell cycle control is the major defect encountered in most cancers. Many 
of the genes mutated in human cancers are directly involved in the regulation of cell cycle 
[reviewed by (Bell et al, 2005)]. The point between the early G1 and late G1 phase that 
represents an irreversible commitment to undergo one cell division is termed the 
restriction point. The restriction point divides the cell cycle into a mitogen dependant 
(growth factor), early G1 phase and a growth factor independent phase (late G1 through 
mitosis). Oncogenic processes exert their greatest effect by targeting particular regulators 
of G1 phase progression. G1 progression depends on stimulation by mitogens. Passage
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through the restriction point and entry into S phase is controlled by cyclins, cyclin 
dependant kinases (Cdks) and the Rb protein.
1.321 THE RETINOBLASTOMA GENE
The key player in G1 phase cell cycle control is the Rb protein, which is the product of 
retinoblastoma the gene. Rb gene was the first tumour suppressor gene to be identified 
well over a decade ago (Friend et al., 1986). The Rb protein is a 928 amino acid phospho- 
protein, which arrests the cells in the G1 phase (Weinberg 1995). In cycling cells the 
retinoblastoma protein (pRb) is un- and/or hypo—phosphorylated in early G1 and 
becomes hyper-phosphorylated (inactive form) on late Gl. The hypo-phosphorylated Rb 
is the active form, which suppress cell proliferation in Gl phase. Phosphorylation of Rb 
inactivates the growth suppressive function of Rb allowing the cells to progress through 
the restriction point [reviewed by (Harbour et al., 2000; Mittnacht 2005)]. The Rb protein 
forms complexes with the E2F family of transcription factors and inhibits the 
transcription of E2F regulated genes (see figure 1.5). E2F consists of a heterodimeric 
complex of an E2F polypeptide and the DP protein. The phosphorylation of Rb results in 
its dissociation from E2F leading to activation of E2F target genes. E2F is a potent 
stimulator of cell cycle entry. E2F target genes include the ones required for Gl cycle 
progression and DNA synthesis such as:
• C-myc, B-myb, Cyclin E, Cdc2 and those encoding thymidine kinase, 
dihydrofolate reductases, DNA polymerase.
• P19ARF (involved in apoptosis)
DNA damage
ATM/ATR DNA-PK
p63
p,5 y
MAPK
P27
fi-catenin myc
Cyclin £ ■GSK3|i
" / ( Cydin D
Cdk2
Cdk4/6
Cdk7
R!) Transcrtotion of 
S-phase genesE2F
E2F
E2F targe: genes
Figure 1.5 Mechanisms controlling S-phase initiation in animal cells. The cyclin/cdk  
com plex becom es activated by phosphorylation in specific residues o f  the catalytic subunit o f  the 
cdk by another cdk, cdk7/cyclinH , also known as‘cdk activating kinase’ (CAK) (red).These 
com plexes are in turn regulated by a stoichiometric combination with small proteins. These 
proteins, called cyclin-dependent kinase inhibitors(CKls), include p l6ink4a, p l5ink4b, 
pl8 in k 4c, p!9ink4d, p 21w afl, p27Kip 1 and p57kip2(yellow). DNA synthesis (Sphase) occurs 
when Rb is phosphorylated by active cdk4 and/or cdk6 releasing the transcriptional factor E2F 
from Rb allowing cells to progress to Sphase. Arrest o f  cells at G l follow ing DNA damaging 
agents are due to the transcriptional activation o f  the tumor-suppressor gene p53, leading to the 
up regulation o f  p21, there by inhibiting cdks. R, Restrictionpoint. Adapted from Senderowicz et 
al, 2004.
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Thus activated E2F promotes Gl-S transition and DNA synthesis through transcription 
factors. The phosphorylation of Rb is brought about by Cdk/cyclin D complexes (blocked 
by p i6 CDK inhibitor). The E2F’s are regulated by two pRb family members -  p i30 and 
p i07 during GO and S phase respectively.
Allelic loss of the Rb gene occurs late in the metaplasia-dysplasia-carcinoma sequence in 
BE (Sarbia M 2001). About 50% of Barrett’s adenocarcinoma’s show loss of the 13q 
allele (Boynton et al., 1991). Decrease in the size of Rb m-RNA transcript and quantity 
have also been seen in patients with Barrett’s dysplasia and cancer (Huang et al, 1993). 
There are no studies which have demonstrated mutation of Rb gene either in Barrett’s 
metaplasia or Barrett’s adenocarcinoma.
1.322 CYCLIN-CDK COMPLEXES
Entry into the S phase of cell cycle depends on the activation of cyclin dependent 
kinases(CDKs).Cyclins are a diverse family of proteins which bind and different 
members of the CDK family [reviewed by (Evan et al, 2001; Sanchez et al., 2005)]. The 
concentration of most cyclins changes during various stages of the cell cycle, resulting in 
oscillations of CDK activity that forms the foundation of the cell-cycle control system. 
The regulation of cyclin concentration is primarily by changes in cyclin gene expression 
and cyclin proteolysis, and hence is of fundamental importance in cell-cycle control.
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Cyclins D1 and E are proto-oncogenes. Over expression of these cyclins leads to 
phosphorylation and inactivation of pl05-Rb.Amplification of cyclin D1 gene (located in 
llq l3 ). Arber et al showed that there was an increased nuclear expression of cyclin D1 
in patients with Barrett's oesophagus (34%) compared to normal squamous controls 
(Arber et al, 1996). Recent studies have shown that amplification cylcin D1 occurs in 
early stages of barrett’s and is found to correlate negatively with survival (Miller et al, 
2003; Trudgill et al, 2003). Overexpression of cyclin E has not been found in early 
stages of BE and low grade dysplasias. However, Sarbia et al showed cyclin E was 
over-expressed in 10% of cases with low grade dysplasia, 18% of those with high-grade 
dysplasia, and in 14% of adenocarcinomas in Barrett's oesophagus (Sarbia et al, 1999).
1.323 CDK REGULATION BY CDK INHIBITORS (CKIs)
The activity of CDK is extensively regulated by Cdk inhibitor proteins (CKIs) that bind 
and in-activate various Cdks and cyclin-Cdk complexes.Based on their structures and 
affinities two families of CKIs have been identified. Members of the Cip/Kip family(p21, 
p27, and p57) inhibit CDK2 while members of the INK family(pl5, p i6, p i8) inhibit 
CDK4 and CDK6 (Sherr et al, 1999; Vidal et al, 2000).
1.324 THE p l6  GENE (INK4a/ARF)
The p i6 gene is located on chromosome 9p21 and belongs to the INK4 family of CKIs. 
The pl6 gene encodes the CDKI, which regulates progression through Gl/S of the cell-
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cycle by binding CDK 4/6, and so limits CDK 4/6-cyclin D complex formation and 
phosphorylation of Rb. This locus also encodes pl4ARF, which functions to sequester 
MDM2 and inhibit p53 degradation (Sharpless 2005). p i6 and pl4ARF have unique 
promoters and first exons but share common second and third exons. Alteration in the 
shared exon region can affect the function of both genes simultaneously. Alterations of 
p 16 are reported in various human malignancies, exceeded in frequency only by the p53 
tumor suppressor gene. Loss of p i6 basically mimics cyclin D1 over-expression. 
Homozygous deletion, point mutation, and hypermethylation of the promoter region of 
pl6 have been described (Barrett et al, 1996; Wong et al., 2001).
1.33 INVOLVEMENT OF MITOGENIC SIGNALLING PATHWAYS
1.331 C-erbB2 (HER-2/neu) and EGFR
The C-erbB2 (also called HER-2/neu) is located on the chromosome 17q21 and encodes 
for the epidermal growth factor receptor (EGFR) which belong to subclass 1 of the 
receptor tyrosine kinase superfamily (Normanno et al, 2006). The ErbB receptors and 
their ligands play a fundamental role in development, proliferation, cell differentiation 
and carcinogenesis. CerbB2 and its ligands have been implicated in the development of 
OADC and BE (Jankowski et al, 1992). The amplification of this gene occurs at a late 
stage (Nakamura et al, 1994). In one study, 10% of adenocarcinomas and 31% of high 
grade dysplasias in Barrett's oesophagus exhibited erbB-2 overexpression (Kim et al, 
1997). Overexpression of erbB-2 in oesophageal adenocarcinomas has been associated 
with a poor outcome and a poor overall survival rate (Brien et al, 2000).
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1.332 TRANSFORMING GROWTH FACTOR p SIGNALLING
Transforming growth factors are a large family of highly conserved growth regulatory 
polypeptides which govern a number of biological activities including cellular growth, 
differentiation and adhesion (de Caestecker 2004). Its effects on cell growth vary 
depending on the cell type and growth conditions and could be either stimulatory or 
inhibitory [Reviewed by (Massague et al, 2000; de Caestecker 2004)]. TGF-P plays an 
essential role in a wide array of cellular processes. Transforming growth factor beta 
(TGFp) is a potent anti-proliferative agent acting through two receptors (TGFpRI and 
TGFpRII) which transduce downstream signals via cytoplasmic transcription factors 
called Smad proteins (derived from Sma- and Mad- related protein). The loss of function 
of TGFp signalling in Barrett's associated adenocarcinoma could be related to Smad 4 
mutations (Lebman et al, 2002; Onwuegbusi et al, 2005) or to the loss of mRNA 
expression of TGFpRII (Garrigue-Antar et al, 1996).
1.34 TUMOR SUPPRESSOR GENES
1.341 THE ROLE OFTHE p53 TUMOUR SUPPRESSOR GENE
p53 was the second tumour suppressor gene to be characterised after Rb and is located on 
the short arm of chromosome 17 (17pl3). It is the most commonly mutated gene in most 
human cancers (Sherr et al, 2000; Yee et al, 2005). Activation of p53 results in 
increased transcription of genes involved in DNA repair, Gl arrest and apoptosis. The 
p53 protein is a transcription factor that enhances the rate of transcription of six or seven 
genes. The human p53 protein contains 393 amino acids. The activation of p53 is 
negatively regulated by the MDM2 protein (see figure 1.6).
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PRODUCTS OF GENES TRANSCRIPTIONALLY ACTIVATED BY P53
P21/WAF1, Cipl Inhibits several cyclin-cyclin dependent kinases.
MDM2 product of an oncogene; inactivates p53-mediated 
transcription
GADD45 Induced upon DNA damage, binds to PCNA and can arrest the 
cell cycle. It is is involved in the DNA nucleotide excision 
repair
CYCLING Novel cyclin of unknown function and no known cyclin 
dependent kinase.
BAX A member of the BCL2 family that promotes apoptosis.
IGF-BP3 The insulin like growth factor binding protein 3; blocks 
signalling of a mitogenic growth factor.
The p53 protein is normally kept at a low concentration by its short half life (about 20 
minutes). p53 is stimulated by several types of DNA damage and hypoxia. p53 is also 
activated when the ribonucleoside triphosphate pool falls below a critical threshold. DNA 
damage activates the ATM protein (mutated in ataxia telangiectasia) which in turn can 
activate p53 either by direct (phosphorylation) or indirect means (initiates 
phosphorylation cascade). p21, which is one of the downstream transcription products 
binds to a number of cyclin and cdk complelxes and inhibits phosphorylation. It also 
binds to PCNA (Proliferating Cell Nuclear Antigen). p21 by its interaction with cyclins 
and PCNA stops DNA replication (Meek 2004).
STIMULI
PARP, ATM,NBS,BLS,FAS, 
BIOCHEMICAL 
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FIGURE 1.6 SHOWING THE COMPONENTS OF P53 SIGNALLING PATHWAY 
(Adapted from Agarwal et al., 1998 )
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Transcription of Gadd45 (growth arrest and DNA damage-inducible) by activated p53 
produces a protein which can recognize an altered chromatin state and cause de- 
stabilisation of histone-DNA interactions by interacting directly with the four core 
histones. This enables increased acessability of damaged DNA to proteins involved in 
repair processes. Gadd45 also causes G2 arrest by direct interaction with Cdc2 proteins 
which results in dissociation of Cdc2-cyclinBl complex.
1.3411 P53 AND APOPTOSIS
A number of factors affect the decision of the cell to enter the p53 mediated cell cycle 
arrest or apoptotic pathway [reviewed by (Hengartner 2000; Hickman et al, 2002)]. 
When the genomic damage is significant and non-repairable, p53 levels continue to rise 
til caspases cascade leading to apoptosis.Recent studies have also shown that p53 can 
induce apoptosis by translocation into the mitochondria (Murphy et al, 2004). 
p53 Alterations (mutation, LOH) occurs later in the disease progression and is 
associated with increased risk to progression to OADC (Paulson et al, 2004; Novotna et 
al, 2006).
P53 mutations frequently occur in BE [(with mild or no dysplasia ) 30-66%] and OADC 
(40-88%) (Doak et al, 2003). Mutated p53 molecules have an altered conformation and 
do not form a complex with MDM2 and are therefore not degraded and accumulate inside 
the cell. This is detected by immunohistochemistry and is seen in LGD (7%), HGD (30- 
60%) and OADC (45-85%) but not in patients with BE (Doak et al, 2003). LOH of 17p 
(the p53 locus) increased from 6% in patients without dysplasia to 57% in HGD (Reid et 
al, 2001). Accumulation of p53 protein was found to be common in patients with BE 
(Segal et al, 2004). However studies have shown that p53 accumulation seen detected
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by immunohistochemistry does not correlate with presence of p53 mutation and the exact 
mechanism for accumulation of p53 protien is yet to be determined (Doak et al, 2003).
1.3412 MDM2 (MURINE DOUBLE MINUTE-2 GENE)
MDM2 negatively regulates p53 in several ways (Levine 1997; Murphy et al, 2004). 
Firstly its binding with P53 interferes with p53’s ability to transactivate target genes. 
Secondly MDM2 has an intrinsic ubiquitin ligase activity which contributes to p53 
degradation. Thirdly it relocalizes p53 from the nucleus to the cytoplasm where it 
undergoes proteosomal degradation. MDM2 is inhibited by ARF (pi9 ARF). ARF can 
antagonize any or all of the adfore mentioned functions of MDM2. Therefore, activated 
ARF keeps p53 induced, active, mostly confined to the nucleoplasm and hence stable. 
MDM2 amplification has been seen in patients with oesophageal adenocarcinoma 
(Morgan et al., 1999). Soslow et al (Soslow et al., 1997) found that significant expression 
of MDM2 occurred only in cases with wild-type p53, whereas the cases with mutated p53 
showed little if any expression of MDM2. Studies have shown increased expression of 
MDM2 in areas specialised intestinal metaplasia compared to normal squamous mucosa 
(Fujii et al, 2003).
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1.342 RAS AND CELL CYCLE REGULATION
Ras genes are among the most frequently activated oncogenes in cancer. They were the 
first oncogenes to be implicated in human cancer. Mammalian cells encode three 
functional ras genes: H-ras, K-ras and N-ras all of which show a similar structure and 
function [Reviewed by (Takuwa et al., 2001; Cox et al., 2002)]. The Ras proteins are 
proto-oncogene products that are critical components of signalling pathways leading from 
cell surface receptors to the control of cellular proliferation, differentiation or cell death. 
K-ras mutation is common in several human cancers. K-ras codon 12 mutation is found in 
about 70% of pancreatic cancers and 50% of colorectal cancers. Role of ras in 
progression of BE is uncertain. Mutation of codon 12 of kras was seen in BE (0.4%), 
dysplasia (4%) and oesophageal cancer (36%) (Trautmann et al., 1996). K-ras mutation 
appears to be a late event in the progression of BE to OADC although no correlation has 
been established with prognosis or evolution of the disease (Kyrgidis et al, 2005).
1.343 THE APC GENE
The APC gene (Adenomatous polyposis coli gene) is located on chromosome 5q21. 
Germ line mutation in the APC gene results in familial adenomatous polyposis, which is 
a dominantly inherited disorder that predisposes patients to colorectal cancer. APC 
mutation is also seen in about 80% of sporadic colorectal cancers (Bienz et al., 2004). 
The major function of APC is the negative regulation of p-catenin levels. P-catenin is 
involved in both the E-Cadherin cell adhesion system and the Wnt-1 signalling pathway. 
Studies have shown that APC gene mutation can occur in patients with oesophageal 
adenocarcinoma though it is not as common as in colon cancer (Kyrgidis et al, 2005).
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LOH of APC gene locus and hyper-methylation of APC gene has been reported in 
patients with BE with dysplasia (Bektas et al, 2000; Kawakami et al., 2000).
1.35 CHROMOSOMAL STRUCTURE
Chromosomes are distinct dense bodies found in the nucleus which are composed of 
protein and DNA. The DNA carries the genetic information of the cell. Each 
chromosome consists of a single, continuous linear double-stranded DNA molecule. The 
DNA molecule of the chromosome is found as a complex with a family of basic 
chromosomal proteins called histones and with a heterogeneous group of acidic, non­
histone proteins. The complex of DNA and protein together are called chromatin. During 
most of the cell cycle (i.e. interphase) the chromosomes are less condensed and are not 
visible as individual objects under the light microscope. The chromosomes are visible 
during the metaphase of cell division as dark dense bodies as they become highly 
condensed. Five major histones are involved in the packaging of the chromatin (HI, 
H2A, H2B, H3 and H4). The basic unit of chromatin structure is called nucleosome. Each 
nucleosome consists of an octamere made up of two copies each of the four core histones 
namely H2A, H2B, H3, and H4 (see figure 1.7). The DNA double helix winds round the 
histone core making almost two turns. Approximately 140 base pairs of DNA are 
associated with each histone core and they are called the core DNA. The linker or the 
spacer DNA (20 to 60 base-pair) which is associated with HI histone connects one 
nucleosome to the other. This gives chromatin the beads on a string appearance. The long 
strings of nucleosomes are further condensed into 30-nm-diameter cylindrical fibers 
called “solenoid” fibers”. The solenoids are further packed into loops or domains 
attached at intervals to a nonhistone protein scaffold or matrix. During metaphase the
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condensation starts at the centromere, which is composed mainly of matrix fibers, and 
ends at the telomeres.
1.35 CANCER AND CHROMOSOMAL MUTATION
Cancer is a genetic disease of the somatic cells and is characterised by deviations of the 
normal genetic mechanism which regulate the cell growth. Uncontrolled cellular 
proliferation is the hallmark of cancer cells. Carcinogenesis is a complex multi-step 
process in which a succession of genetic changes, each conferring one or another type of 
growth advantage, leads to the progressive conversion of normal human cells into cancer 
cells (Foulds 1954; Nowell 1976). It is well accepted that the fundamental features of 
cancer is tumour clonality, which involves the development of tumours from single cells 
that begin to proliferate abnormally. The initial step in carcinogenesis is called 
INITIATION during which a normal cell undergoes an irreversible genetic change which 
confers on it the capacity for autonomous growth. Initiation can occur following a single 
exposure to a carcinogen, and the changes, though irreversible, can remain latent for a 
long period of time (weeks to months or longer if promotion does not occur). The next 
step involves promotion in which the initiated cells, upon repeated exposure to specific 
agents (promoters), become expanded to a visible population (Cooper et al, 1995). One 
or more of the clonally expanded initiated cells, as a result of additional mutations, 
evolve into a cancer cell. This cell again undergoes clonal expansion, and through further 
changes becomes progressively malignant. This process of development of an initiated 
cell into biologically malignant cell population is called tumour progression.
(FIGURE 1.7 SHOWING THE STRUCTURE OF CHROMOSOME 
Modified from Alberts et al., 2002
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1.36 TYPES OF CHROMOSOMAL MUTATION
Chromosomal aberrations are common in cancer. David von Hansemann in 1890 was the 
first to describe the occurrence of aberrant mitoses in cancer cells. A few decades later 
Theodor Boveri in his Zur Frage der Entstehung Maligner Tumoren (“The Origin of 
Malignant Tumours” 1914) postulated that cancer originates as a consequence of 
disturbance in chromosomal balance. Chromosome aberrations could be either in the 
form of variation in chromosome number or variation in chromosome structure. 
Aberrations in chromosome structure occur following breakage of the chromosome. 
Chromosome breakage could be either spontaneous or induced by mutagenic agents such 
as ionizing radiation, ultraviolet light, viruses and chemical agents. The broken ends of a 
chromosome are sticky and tend to rejoin. Change in the chromosome structure can be in 
the form of deletions, duplication, translocation and inversion.
1.361 STRUCTURAL CHROMOSOMAL ABERRATIONS
1.3611 DELETIONS
Deletions can arise from either a single or double break in the chromosome. Double 
breaks can produce interstitial deletion while a single break can produce a terminal 
deletion. If the double break occurs in the different arm of the chromosome it can lead to 
the formation of a ring chromosome. Chromosome deletions can vary in size from few 
base pairs to many mega base pairs. The effect of deletion depends upon the size of the 
deletion. A small deletion within a gene, called an intragenic deletion, inactivates the 
gene. Larger deletions (multigenic) involving two to several genes can be lethal or have
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very severe consequences. Homozygous deletions of essential segments can be lethal. 
Heterozygous deletions could be lethal or can uncover recessive alleles, causing them to 
be expressed phenotypically. An example is cri du chat syndrome caused by 
heterozygous deletion of the short arm of of chromosome 5 which is characterised by 
physical and mental retardation and striking cry that resembles that of a cat (Griffiths et 
al., 2002). Deletion of tumour suppresor gene can lead to cancer. Deletion of 13ql4 can 
lead to Retinoblastoma (Heim S 1995). Deletions are common in epithelial 
adenocarcinomas and are usually multiple in numbers.
1.3612 DUPLICATION
Duplication is an aberration in which a segment of a chromosome is repeated and thus is 
present in more than one copy within the chromosome. The chromosomal segment may 
be repeated side by side in an original order (tandem duplication) or in a reverse order 
(reverse tandem). The duplicated segments can be in a novel location on the same 
chromosome or on another chromosome. Duplications are generally rare and hard to 
detect. Most duplication consists of an extra chromosomal arm or part of an arm, 
generally attached to a non-homologous chromosome (Griffiths et al., 2002). 
Duplications may or may not be lethal. Pallister Killian syndrome characterised by 
mental and physical retardation is associated with duplication of short arm of 
chromosome 12 (Adachi et at, 2003). In fact duplications can provide additional genetic 
material which can carry out new functions (evolutionary significance).
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1.3613 INVERSION
Inversion is a chromosomal mutation in which the chromosomal segment is turned 
around by 180°. Inversions can either be pericentric (when the inverted segment involves 
the centromere) or paracentric when the inverted segment involves the chromosome arm 
without including the centromere. Genetic material is not lost following inversion. If the 
break points occur within a gene or a region which controls gene expression then 
inversion can lead to phenotypic consequences. Though duplication and inversion are 
both rare, like translocation, it can cause abnormal juxtaposition of genetic materials 
resulting in the formation of chimeric genes producing abnormal proteins that can initiate 
neoplasia. Inversion of RET (rearranged during transfection) proto-oncogene on 
chromosome 10 leads to the formation of oncogene RET/pfc which is found frequently in 
the papillary carcinoma of the thyroid (Kufe, et al., 2003).
1.3614 TRANSLOCATION
Translocation involves change in the position of the segment of chromosome and the 
gene sequence contained in it. Translocation does not involve loss or gain of genetic 
material. Translocation can occur within the same chromosome (intra-chromosomal 
translocation) or between two non-homologus chromosomes (inter-chromosomal 
translocation). If the transfer occurs in one direction it is called non-reciprocal 
translocation and reciprocal translocation when it involves exchange of segments 
between the two chromosomes. Reciprocal translocations are the commonest type of 
translocation. Translocations are quite common in leukemias and sarcomas and 
sometimes may be the only genetic change seen in these tumours. The Philadelphia
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chromosome in chronic myeloid leukaemia is a good example of translocation. Its 
characterised by the movement of Abelson proto-oncogene (ABL) which is normally on 
chromosome 9 next to the breakpoint cluster region (BCR gene) on chromosome 22 [t 
(9;22)(q34;qll)] (Kufe et al, 2003).
1.372 NUMERICAL CHROMOSOMAL ABERRATION
1.3721 ANEUPLOIDY
Aneuploidy is characterised by gain or loss of individual chromosomes from the normal 
diploid set of 46. Monosomy (i.e. loss of a chromosome) is rare in humans and the vast 
majority of them abort spontaneously. Most cases of aneuploidy are due to non- 
dysjunction during mitosis or meiosis. It has been shown that aneuploidy is the most 
prevalent genetic change recorded among over 20,000 solid tumours analyzed so far 
(Mitelman 1994). Whether aneuploidy is the cause or consequence of cancer it has been 
the subject of a long standing debate. There is increasing evidence accumulating in 
favour of aneuploidy as a discrete chromosome mutation event that contributes to 
malignant transformation and tumour progression. Studies have shown that the genetic 
instability of cancer cells is due to aneuploidy and that aneuploidy is a transformation- 
related event, because it precedes malignant transformation (D.A. Eastmond 1989; 
Duesberg P 2000; Li R 2000). Aneuploidy has been shown to be a dynamic chromosome 
mutation event which is associated subsequently with increased rate of chromosomal 
instability. It has been shown that the rate of subsequent chromosomal aberration is 
proportional to the degree of pre-existing aneuploidy (Duesberg et al, 1998).
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1.3722 MECHANISMS LEADING TO ANEUPLOIDY
The two most important mechanisms leading to aneuploidy are chromosome non- 
dysjunction and chromosome loss. Other mechanisms that can lead to aneuploidy include 
non-conjunction, defective centromere division or extra replication of chromosome 
(Kirsch-Volders et al, 2002). Mitosis is an important process of the cell cycle which is
j
I characterised by irreversible segregation of sister chromatids to the daughter cells. 
Defects in the mitotic-spindle checkpoint and sister-chromatid separation pathways which 
i maintain the fidelity of the process can lead to chromosomal instability and aneuploidy. It 
■is important to know the basic biology of the mitotic-spindle checkpoint and its 
. relationship to chromosome segregation to understand the different mechanisms by which 
aneuploidy can arise.
During the pro-metaphase the nuclear membrane breaks down and the centrosomes move 
to the opposite poles. The mitotic spindles are organised between the two centrosomes. 
The centrosomes are the major microtubule organizing centres (MTOC) and are 
composed of the centrioles and its surrounding proteinacious matrix such as gamma 
tubulins and centrosomins A and B (Fukasawa 2005). The slow growing ends of the 
microtubule (minus end) are anchored in the gamma tubulin and the fast growing ends 
(plus end) project to find and associate with the kinetochore and are stabilised by this 
interaction. The spindle checkpoint ensures that all replicated chromatids are properly 
connected to opposing spindle poles before separation (anaphase) can begin.
Normally anaphase is inhibited by an anaphase inhibiting protein called securin. APC/C 
(a large Ubiquitin-Protein Ligase) which is the major compoment of the check point 
triggers anaphase by degradation of securin. APC/C is in turn under the inhibitory control
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of MAD2 and BUB3 proteins (Stewart et al, 2003). The BUB and MAD proteins are 
found to be localised in the unattached kinetochores in the pro-metaphase. Mad2 inhibits 
the APC activity through direct binding to Cdc20 in the APC complex. MAD2- 
independent mechanism that involves BUBR1 and BUB3 has also been reported. When 
all kinetochores of the entire sister chromatids are attached to microtubules, the inhibitory 
signal is inactivated, and the APC couples ubiquitin chains to its targets.
The targets of the APC/C include the protein securin that hold sister chromatids together 
and mitotic cyclins (Cyclin-B the mitotic partner of Cdkl) that blocks the onset of 
anaphase. The sister chromatids are usually joined together at the centromeres and along 
the chromatid arms by a protein called cohesin. Cohesin is normally disrupted by separin 
which is under the inhibitory control of securin. Destruction of securin by APC/C 
activates separin which in turn destroys cohesins resulting in the separation of the two 
sister chromatids. The mitotic cyclins are destroyed, activating the motors that pull the 
chromatids to the poles of the spindle (Stewart et al, 2003; Kops et al, 2005). 
Mis-segregation of chromosomes may occur as a consequence of a number of problems 
associated with the separation of sister chromatids during anaphase (figure 1.8). Defects 
in sister chromatid cohesion, resolution, and separation could all contribute to the genesis 
of aneuploidy. Failure of the pre-anaphase checkpoint can lead to production of somatic
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cell populations with abnormal chromosome numbers (Cimini et al, 2005). Other factors 
which can lead to aneuploidy include abnormal function and number of centrioles leading 
to multipolar mitoses, kinetochore defects leading to chromosome loss and mitotic 
slippage resulting from inhibition of mitosis (Fenech 2002).
1.3723 POLYPLOIDY
Polyploidy is the presence of whole sets of chromosomes in excess of the normal number 
(multiple of the normal 2N). There are various ways in which polyploidy can arise. Errors 
of fertilization in which a single haploid egg is simultaneously fertilized by two haploid 
sperm (dispermy) (resulting in three sets of chromosomes, or triploidy) or due to errors in 
the early mitosis or meiosis due to which chromosomes duplicate but cytokinesis 
(separation of the cytoplasm) fails to occur. Cancer cells frequently show polyploidy.
1.4 PURPOSE OF THE PRESENT STUDY
The strong association of Barrett’s oesophagus with oesophageal adenocarcinoma, the 
incidence of which is rapidly rising makes it a very significant clinical problem. Despite 
an increase in our knowledge regarding BE the process whereby metaplasia progresses 
from dysplasia to adenocarcinoma are not completely understood.
Although the progression of BE to OADC occurs in a stepwise manner it is almost 
impossible to recognize these changes clinically and the only way of monitoring these 
patients is by periodic surveillance. Surveillance involves endoscopy at regular intervals 
with four quadrant biopsies being taken at 2cm intervals throughout the length of 
Barrett’s. Owing to the difficulty in detecting patients who progress to adenocarcinoma
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the treatment of BE has been controversial and inconsistent. Histology (grade of 
dysplasia) and patient’s symptoms are unreliable parameters to make decisions regarding 
their management. Almost 20% of the general population suffers from GERD of which 
almost 10% of these will have BE. Screening all patients with GERD with endoscopy to 
detect BE would be extremely expensive. We know that inspite of the increase in 
incidence of OADC the overall five year survival (around 7%) has not improved 
dramatically. This is mostly because lymphatic vessels (small thin channels similar to 
blood vessels that do not carry blood, but collect and carry tissue fluid (called lymph) 
from the body to ultimately drain back into the blood stream) are found in the most 
superficial aspect of oesophageal mucosa, the involvement of which leads to early lymph 
node metastasis. Obviously detection of the disease at an early stage would drastically 
improve the five year survival and cure rates. Current evidence shows that only surgery 
can eliminate the disease and none of the other treatment modalities have been shown to 
have any appreciable effect on the progression of dysplasia to OADC. Clearly the best 
treatment option would be to perform surgery in patients in whom we could predict 
reliably the progression to OADC. The question which still remains unanswered is which 
subset of patients should be followed in order to detect OADC at an early and potentially 
curable stage? The current recommendations of surveillance are imperfect, inefficient and 
expensive. This is because the guidelines for surveillance are based entirely on the grade 
of dysplasia which although is the gold standard at the moment, is not a very reliable 
indicator. Surveillance has not been proved to be cost effective and subjects patients to 
regular and prolonged discomfort of going through the very unpleasant procedure of 
endoscopy.
Dysplasia is not a reliable indicator of progression to OADC due to several reasons. 
Firstly there is considerable inter and intra-observer variation on the interpretation of 
different grades of dysplasia. Studies comparing the interpretation of eight different 
pathologists showed that there was an 86% inter-observer agreement for high grade 
dysplasia and intramucosal-adenocarcinoma while the agreement was 58% and 75% for 
indefinite dysplasia and low grade dysplasia respectively. This interpretation is further 
confounded by the presence of oesophageal inflammation (Reid et al, 1988; Kim et al,
1997). The problem of accepting dysplasia as a marker for malignancy is that the natural 
history of dysplasia is not well defined. It is still not known how fast and how frequently 
cancer develops in patients with high grade dysplasia (Spechler 2001). Some studies 
reveal that cancer could develop from high grade dysplasia in a period of 2 to 46 months 
from the time of diagnosis (Levine 1997) while other studies reveal that high grade 
dysplasia can persist for years without any progression (Lee 1985; Hameeteman et al, 
1989).
The lack of reliability of dysplasia as a marker has lead investigators to seek for more 
reliable alternative biomarkers. A number of biological events (involving cell 
proliferation and differentiation) occur during the process of progression to 
adenocarcinoma. Genetic and molecular changes are the initial events in carcinogenesis. 
These genetic and molecular signatures could facilitate early detection by high- 
throughput technologies. Biological markers associated with these events when used 
alone or in conjunction with histology may help in predicting the progression to 
carcinoma in these patients. Some of these molecular events may not only help in 
supplementing and standardizing the diagnosis and progression of dysplasia but may also
serve as targets for therapeutic interventions. The pursuit for biomarker is based on the 
fact that the onset of disease occurs long before the stage when it can be recognised and 
identified by pathological means. Hence the usefulness of the biomarkers lies in its ability 
to provide early indication of disease or progression of the disease. Biomarkers should be 
easy to detect and measurable across populations. They should enable early detection, 
identification of high risk individuals and aid in monitoring recurrence. An ideal marker 
would be one which has low prevalence in non-dysplastic cases and increases with the 
grade of dysplasia. Theoretically, they could provide the opportunity to intervene during 
the stage of natural progression of dysplasia to cancer, to cause inhibition, regression, or 
even elimination of the disease. To be effective and reliable the biomarker should be 
found in highest frequency in patients with high grade dysplasia and OADC. A large 
number of biomarkers have been investigated with regards to progression of BE. Some of 
these include secretory factors, cell cycle regulating factors, adhesion molecules, 
chromosomal abnormalities, activation of oncogenes (CDKN2/pl6, c-src, c-jun, c-Ha- 
ras, c-erb-B), loss of tumour-suppressor genes (p53), abnormalities in growth regulatory 
factors (epidermal growth factor, transforming growth factor-alpha) and cell proliferation 
markers (PCNA) (Fitzgerald et al., 2001; Spechler SJ 2001). Of the numerous biomarkers 
that have been described the ploidy status and p53 and p i6 gene abnormalities are the 
ones which are most important and intensively documented. Immunohistochemical 
staining for p53 has been regarded as a marker for malignant progression in Barrett’s
I
oesophagus. Not only have several studies shown a poor correlation between positive 
staining and p53 gene mutations but also frequent accumulation of p53 protein in normal
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proliferating epithelium. Mutation of p53 gene or LOH of 17p have been found to be 
more reliable markers.
The purpose of this study was to:
• Understand the genetic changes in the early stages of BE with a view to identify a 
biomarker which could reliably predict the progression of BE to OADC.
• To develop an in-vitro model of Barrett’s oesophagus
• To evaluate the role of bile and acids in the pathogenesis of BE.
1.41 EVALUATION OF EARLY CYTOGENETIC MARKER
A proper understanding of molecular events which trigger the neoplastic process is 
required in order to potentially identify early markers of malignant transformation which 
could help in developing treatment and prevention strategies. In order to better 
understand this process a variety of molecular studies have been carried out in recent 
years on OADC and BE. Studies have shown that patients with OADC and BE frequently 
have cells which are aneuploid. Aneuploidy has been detected by various means 
including DNA flow cytometry, DNA image cytometry, CGH, karyotyping and FISH. 
Almost 79% to 100% of the patients with OADC have multiple aneuploid populations 
j (McKinley et al., 1987; Reid et al., 1987; Rabinovitch et al., 1989; Krishnadath et al, 
1995). Although there are a large number of studies on cytogenetic changes in OADC the 
number of studies on cytogenetic changes in Barrett’s oesophagus is limited. A number 
of chromosomal aberrations have been described in patients with BE. Persons et al 
showed amplification of multiple chromosomes (6, 7, 11, 12) in patients with BE using 
fluorescence in-situ hybridization (FISH) with chromosome-specific centromere DNA
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probes (Persons et al, 1998). Rabinovitch et al using flow cytometry demonstrated 
aneuploidy in the oesophagus of 14 patients with Barrett's adenocarcinoma (Rabinovitch 
et al, 1989). Multiple (2 to 14) populations of aneuploid cells were seen in many of the 
cases. This shows that neoplastic progression in Barrett's oesophagus is associated with a 
j process of genomic instability which leads to evolution of multiple aneuploid 
populations, with the ultimate development of a clone of cells capable of malignant 
invasion. Detection of multiple aneuploid populations of cells in Barrett's oesophagus 
may therefore indicate a high risk of cancer. Aneuploidy has been seen in early stages of 
BE and the prevalence of aneuploidy has been known to increase with the progression of 
dysplasia. This could range from 4-6% in early stages to 63-86% in late stages with high 
grade dysplasia and invasive carcinoma (Reid 1991).
Current data on chromosomal aberrations in BE shows a wide variety of changes, none of 
which are consistent or reliable in risk assessment. Studies in our own laboratory using 
comparative genomic hybridization (CGH) on samples from BE revealed widespread 
chromosome instability in patients with HGD with no significant chromosome changes in 
patients with LGD (Croft et al, 2002). Amplification of chromosome 4 and 8 were the 
predominant changes seen in the patients with HGD. CGH is a global assay which can 
use a small amount of DNA in a single experiment to provide detailed information on 
gains and losses of genetic material in a tumour. Although CGH is an effective screening 
tool, it cannot detect aberrations if they are not found in a significantly high proportion in 
the given tissue. Hence the sensitivity for small amplifications and deletions is poor. 
FISH on the other hand analyses a specific region of the DNA in the cell. FISH enables 
more targeted investigations of certain areas of the genome and can detect changes when
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found in small magnitude unlike CGH. FISH has become the standard approach for 
commonly known micro-deletions and micro-duplications.
Our aim was to specifically investigate and compare the numerical aberrations of 
chromosomes 4 and 8 in patients with BE with various grades of dysplasia using the 
FISH technique. The specimens were to be obtained from patients undergoing endoscopic 
biopsy who were already diagnosed with BE. The biopsy samples were to be cultured for 
a short-term in order to obtain a greater yield of the cells. Theoretically the short-term 
culture would provide us with actively multiplying cells which could then be arrested in 
metaphase. The metaphase samples could then be used for karyotyping studies. Whole 
chromosome probes could be used to detect the karyotypic changes and structural 
abnormalities of the chromosomes. The short-term cultures could also provide us with 
interphase cells for cytogenetic analysis with centromeric FISH probes which could 
potentially detect important numerical chromosomal abnormalities. The advantage of 
primary culture would be its direct comparibility as they would contain the same 
combination of cell populations that are also present in the tissue and not sufficient time 
would have elapsed for selection mechanisms to have taken effect.
1.42 DEVELOPMENT OF IN-VITRO MODEL OF BARRETT’S OESOPHAGUS
One of the purposes of this study was to develop in-vitro model of Barrett’s oesophagus. 
This was to be achieved by long term culture of BE cells obtained from patients 
undergoing routine endoscopy. Currently there is lack of suitable in-vitro model to study 
directly the physiology of human oesophageal disease. There are very few investigators 
who have successfully cultured Barrett’s epithelium. Research into molecular and genetic
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mechanisms underlying Barrett’s oesophagus would be greatly advanced by in- vitro 
model of Barrett’s cells. The development of novel cell culture models of Barrett’s 
oesophagus could provide important research tools with which to investigate relevant 
cellular alterations that may be pertinent to the human disease. Availability of human 
oesophageal cell culture model could serve as an excellent tool to understand the 
pathogenesis of human lesions in-vivo, particularly the neoplastic phenomenon. Barrett’s 
cell culture, both long-term and short-term would be an excellent model to study the 
metaplasia-dysplasia-cancer sequence. Apart from improving our knowledge regarding 
neoplastic transformation it could also be used to study the effects of carcinogens in- 
vitro. In addition, such models can serve as the basis for the preclinical testing of new 
therapeutic strategies. Cell culture model could also be used to obtain sufficient material 
for a variety of molecular biology, cytogenetic and biochemical and physiological 
studies. The advantage of in-vitro cell culture is that they allow investigators to study a 
single effect of a substance or an action in isolation. They also offer high sensitivity 
without interference from other biological phenomena, such as hormones or immune 
responses. They can also generate results at faster and far lower cost than methods using 
live animals. In-spite of all the progress in our knowledge regarding BE the exact 
aetiology of BE is still unknown. Various factors have been implicated in the 
development of BE including acid and bile. The cell culture model could be used to study 
the role of acid and bile which are the most important components implicated in the 
pathogenesis of the BE and its progression to oesophageal adenocarcinoma. In-vitro 
studies would give an idea about the cytotoxic and genotoxic effect of these substances. 
Using natural human cells would make extrapolation of the results easier. It could also be
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used as an in-vitro model to study the effects of various carcinogens like polyaromatic
I hydrocarbons and nitrosamines. Long-term oesophageal organ culture would be an excellent system to study the phenomenon of promotion. This could be achieved by 
continuous and intermittent exposure of the cells to suspected carcinogens and 
iprocarcinogens.
1.43 EVALUATION OF ROLE OF BILE AND ACIDS
Although the exact factors involved in the development of BE are obscure there is ample 
^evidence to prove the strong association between chronic DGER and BE. Various 
components of the refluxate including gastric acid, bile acids and pancreatic enzymes 
may be involved in the development of oesophageal injury. Bile acids and gastric acid are 
the major components of the refluxate which have been implicated in the pathogenesis of 
BE. To develop better and effective management strategies it is very important to 
understand the basic factors and the mechanism underlying the development of BE. 
Studies have shown that patients with BE have more bile reflux compared to patients 
with uncomplicated GERD. Most of these studies measuring bile reflux are based on 
Bilitec which is semi-quantitative at best and unreliable in quantifying reflux. With 
increasing studies showing elevated concentration of bile in patients with BE, the 
question that remains unanswered is what is the profile of bile acids seen in these patients
i
and in what concentration are they found? Very few studies have actually measured the 
concentration of different bile acids in these patients. Nehra et al., showed that patients 
with BE had predominantly taurocholic and glycocholic acids with significant 
concentration of DC A and TDCA in their bile reflux (Nehra et al., 1999). Most patients 
had reflux of bile acids in concentrations greater than 200 pmol. Iftikhar et al, found
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that patients with BE had bile reflux which was comprised predominantly of GCA and 
TCA and significant amounts of Taurochenodeoxycholic acid (Iftikhar et al., 1993). The 
concentration of various bile acids in their study ranged from 20 pmol -  2000 pmol. 
.Having shown that there is increased bile reflux in patients with BE the next question that 
needs answering is are they found in significant concentration to cause oesophageal 
damage or do they have cytotoxic and genotoxic effect in the concentration that they are 
. found in patients with BE.
I Information regarding the effects of various bile acids on oesophageal cell lines in-vitro is 
lacking. Studies performed so far have evaluated the effect of bile acids on colonic 
mucosa, gastric mucosa or hepatocytes. Bachir et al evaluated the effects of high 
i concentration of bile acids (1-3 mmol per litre) on oesophageal organ culture (Bachir et 
al., 1982). They demonstrated their cytotoxic effects on organ culture at concentrations 
greater than 2 mmols. There are hardly any studies demonstrating the effects of 
physiological concentrations of various bile acids on oesophageal cell lines. None of the 
studies so far have evaluated the genotoxic and cytotoxic effects of various bile acids 
seen in patients with BE. Evaluation of their cytotoxic and genotoxic potential at various 
concentrations would give us an idea about their significance and role in the pathogenesis 
in patients with Barrett’s oesophagus. Our study aimed at evaluation of the cytotoxic and 
genotoxic effects of physiological concentrations of various bile acids seen in patients
i
with BE. The in-vitro studies were to be conducted using oesophageal cell culture model. 
Long-term primary culture of Barrett’s epithelial cells would be an ideal model for this 
purpose. This would more closely resemble the in- vivo situation with regard to cell type 
and physiology and biological behaviour. This would make interpretation of results easier
and more readily comparable to the in- vivo situation. The samples for the study were to 
be obtained from patients with BE undergoing routine endoscopy. Failing this an 
alternative model of OE33 cells derived from Barrett’s oesophageal carcinoma cells was 
to be used to evaluate the cytotoxic and genotoxic effects of the bile acids. The cytotoxic 
and genotoxic effects of bile acids were to be evaluated with the in-vitro micronucleus 
pssay which is a validated multi-end point assay. The in-vitro MN assay can 
simultaneously detect mitotic delay, apoptosis and chromosomal aberrations (both 
structural and numerical). In the past studies have shown that the bile acids have varying 
effects depending on the pH and their ionisation state. Conjugated bile acids have a pKa 
of about 2 and are hence freely soluble at an acidic pH whereas they tend to be 
precipitated at an alkaline pH. Un-conjugated bile acids on the other-hand have pKa close 
to 7 and are hence soluble at neutral pH and precipitate in solution at acidic pH. Owing to 
this, conjugated bile acids can be most harmful at acidic pH while un-conjugated bile 
acids can be more harmful at neutral pH. In order to evaluate the effects of bile acids in 
varying pH conditions the experiments were to be conducted in both acidic and neutral 
pH conditions.
Although demonstration of tumour induction in vivo would be a definite proof for tumour 
| promoting or carcinogenic activity of an agent it may not be always possible. Animal 
experiments can be expensive and time consuming. A number of studies have shown the 
tumour inducing capacity of bile acids in animals but extrapolation of these results to 
human situation is difficult. Owing to this our in-vitro model would be a good tool to 
demonstrate the effect of various agents possibly involved in the development of BE.
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CHAPTER TWO 
BARRETT’S CELL CULTURE MODEL 
AND INTERPHASE FISH STUDIES
2.1 REVIEW OF OESOPHAGEAL / BARRETT’S TISSUE CULTURE
Tissue culture has been performed since the beginning of the twentieth century (Harrison 
1907). The first solid tumour-derived cell line, termed HeLa, was established by George 
Gey at the Johns Hopkins Medical School in 1951 from a 31-year-old mother of four, 
Henrietta Lacks (Gey et al, 1951). Since the classical work of Hayflick and Morrhead 
(Hayflick et al., 1961). There has been an explosive expansion in tissue culture 
technology. Browning and Trier were the first to culture adult human intestinal mucosal 
biopsies in vitro for a twenty four hour period (Browning et al, 1969). A number of 
workers have used the technique described by Browning and Trier with minor 
modifications which is based on supporting the tissue in contact with, but not submerged, 
in suitable culture medium, in an oxygen enriched atmosphere. Browning and Trier 
placed the mucosal specimen on a sterile steel wire grid placed on a central well of a 
culture dish as shown in the diagram (figure 2.1). The central well was filled with culture
j
medium so as to just touch the under surface of the mucosa. The principles of explant 
tissue culture still remain unchanged. Culture of alimentary tract mucosa has proved to be 
very difficult compared to cells and tissues from most other organ systems (Trier 1976). 
Availability of human oesophageal cell culture could serve as an excellent model to 
understand the pathogenesis of human lesions in-vivo, particularly the neoplastic
phenomenon. It could also be used as an in vitro model to study the effects of various 
carcinogens like polyaromatic hydrocarbons, nitrosamines, bile acids and stomach acid. 
Long-term oesophageal organ culture would be an excellent system to study the 
phenomenon of promotion. This could be achieved by continuous and intermittent 
exposure of the cells to suspected carcinogens and pro-carcinogens. Availability of 
|Barrett’s cell culture, both long term and short term, would be an excellent model to 
study the metaplasia-dysplasia-cancer sequence, effects of carcinogens and neoplastic 
transformation, to test potential therapies for BE and to acquire sufficient material for a 
variety of molecular biology, cytogenetic and biochemical and physiological studies.
A review of the literature shows that there are very few reports of methods for in vitro 
culture of Barrett’s epithelial cells with varying degrees of success (table 2.1). A long 
term model of non transformed primary cell line is still lacking for Barrett’s oesophagus. 
The first attempts to culture human oesophagus was made by Syverton and Mclaren in 
1957. Syverton and Mclaren reported the establishment of an oesophageal epithelial 
strain from a one day old infant with tracheobronchial fistula (Syverton et al, 1957). 
Aydeolotte was successful at growing animal embryonic oesophageal epithelium for 
more than two weeks (Aydelotte 1963).
FI
G
UR
E 
2.1
 
D
ia
gr
am
m
at
ic
 
re
pr
es
en
ta
tio
n 
of 
or
ga
n 
cu
ltu
re
 
us
ed
 
by 
Br
ow
ni
ng
 
an
d 
Tr
ier
 ( 
Ad
ap
te
d 
fro
m 
H
ow
dl
e 
19
84
)
57
In 1975 Rosztoczy et al, cultured normal human fetal, and adult oesophageal epithelium 
.for up to seven days. His organ culture supported the replication of influenza virus for 
about four days (Rosztoczy et al, 1975). Hilman et al., were the first to maintain normal 
oesophageal tissue in organ culture for a long period of time (Hillman et al., 1980). They 
were able to maintain oesophageal explants obtained from autopsy specimens or 
surgically resected specimens for a period of 6-16 weeks. Hilman et al, used explants of 
lcm3 from various segments of oesophagus. The explants were grown in 3-5ml of culture 
medium (CMRL 1066) which was supplemented with insulin, hydrocortisone and 5% 
fetal calf serum. The culture dishes were placed on a rocker platform to make the medium 
flow intermittently over the epithelial surface. Although Hilman et al, managed to 
maintain explants for more than a few weeks they never grew cells in monolayers 
(Hillman et al, 1980).
Hilman et al, attempted cultures from 18 subjects of which seven were lost due to 
infection and the rest were maintained in culture for about 6-16 weeks. Katayama et al, 
used tissue samples from non-tumorous part of surgically resected specimen (Katayama 
et al, 1984). They disaggregated the cells by means of tryptic digestion and grew them in 
RITC80-7 supplemented with 10% fetal bovine serum (FBS). They established primary 
cultures from 20 donors and were able to passage them three to five times. Additional 
supplements to their media included epidermal growth factor (EGF), insulin, transferrin, 
FN and BSA.
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TABLE 2.1
Showing list of studies conducted on oesophageal cell culture
AUTHORS YEAR BARRETT’S/
NORMAL
SOURCE OF TISSUE TECHNIQ1UE USED
Explant* Enzymatic
1 Hilman 
et al.,
1980 Normal Autopsy/
Surgically Resected
+ + + +
Zboralske 
let al,
1984 Normal Autopsy &
Heart/Lung
Transplant
+ + + +
Katayama 
et al.,
1984 Normal Surgically Resected + + + +
Mothersill 
et al.,
1989 Normal Surgically Resected + + + +
- Resau et al, 1990 Normal Autopsy + + + + + + + +
Garewal 
et al.,
1992 Barrett’s Endoscopic biopsies + + + +
Washington 
et al.,
1994 Barrett’s Endoscopic biopsies + + + + + + + +
Khan et al, 1997 Barrett’s Endoscopic biopsies + + + +
Wessels et 
al,
1998 Barrett’s Endoscopic biopsies + + + + + + + +
Wessels et 
al,
2003 Barrett’s Endoscopic biopsies Telomerase Reverse 
Transcriptase
* Most authors have used the explant method, and in those studies where both methods 
have been used, it is mostly the explant method which has been employed predominantly.
Zboralske et al, used tissue samples from heart/lung donors and autopsy specimens. 
They used explants of 1.5 x 1.5 mm3 (Zboralske et al., 1984). They used a unique method 
to fix the explant to the culture dish. A drop of chick plasma with fibrinogen (18mg /ml) 
was used and one to two drops of bovine thrombin (lOOU/ml) to anchor the explant to the 
plastic Petri-dish. After clot fixation of the explant 1.5ml of the culture medium was 
added. They used Eagle’s minimum essential media supplemented with penicillin 
(200U/ml) /streptomycin (lOOpg/ml), 10% fetal bovine serum and dexamethasone
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1 pg/ml. Of the eleven different samples used they were able to obtain cultures from six 
patients and a maximum of two serial passages of the cells.
Mothersill et al, in 1989 described a technique for short-term culture of human 
oesophageal epithelial cells (Mothersill et al, 1989). They used a combination of explant 
jand enzymatic methods to grow normal oesophageal mucosa obtained from surgically 
jresected specimen. In their attempts to optimise medium for the culture of oesophageal 
.cells, Mothersill et al, found that a medium rich in amino acid supplements promoted 
healthy fibrobast free growth. They found that supplementation of these amino acid rich 
mediums with 10% serum (horse, newborn or foetal calf serum), insulin, hydrocortisone, 
insulin and EGF was ideal for the growth of oesophageal cells. The techniques used by 
Mothersill et al, enabled them to grow the cells for a maximum of four weeks.
Resau et al, obtained oesophageal cells from autopsy specimens (Resau et al, 1990). 
They used both explant and enzymatic method to initiate their cultures. They compared 
|the effect of serum free keratinocyte growth medium and serum supplemented CMRL 
1066 on the growth of cells in culture. They found that the viability and differentiation of 
the epithelial cells was better in KGM compared to serum supplemented media.
The first report of culture of Barrett’s oesophagus was made by Garewal et al, in 1992. 
They were the first to obtain monolayer cultures from Barrett’s cells (Garewal et al, 
1992). They used the explant method to culture Barrett’s specimens obtained from 
endoscopic biopsies. The tissue was finely minced and were grown in T25 plastic 
collagen coated culture flasks. They used the M-19 medium with bovine pituitary extract 
supplemented with 20% foetal bovine serum. By using this technique they were able to 
subculture the cells by about six times on an average mid most cells showed degenerative
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changes by passage 8-10. None of their cells were immortal. Garewal et al had 60-70% 
success, with others lost either due to inability to grow, fibroblast overgrowth or 
infection.
Washington et al, obtained tissue from surgically resected specimens (Washington et al., 
1994). They used both explant and enzymatic method (using trypsin) to initiate their 
cultures. Their culture media consisted of MCDB-153 with 5% calf serum and 
supplemented with hydrocortisone, bovine pituitary extract, penicillin, streptomycin and 
amphotercin. They were able to subculture for a maximum of six to eight times with 
tissues being maintained in vitro for an average of three months. Of the 12 cultures that 
were started four were lost to infection and one failed to grow. Washington et al noticed 
| that cells grown on type IV collagen grew more slowly than cultures grown on uncoated 
plastic, and could be sub-cultured fewer times.
Khan et al., used the explant technique to culture Barrett’s samples from endoscopic 
biopsies(Khan et al, 1997). They used DMEM and HAM F12 in the ratio 3:1 
supplemented with 10% fetal bovine serum to initiate their cultures (table2.2). This 
medium was later replaced by keratinocyte serum free medium for culture propagation. 
Of the sixteen samples five were lost due to infection. Eleven samples could be sub­
cultured several times (most of them 8-10 times and a maximum of 20). According to 
Khan et al the use of keratinocyte serum free medium not only eliminates the fibroblast 
overgrowth, but also prevents serum induced terminal differentiation of the epithelial 
cells.
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TABLE 2.3
Showing the results of oesophageal cell culture from various studies
ZBORALSKE 
ET AL
GAREWAL 
ET AL
WASHINGTON 
ET AL
KHAN 
ET AL
WESSELS 
ET AL
No of 
Samples
11 - 12 16 33
Infection in
%
5 - 4 5 -
No of 
passages
2 8-10 6-8 8-10 20
No Positive 
cultures
6 60-70% 7 11 4
Immortal
lines
None None None None None
%age of 
success
55% 60-70% 58% 69% 12%
Graph showing the success rate of various studies for oesophageal cell culture
Wess Khan Wash Gar Zbor
□  Wess DKhan DW ash D G ar DZbor □  |
Wessels et a l used both enzymatic and explant technique for initiation of culture of 
their samples obtained from endoscopic biopsies(Palanca-Wessels et al., 1998). Like 
Washington et a l they used MCDB 153 and 5%fetal bovine serum and other 
ingredients to initiate and propagate their cultures
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Attempts were made to initiate 39 primary cultures from thirty three different patients. 
They managed to obtain long term culture from four different samples which could be 
sub-cultured up to 20 times (see table 2.3). The rest of the samples failed to grow or 
were lost to infection.
Recent studies have shown that cell culture life span is related to chromosomal 
telomere length, and cellular senescence results from progressive telomere shortening 
(Bodnar et al., 1998). Based on this findings Wessels et al., (Palanca-Wessels et al, 
2003) transduced primary cultures of Barrett's esophageal epithelium with a retrovirus 
containing hTERT (human catalytic subunit of telomerase reverse transcriptase). The 
reactivation of telomerase enhanced the genomic stability and increased the life span 
of the Barrett’s cells.
2.2 FISH
2.21 INTRODUCTION
FISH has become a powerful molecular tool for detecting cytogenetic and molecular 
genetic alterations, and is widely applied in various fields of study (Ekong et al.,
1998). Since its inception about 30 years ago it has evolved into a highly effective 
technique which can detect multiple unique sequences simultaneously with different 
colours (Andreeff M 1999). In situ hybridization was first described by Pardue and 
Gall in 1969. They used radioactive labeled repetitive DNA probes in their studies 
(Pardue et al., 1969). This technique had obvious limitations due to its heavy 
reliability on radioisotopes and autoradiography for the visualization of the hybridized 
gene probe.
The current technique of FISH using non-radioactively labeled probes was developed 
Pinkel et al (Pinkel et al., 1986). Genomic in-situ hybridization can be defined as a 
method involving hybridization of labeled total genomic DNA, used as a probe, to
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spread or sectioned denatured chromosome preparation in-situ, followed by detection 
and visualization of the sites of hybridization (Clark 2002).
2.22 PRINCIPLES OF FISH
The nucleic acid in the target cells or chromosomes is denatured i.e. made single 
stranded (e.g. by heating). Once the DNA is denatured it is incubated with labelled 
single stranded probe nucleic acid molecule under conditions that permit binding of 
molecules that have complementary base pair sequences. The probe is then detected 
either by direct or indirect method (see figure 2.2). In the direct method labels such as 
flurochromes [FITC, Texas Red or Cyanine dyes (Bauman et al, 1980) or enzymes 
(Renz et al., 1984)] are directly coupled to the nucleic acid probe molecule. In the 
indirect technique the nucleic acid probe is labeled with a hapten (such as biotin or 
digoxigenin) which after in situ hybridization, is detected by immunocytochemical 
means (Raap 1998). The haptens can be detected by means of fluorescently labelled 
molecules which have a very high affinity for the haptens. The signals may be 
amplified by the use of simulataneous layers of antibodies and antibodies conjugated 
to fluorescent molecules (Ekong et al, 1998).
In the direct method, apart from being able to visualize the results directly, there is no 
background staining due to nonspecific binding of the immunocytochemical reagents 
(Raap AK 1990). After hybridization the numbers, intensities, and spatial distribution 
of each of the different coloured hybridization signals can be determined (Andreeff M
1999).
2.23 APPLICATIONS OF FISH
FISH can be used for the detection of numerical and structural chromosomal 
aberration. A variety of FISH probes are available, the choice of which depends on 
the purpose of the study. FISH probes can detect tandem repeats, dispersed repeats 
and complete genes in the chromosome. Repetitive a  satellite DNA sequences specific
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for centromeric region can be used to detect the chromosome copy number in the 
interphase cells. FISH has been successfully used for the analysis of numerical 
chromosomal abnormalities in interphase nuclei of various solid tumors (Hopman et 
al, 1989; Baretton et al, 1994). Interphase FISH enables examination of cells from 
tissue sections or tumour cell suspension without resorting to tissue culture. It can also 
be used to analyze stored archival samples ranging in age from a few months to 
several years. Because of the ease and speed with which it can be performed, 
interphase FISH has become a well accepted technique in cancer cytogenetics. With 
efficient hybridization and proper scoring interphase FISH can produce results 
comparable to metaphase analysis (Eastmond et al, 1995).
Whole chromosome probes which label the entire length of the chromosome can be 
used to analyze metaphase cells for both numerical and structural chromosomal 
abnormalities. Whole chromosome probes make it possible to detect translocations, 
insertions and breakage points (Sharma et al, 2001).
Fish can also be used for karyotyping of cells. Several new techniques like M-FISH 
(Multiplex fluorescence in situ hybridization), SKY (spectral karyotyping) and colour 
changing karyotyping have been used to detect complex structural and numerical 
chromosomal aberrations. Although the conventional G banding is commonly used 
for karyotyping, it cannot detect minute structural aberrations. SKY/M-FISH can 
localize all the genes simultaneously and hence can be used for marker chromosome 
characterisation in cancer and other disease states. The limitations of M-FISH /SKY 
are that they are expensive, technically demanding and need proliferating material. 
Another recent FISH technique is CGH (comparative genomic hybridisation) which 
involves the hybridisation of equal amounts of test and reference DNA, labelled in 
two different colours, to a normal metaphase spread. Regions with equi-molar DNA
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appear yellow, where as regions with under or over represented DNA appear red or 
greenish (van Ommen et al, 1995). CGH is a powerful tool which can be used to 
detect inter and intra-chromosomal imbalances, gene amplifications and for marker 
chromosome characterization. The limitations of CGH is that it cannot detect 
balanced aberrations or small imbalances, needs cytogenetic expertise for 
karyotyping, and small mosaics can be easily missed (Tonnies 2002).
Fibre FISH is another sensitive high resolution technique. It enables inspection 
specific DNA sequences along a stretched single DNA fibre. The theoretical 
resolution of fibre fish is almost 1 kb. Thus the applications of FISH are widespread 
and continuously expanding, with the evolution in the FISH techniques.
2.3 MATERIAL AND METHODS
2.31 ROUTINE LABORATORY PROCEDURES
TISSUE CULTURE EQUIPMENT
Glassware and pipette tips were sterilised in an autoclave (Prior Clave Ltd) at 121 °C 
and 15p.s.i for 30 minutes. Disposable sterile plastic tissue culture flasks, wells, 
pipettes, syringes, centrifuge tubes, Petri-dishes, cryovials and universals were 
purchased from Nunc A/S, Life Technologies Ltd. UK, Sterilin Ltd. Staffordshire UK 
or Alpha. All cell cultures were carried out under sterile conditions in a laminar flow 
cabinet (Cytomat Safety Cabinet, Medical Air Technologies Ltd, Manchester UK.). 
All incubations were done in LEEC M kll Proportional Temperature Controller 
(LEEC Ltd Nottingham UK) incubators at 37°C and 5% CO2 .
MEDIA, REAGENTS AND CHEMICALS
Chemicals and media were purchased from the companies mentioned previously with 
the respective product. Growth media and other culturing solutions prepared in the 
laboratory were sterilised by autoclaving at 121 °C and p.s.i for 30 minutes. Where
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reagents were unsuitable for autoclaving, filter sterilisation using 0.2pm filtration 
discs (Acrodiscs, Gelman Sciences) was employed. Purified water was obtained from 
a reverse-osmosis water purification system (Millipore).
1. Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco-Brl)
2. Ham’s F-12 Nutrient Mixture (Gibco-Brl)
3. Epigrow / Keratinocyte Serum Free Medium
4. Foetal Bovine Serum-FBS (Gibco-Brl)
5. 0.05% (w/v) Trypsin- 0.02% (w/v) EDTA (Gibco-Brl)
6. Adenine
0.97g of adenine (Sigma) was added to 20ml of distilled water. 10 Molar sodium 
hydroxide was added dropwise until adenine dissolved or a pH of 9.0 was reached. 
This 0.36M stock of adenine was aliquoted into 0.1ml volumes into cryovials and 
stored at -20°C until required. A further working stock of adenine was prepared by 
diluting a 1.0ml aliquot of 0.36M stock one in twenty in DMEM to give a 0.018M 
working stock. This 0.018M stock was aliquoted into 1.0ml volumes into cryovials 
and stored at -20°C until required.
7. Cholera Toxin
l.Omg freeze-dried preparation of Cholera toxin (sigma) was added to 12.0ml of 
DMEM and aliquoted into 1.0ml volumes and stored at 4°C until required.
8. Transferrin
A lOOmg quantity of transferrin (Sigma) was dissolved in lOmls of distilled water to 
produce a stock of lOmg/ml transferrin. This was aliquoted into 1.0ml volumes into 
cryovials and stored at -20°C until required.
9. Insulin Stock
lOOmg if Insulin (Sigma) was dissolved in lOmls of 0.05M hydrochloric acid to 
produce a stock of lOmg/ml insulin. This was aliquoted into 1.0ml volumes and
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stored at -20°C until required. 1.0ml of lOmg/ml insulin was added to 9.0ml DMEM 
to produce a working stock of l.Omg/ml. This was aliquoted into 0.5ml volumes into 
cryovials and stored at -20°C until required.
10. Epidermal Growth Factor Stock
lOpg of epidermal growth factor (Sigma) was dissolved in 1.0ml DMEM to produce a 
stock of lOpg/ml. This was aliquoted into 5pg volumes into small eppendorf tubes 
and stored at -20°C until required.
11. Hydrocortisone Stock
1 .Omg of hydrocortisone (Sigma) was dissolved in 1.0ml absolute ethanol and then 
added to 19.0ml DMEM to produce a 50pg/ml stock. This was aliquoted into 800pg 
volume in cryovials and stored at -20°C until required.
12. Bovine Pituitary Extract (Sigma)
13.1% (v/v) 200mM 1-Glutamine (Gibco-Brl)
14. Penicillin-Streptomycin, 10,000 units of penicillin G and 10,000 pg of 
streptomycin sulfate per ml (Gibco-Brl)
15. Amphotericin B 0.125pg/ml (Gibco-Brl)
16. Sterile scalpel and two pairs of forceps
17. Collagenase (Sigma)
The culture media was freshly prepared and used for no longer than three weeks. The 
culture medium was stored in the fridge at 4°C. The composition of the medium used 
for the intiation of primary culture was as follows:
3:1 (v/v) mixture of Dulbecco's modification of Eagles medium-DMEM (Gibco-Brl) 
and Ham FI 2 nutrient mixture (Gibco-Brl). To this was added
• Serum 10% FBS
• Insulin 5pg/ml
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Hydrocortisone 4 jug/ml 
EGF 20ng/ml
Cholera Toxin 1 O'10 Mol/ml
Transferrin 5pg/ml
Bovine Pituitary Extract 140jLig/ml
Adenine 1. 8x 10"4 M
Glutamine 4mmol/ml
Penicillin
Streptomycin ^
Amphotercin-B
Varying concentrations used 
for different experiments
CHEMICALS AND REAGENTS FOR FISH 
2 X SSC: 40mls of 20X SSC + 360mls of water
0.4 X SSC with 0.3% NP-40: 2ml of 20 X SSC+ 98ml of water + 300pL of NP-40 
2 X SSC with 0.1% NP-40: lOmls of 20 X SSC+ 90ml water + lOOpL of NP-40
2.32 TISSUE COLLECTION
Tissue samples were obtained from patients with previously diagnosed Barrett's 
oesophagus attending endoscopy clinic at Morriston Hospital, Swansea. Ethical 
approval was obtained from local research ethics committee. All patients gave 
informed consent to participate in the study. Three to six biopsies were taken from 
each patient depending on the length of Barrett's segment. For the confirmation of the 
diagnosis, either an adjacent biopsy was taken or, if a single biopsy was large it was 
split and sent for histological evaluation. The tissue sample was placed immediately in 
the transport medium (TCM) and kept at 4° C until further processing. All the 
specimens were processed on the same day approximately within two hours of 
procuring the biopsy specimen.
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2.33 CELL CULTURE PROCEDURE
The cell culture was initiated using two different techniques, namely the explant 
technique and the enzymatic technique.
2.331 EXPLANT TECHNIQUE
The explant technique used was similar to the one described by previous workers 
(Garewal et al., 1992, Khan et al, 1997). The biopsy specimens were placed in a 
sterile Petri-dish, and minced to fragments of approximately l-2mm in size using a 
sterile scalpel blade (see fig.2.3). The minced fragments were suspended in 5ml of the 
growth medium and centrifuged at 1500rpm for eight minutes. The supernatant was 
discarded and the pellet was washed three times by re-suspending in the growth media 
and mixing the cells with a pipette, and centrifuging at 1500rpm. Finally the 
supernatant was discarded and re-suspended in 1ml of the tissue culture medium. This 
was transferred to 25cm3 tissue culture flask. The minces were distributed uniformly 
with the help of a Pasteur pipette on the bottom of the flask. The flasks were then left 
upside down for an hour. This hanging drop effect enabled the attachment of the 
minces to the surface of the flask. Later on 0.5ml to lml of the tissue culture medium 
was added to each flask and incubated at 37°C in a humidified atmosphere containing 
5% CO2 . On average, three to five flasks containing three to five explants per flask 
were used. The flasks were left undisturbed for about 3-4 days. Once the pieces were 
seen to have cells growing from them, the volume of the medium was gradually 
increased to 5ml over several days.
FIGURE 2.3 PRIMARY EXPLANT TECHNIQUE
TISSUE WAS FINELY CHOPPED 
WITH A STERTLE KNIFE AND 
WASHED SEVERAL TIMES IN THE 
CULTURE MEDIUM BY CENTR 
-IFUGING AT AT 1500 RPM FOR 8 
MINUTES
THE FLASKS WERE LEFT UPSIDE 
DOWN FOR AN HOUR IN ORDER TO 
AID THE ATTACHMENT OF THE 
BIOPSY FRAGMENTS TO THE 
SURFACE OF THE FLASK
O o
X  7
THIN FILM OF MEDTUM WAS ADDED TO THE 
FLASKS, AND THE FLASKS WERE LEFT 
UNDISTURBED FOR 3-5 DAYS
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2.332 ENZYMATIC METHOD
In the enzymatic method, the whole biopsy specimen was placed in a sterile Petri-dish 
containing 1 mg/ml of collagenase III in lx  phosphate buffered saline and incubated at 
37°C for about one to two hours. The tissue was gently syringed to dissociate the 
cells. The resulting suspension was centrifuged at 1500rpm for eight minutes.
The supernatant was discarded and the pellet was re-suspended in culture medium. 
The cells were counted using a haemocytometer. They were then seeded into tissue 
culture flask (T25) at a cell density of 2x10 cells/cm . The flasks were then incubated 
at 37°C in a humidified atmosphere containing 5% CO2 .
After initiation of the primary cell growth the medium was changed twice a week. 
When the cells covered more than 50% of the surface of the flask they were split by 
incubating with 0.25% trypsin with EDTA at 37°C for 5-10 minutes. The resulting 
suspension was then transferred into a centrifuge tube and centrifuged at 1500rpm for 
eight minutes. The cells were then plated in the tissue culture flasks at a density of
c 9
2x10 cells/cm . For the subsequent culture of the cells Epigrow, a commercially 
available serum free medium for epithelial cells was used.
HARVESTING CELLS
Once the cells occupied more than 75% of the surface of the flask they were split with 
0.25% trypsin with EDTA. The culture medium was removed by suction and 
discarded. About 3ml of 0.25% trypsin with EDTA solution was added to the flask. 
The solution was discarded immediately and another 3ml of Trypsin/EDTA solution 
was added. The cells were detached completely by shaking the flask several times and 
about 10 ml of medium was added to the flask. The cells were sub-cultured in a ratio 
of 1:2. Fresh culture medium was added to each flask to make up the quantity to
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lOmls. The flasks were gassed with CO2  and then incubated at 37°c in humidified 
atmosphere and 5% CO2 .
2.34 SLIDE PREPARATION
The cells were detached with Trypsin EDTA, as described in the previous section. 
The cells were re-suspended in the culture medium in a concentration of about 1 x 105 
cells/ml. Aliquots of 50- lOOpl were centrifuged in the cytospin (Shandon) for 8 
minutes at 200 x g. The quality of the slides was checked under a light microscope. 
The slides were then air dried for a brief period and then fixed with 90%v/v methanol 
at -20°C for 10 minutes. 2-4 slides were prepared from each culture. After fixing the 
cells were air dried.
2.35 INTERPHASE CYTOGENETICS (FISH WITH CEP PROBES)
The slides were prepared as described in the previous section. Fish was performed 
according to the protocol supplied with the Vysis probes with minor modifications 
(0.5pi of each CEP DNA probe was useed instead of lpl).
Vysis CEP probes -  Chromosome Enumeration Probes -  obtained from Vysis UK 
(Vysis, Surrey UK). Chromosome enumeration probes (CEP) consist of chromosome- 
specific tandem repeat DNA sequence (alpha satellite, satellite-I or satellite-III DNA). 
They are directly labelled with a Vysis fluorophore for detection. Unlabelled blocking 
DNA is mixed with the DNA sequence to suppress the more highly repetitive 
sequences that are common to many different chromosomes. To minimise cross -  
hybridization to other similar repeat sequences on other chromosomes the DNA 
sequences are hybridizesed under conditions of high stringency. For each test 
specimen a minimum of 200 nuclei were counted and the number of fluroscent signals 
per nucleus was recorded. FISH was performed using the following protocol:
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Slide preparation:
The slides were washed in 2xSSC for 2 minutes at room temperature. The slides were 
then dehydrated in a series of ethanol, 2 minutes in each of 70%, 80% and 100% v/v 
ethanol and air dried.
Probe preparation:
Due to limited number of slides available for each sample, two probes were 
simultaneously hybridized in each reaction. The probe was prepared by adding the 
following constituents to a micro-centrifuge tube at room temperature: 3.5pi of CEP 
hybridization buffer, 0.5pi of each CEP DNA probe, and, to a 5pi volume. The 
mixture was centrifuged 1 -3 seconds, vortexed and re-centrifuged briefly.
Hybridization:
5 pi of each probe mix was added to the cytodot. A plastic cover-slip on top of the 
cytodot and immediately the edges were sealed with rubber cement. The slides were 
then placed on a hot plate at 75 °C for 2 minutes in order to denature the probe. The 
slides were then incubated at 37°C for 30 minutes. A Coplin jar with a solution of 
0.4xSSC/0.3% NP-40 was pre-warmed in a 73°C water bath at least 30 minutes prior 
to use. After incubation, the cover-slips were removed and the slides were immersed 
in the pre-warmed solution for 2 minutes. The slides were then washed in 
2xSSC/0.1% NP-40 for 5-10 seconds. The slides were dried and lOul of DAPI was 
applied to each slide. The slides were viewed after 10 minutes under a fluorescence 
microscope using a triple band-pass filter, which permits the simultaneous detection 
of DAPI (white), propidium iodide (orange), Cy-3 (red) and FITC (green). The 
excitation and emission wave lengths for different colours were as show below:
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Colour Excitation (k) Emission(l)
DAPI (white) 345 455
FITC (green) 494 518
Prop Iodide (orange) 536 617
Cy3 (red) 550 565
2.36 FISH ANALYSIS USING WHOLE CHROMOSOME PROBES 
WHOLE CHROMOSOME FISH SOLUTIONS
20 X SSC 3.0M NaCl (17.53g per 100ml)
0.3M Trisodium citrate (8.82g per 100ml)
Formamide (SIGMA)
De-iodinise by stirring for 30 min with lOg of amberlite monobed resin (SIGMA) per 
100ml, then filter twice.
Denaturation solution
4ml 20 X SSC 
8ml distilled water 
28ml formamide 
Post-hybridization washing solution
7.5mls 2 X SSC pH 7.0
7.5 ml distilled water 
15mls formamide
Washing solution
100ml 20 X SSC 
400ml distilled water 
250 Tween-20
Blocking reagent
2mg sodium azide
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10ml washing solution 
500mg Bovine Serum Albumin
Warm to 37 ° C to dissolve. Store at 4 ° C for up to 2 weeks.
2.361 METAPHASE PREPARATION
A confluent 50cm flask was split and seeded into a 25cm flask with a cell 
concentration of about 1-2 x 105cells/ml in 10 mis of the culture medium. The flasks 
were gassed and incubated at 37°C for 48hrs to recover from the trypsin treatment. 
After 48 hrs the medium was renewed and gassed and the cells were treated with 10pl 
(lpg/ml) colcemid (Life Technologies) and left overnight in the incubator at 37°C. 
The next day the cells were trypsinised and centrifuged at 1200rpm for 8 minutes. 
After centrifugation the cell pellet was re-suspended slowly in warm (37°C) KC1 
(0.56%) incubated for about 10-12 min at 37°C. The cells were then centrifuged at 
1200rpm for 8 min. The cell pellets were re-suspended in ice cold fix (3:1, methanol: 
acetic acid) and centrifuged at 1200rpm for 8 minutes. This procedure was repeated 
two more times. After the final centrifugation the cells were re-suspended in a small 
quantity of fresh ice cold fix. Slides immersed in ethanol were cleaned. With a 
liquipette microtip (Elkay) an aliquot of cells was dropped on to a clean slide from a 
height. The slide was left to dry at room temperature and then was examined for the 
presence of metaphases using a light microscope.
2.362 FISH ANALYSIS USING WHOLE CHROMOSOME PROBES
Whole chromosome painting was done using Cambio FISH probes. The protocol used 
was the one supplied by the manufacturers (Cambio). Whole chromosome probes for 
all the chromosomes except 9, 21,22 and Y chromosome were used (owing to lack of 
probes). The protocol used was as follows:
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DAY 1:
Fresh metaphase slides were prepared and air dried. The slides were then fixed for 1 
hr in fix (3:1 methanol:acetic acid) and then left to dry. The slides were then 
dehydrated in ethanol series for 2 min in each of 70%, 80%, 95% and 100% ethanol 
and left to dry overnight in an incubator at 42°C.
DAY 2:
The slides were fixed in acetone in a Coplin jar for 10 min and then air dried. The 
paints were warmed to 42°C and mixed well before use. An appropriate amount of 
paint (10 pi per slide) was denatured by incubation at 65 °C in a water bath for 10 
minutes. 5 pi of each of two chromosome probes (Cambio) were added to a micro­
centrifuge tube (two tubes were prepared each containing two chromosome probes) 
and was transferred to a 37°C water bath and was incubated for 1 hr.
The slides were then denatured by incubation in a Coplin jar with 70%v/v 
formamide/2xSSC at a water bath at 65°C for 2 minutes. The slides were then 
quenched in an ice cold ethanol series (70%, 80%, 95% and 100%v/v) for 2 minutes 
in each and then left to dry. lOpl of probe was added to each end of the slide (two at 
each end). Cover slips were placed on each end and sealed with rubber cement. The 
slides were then incubated overnight at 42°C in a humidified chamber.
DAY 3:
The following Coplin jars were prepared and pre-warmed in a water bath at 42°C:
3 jars with 2xSSC (pH7)
2 jars with post-hybridization wash 
9 jars with wash solution 
The rubber cement was removed and the coverslips were rinsed in 2xSSC (pH7) at 
42°C. The slides were washed by incubating for 5 minutes in each of two jars of
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50%formamide/0.5xSSC. The slides were then washed by incubating for 5 minutes at 
42°C in 2xSSC.
50|li1 of Avidin Texas Red (Vector) (diluted 1:500 blocking reagent) was added to 
each end of a slide and covered with a plastic coverslip. The slides were incubated at 
37°C for 20 minutes in a humidified chamber. After incubation the slides were 
washed three times in wash solution at 42°C for 5 minutes each.
50jli1 of the following mix was added to each end of the slide:
1.25pi FI (Detection reagent, Cambio)
500pl blocking reagent 
lp l biotin antiavidin (Vector)
The slides were then covered with plastic coverslip and incubated at 37°C for 20 
minutes. After that the slides were washed three times in wash solution at 42°C for 5 
minutes each.
Next 50pi of the following mix was added to each end of the slide:
5 pi F2 (Detection reagent, Cambio)
500pi blocking reagent 
lp l Texas Red (Vector)
The slides were covered with plastic coverslip and incubated at 37°C for 20 minutes. 
The slides were then washed three times in wash solution at 42 °C for 5 minutes each. 
Then the slides were dehydrated using an ethanol series (70%, 80%, 95% and 
100%v/v) and air dried. DAPI was prepared with lp l DAPI, 9pl distilled water and 
300pl mounting medium (Vectashield, Vector). 25pl of DAPI was added to each end 
of the slide. A glass coverslip was placed at each end ant the slides were visualised 
under Olympus BH2 microscope.
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2.4 RESULTS
2.41 GENERAL DATA ON CELL CULTURE
Biopsies were obtained from 38 different patients with BE or BE with various grades 
of dysplasia. On an average 3-4 biopsies were obtained from each patient. Depending 
on the number and size of biopsies, cultures were initiated in 3-5 different flasks from 
each patient. Cultures were initiated exclusively by explant technique in 33 patients 
whilst both explant and enzymatic technique were used to intiate culture in the 
remaining 5 patients. Of the 38 patients 30 were male and 8 were female. 12 of them 
had long segment Barrett’s and 26 had short segment Barrett’s. 6 patients had high 
grade dysplasia, 12 had low grade dysplasia and 20 had Barrett’s metaplasia with no 
dysplasia (see fig 2.4). The mean age of the patients was 64 years (63.89).
FIGURE 2.4A SHOWING PATIENT PROFILE
MALE FEMALE TOTAL
BE 15 5 20
LGD 9 3 12
HGD 6 0 6
LSB 9 3 12
SSB 21 5 26
FIGURE 2.4B SHOWING THE DISTRIBUTION OF THE GRADES 
OF DYSPLASIA IN PATIENTS WITH BE.
□  HGD □  LGD QBE
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2.42 EXPLANT TECH N IQ U E
Cultures were initiated in 38 patients with the explant technique. Of these, samples 
from thirteen patients were successfully cultured while samples from twenty five 
patients either failed to grow or were lost to infection (see fig 2.5).
FIGURE 2.5 SHOWING THE OVERALL RESULT OF BE CELL CULTURE 
WITH EXPLANT AND ENZYMATIC TECHNIQUE
50 
40
30
20
10
0
□  TOTAL □  GROWTH El FAILURE
EXPLANT ENZYMATIC
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2.43 M ORPHOLOGY AND GROWTH
The general cell morphology and growth were assessed using routine microscopy. On 
microscopic examination multiple outgrowths of small epithelial cells were seen 
within the first three to four days. The outgrowths then spread out into a monolayer 
sheet of cells covering the surface of the flask. Morphologically the cells appeared 
polygonal in shape with irregular cytoplasmic processes (see figure 2.6). The 
epithelial nature of the cells was confirmed by the characteristic morphology of the 
cells. No special staining was performed to confirm the epithelial nature of the cells. 
The cultures were deemed positive when they could be maintained in monolayer for 
greater than 6-8 weeks or when they filled up more than 50% of the surface area of 
the flask. Though most of the cultures could be grown in monolayer, not all of them 
could be successfully sub-cultured (only two cultures could be sub-cultured once). 
They were either lost due to fibroblast overgrowth (recognised by their spindle shaped 
morphology) or were lost due to senescence. Although some of the cultures could be 
sub-cultured once, the cells progressively increased in diameter during second passage 
and failed to show attachment and growth. A total of 179 cultures were initiated from 
38 patients. Of the 179 cultures 27 were successful whilst 98 were lost to infection 
and 54 failed to grow (see fig 2.7). Possible associations between the growth 
characteristics (ability to obtain positive) cultures and various culture conditions, 
gender, age and grade of dysplasia were analyzed using the chi-square test. Exact P- 
values were calculated using stata software (Stata Corporation USA).
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2.44 SEX AND GROW TH CHARACTERISTICS
35 samples from eight female patients and 144 samples from thirty male patients were 
used to initiate cultures (see fig 2.8). Of the 35 samples from the female patients two 
samples (from the same patient) were successfully cultured while the rest failed either 
due to infection or inability to grow. Similarly of the 144 samples from male patients 
only 25 showed growth, 81 were infected while 38 failed to grow. Successful cultures 
were more common in male patients compared to female patients. Though there was 
higher yield of positive cultures in male patients it was not found to be statistically 
significant (p value of = 0.084).
2.45 GROW TH CHARACTERISTICS AND HISTOLOGY
The maximum proportion of positive cultures was seen in patients with BE whilst 
patients with HGD had the lowest proportion of positive cultures. The rate of 
infection was the highest in patients with HGD and the least in patients with BE (see 
figure 2.9). The proportion of samples which failed to grow was highest in patients 
with LGD and the least in patients with HGD. Statistical analysis did not show any 
significant relationship between the grade of dysplasia and the ability of the cells to 
grow (p value =0.158 using chi-square test).
2.46 GROWTH CHARACTERISTICS AND AGE
The maximum proportion of growth was seen in the age group 31-40 years and the 
lowest proportion was seen in the age group 81-90 (0%). The highest proportion of 
infection was seen in the age group 81-90 while patients in the age group 51-60 years 
had the highest proportion of samples which failed to grow (see figure 2.10). The 
ability to obtain positive culture did not however show a definite pattern of
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FIGURE 2.7 SHOWING THE NUMBER OF CULTURES INITIATED BY 
EXPLANT TECHNIQUE USING A TOTAL OF 179 SAMPLES
EXPLANT NUMBER PERCENT
GROWTH 27 15.08
INFECTION 98 54.75
NOGROWTH 54 30.17
Total 179 100.00.
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EXPLANT M ETHOD
FIGURE SHOWING THE RESULTS OF THE EXPLANT TECHNIQUE
FIGURE 2.8 SHOWING THE RELATIONSHIP BETWEEN SEX AND GROWTH
CHARECTERISTICS OF THE CULTURES
EXPLANT FEMALE MALE TOTAL
NO. % NO. % NO.
GROWTH 2 5.7 25 17.4 27
INFECTION 17 48.6 81 56.3 98
NOGROWTH 16 45.7 38 26.4 54
TOTAL 35 144 179
FEMALE MALE
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EXPLANT METHOD
Histograms by SEX OF THE PATIENT
FIGURE 2.9 SHOWING THE RELATIONSHIP BETWEEN THE GRADES OF
DYSPLASIA AND GROWTH PATTERN
EXPLANT BE HGD LGD TOTAL
NO. % NO. % NO. % NO.
GROWTH 19 19.8 2 7.7 6 10.5 27
INFECTION 46 47.9 21 80.8 31 54.4 98
NO GROWTH 31 32.3 3 11.5 20 35.1 54
TOTAL 96 26 57 179
BE HGD
o LGD
GRO
Total
INF NOGRO GRO INF NOGRO
EXPLANT METHOD
Histograms by HISTOLOGY OF THE SAMPLES
FIGURE 2.10 SHOWING THE RELATIONSHIP BETWEEN THE AGE GROUP
AND GROWTH PATTERN
AGE GROUP GROWTH INF NO GRO TOTAL
NO. % NO. % NO. % NO. %
1 (31-40) 5 | 18.5 9 1 9.2 6 | 11.1 20 | 11.2
2(41-50) 4 | 14.8 H 1 11.2 3 | 5.6 18 | 10.1
3(51-60) 8 | 39.6 17 | 17.4 15 | 27.8 40 | 22.4
4 (61-70) 6 | 22.2 21 | 21.4 7 | 12.9 34 | 18.9
5 (71-80) 4 | 14.8 19 | 19.4 13 | 24.1 36 | 20.1
6(81-90) 0 1 o 21 | 21.4 10 | 18.5 31 | 17.3
TOTAL 27 98 54 179
agegroup=
ag eg roup— 4
GRO
“i  r
INF NOGRO
a g e g r o u p = 2
i i r
agegroup==5
n
l i r
GRO INF NOGRO
a g e g r o u p = 3
a g e g r o u p = 6
Total
GRO INF NOGRO
EXPLANT METHOD
Histograms by AGE GROUP OF THE PATIENT
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relationship to the age group of the patient. Statistical analysis did not show any 
significant relation between the age of the patient and its ability to grow in vitro (p- 
value =0.104). Hence it is unlikely that the age group of patient’s had a significant 
influence on the growth.
2.47 EFFECTS OF ANTIBIOTIC CONCENTRATION ON THE 
GROW TH PATTERN
Different concentrations of various antibiotics (namely penicillin, streptomycin and
amphotercin-B) were used to control infection. The various concentrations used are
shown in the table (figure 2.11). It is obivious from the histogram, that with lower
concentration of antibiotics the rate of infection was high. Increasing the
concentration of the antibiotics decreased the rate of infection.
Maximum successful cultures were obtained with the antibiotic concentration of 
penicillin and streptomycin in the range of 300-400 Units and amphotercin in the 
range of 50-75pg. Statistical analysis (chi-square test using stata) showed that the 
concentration of the antibiotics had a significant effect (p<0.005) on the overall 
growth pattern (ie growth, inhibition or infection). Individual analysis of the effects of 
antibiotics on growth and infection rate using chi-square test revealed a stastically 
significant association (p values of 0.002 and 0.003 respectively). Though there was 
apparent increase in the inhibitory effect of increasing concentration of antibiotics on 
growth of the cells this was not found to be statistically significant (p= 0.912). The 
enzymatic technique was used to initiate cultures in samples obtained from five 
different patients. Most of the samples were either lost to infection or failed to grow. 
This technique was used only during the initial part of our study. Owing to the poor 
results it was not used subsequently.
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FIGURE 2.11 SHOWING THE RELATIONSHIP BETWEEN THE ANTIBIOTIC
CONCENTRATION AND GROWTH PATTERN
PEN-STREP GROWTH INFECTION NO GROWTH TOTAL
AMP- U/ml & (xg/ml NO. % NO. % NO. % NO. %
100/25 0 0 23 | 23.5 9 | 16.7 32 | 17.9
200125 0 0 17 17.4 5 j 9.3 22 j 12.3
200/50 3 11.1 19 19.4 8 | 14.8 30 | 16.8
300/50 5 18.5 16 16.3 9 | 16.7 30 | 16.8
300/75 6 22.2 10 10.2 8 j 12.9 24 j 13.4
400/100 8 29.6 7 7.1 10 | 18.5 25 j 13.9
400/75 5 18.5 6 12.1 5 | 9.3 16 8.9
Total 27 98 54 179
Pearson chi2( 12) = 28.3006 P value =0.005
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Histograms by ANTIBIOTIC CONCENTRATION
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2.5 INTERPHASE FISH STUDIES
Interphase FISH was used to detect numerical chromosomal abnormalities from the 
cultured samples. Interphase FISH was used because it was extremely difficult to 
obtain proper metaphase spreads from the cultured cells. All the slides were coded 
before counting. The hybridization signals were counted in about 300-400 interphase 
nuclei per sample. Nuclei lacking hybridization signals were excluded from analysis 
in order to avoid erroneous results caused by inadequate hybridization. Nuclei 
showing over-lapping, damage or smearing, or those covered with bacteria were not 
included in the analysis. All the samples were visualized with an Olympus BX50 epi- 
fluorescence microscope with single and multiple band pass filters for simultaneous 
detection of DAPI (white), propidium iodide (orange), Cy-3 (red) and FITC (green). 
All the images were captured with a camera coupled to the Mac-probe version 4.1 
software (Applied imaging software, Newcastle Upon Tyne, UK).
Numerical abnormalities were detected from samples obtained from five different 
patients. Of these three were BE with no dysplasia, one LGD and one HGD. Although 
samples from 13 patients were successfully cultured it was not possible to obtain cells 
for interphase study from all of the cultured samples. This was because at the 
beginning of the study many of the cultures were lost as they were either left in 
culture for a long period of time in order to obtain long-term culture or were lost in an 
attempt to obtain metaphase spreads. Normal controls were not used in the study as it 
was extremely difficult to obtain cultures from normal biopsy specimens. Each half of 
the biopsy specimen was divided into two halves with one half sent for 
histopathological analysis whilst the other half used for culture and interphase FISH 
analysis using centromeric probes for the chromosomes four and chromosome eight. 
The numerical chromosomal abnormalities of chromosomes four and eight 
encountered in five different patients are shown in table 2.4 and table 2.5. Presence of
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more than two signals was interpreted as gain whilst fewer than two signals were 
interpreted as loss of chromosome. All the specimens showed aneusomy ranging from 
0.75 -  20%. Aneusomy was seen for both chromosomes four and eight. Most of the 
samples showed both gain and loss of chromosomes (see figure 2.12 and table 2.6) 
although hyperploidy was the predominant change for both chromosomes four and 
eight. Hyperploidy of chromosome four was seen in all cases ranging from 0.75% - 
18.2%. Hyperploidy was seen in cases with both BE (12.75%) and HGD (12.89%). 
Loss of chromosome four was seen in a range of 0.5 -  1.84% of the counted cells (see 
figure 2.13). Similarly hyperploidy seemed to be the major change with chromosome 
eight. The total gain of chromosome eight varied from 0.29% - 13.2%. Loss of 
chromosome eight ranged from 0.25% - 0.86% (see figure 2.14). Hyperploidy of 
chromosome eight was predominant in one particular patient with HGD. Hyperploidy 
of both chromosome four and eight was common in our study. Owing to the small 
number of samples included in the study and lack of controls, it is extremely difficult 
to interpret the significance of these changes. The study does however suggest that 
hyperploidy of chromosome four could be an early change in the progression of BE to 
adenocarcinoma.
2.6 DISCUSSION
Primary culture of epithelial cells from human gut and oesophagus can be a difficult 
process. Establishment of long-term cell lines is hard, labour intensive, time- 
consuming, and unpredictable work with a very low success rate. Studies have shown 
that cells are more difficult to grow in vitro in the early stages of cancer than in the 
later stages.
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TABLE 2.4 SHOW ING THE RESULTS OF INTERPHASE FISH W ITH CEP
PROBE FOR CHROM OSOM E FOUR
PT
.NO
HISTOLOGY NO OF CHROMOSOME COPIES NO OF 
CELLS 
COUNTED1(%) 3(%) 4(%) 4+ (%)
A BE 5(1.25) 51(12.75) 04(1.00) 0 400
B BE 3(0.75) 38(09.50) 02(0.50) 0 400
C BE 2(0.57) 27(07.71) 03(0.86) 0 350
D LGD 2(0.50) 03(00.75) 00 0 400
E HGD 7(1.84) 49(12.89) 20(5.26) 2(0.53) 380
TABLE 2.5 SHOWINGTHE RESULTS OF INTERPHASE FISH WITH CEP 
PROBE FOR CHROMOSOME EIGHT
PT
.NO
HISTOLOGY NO OF CHROMOSOME COPIES NO OF 
CELLS 
COUNTED1(%) 3(%) 4(%) 4+ (%)
A BE 3(0.75) 4(1.00) 01(0.25) 0 400
B BE 2(0.50) 03(0.75) 02(0.50) 0 400
C BE 3(0.86) 01(0.29) 0 0 350
D LGD 1(0.25) 02(0.50) 0 0 400
E HGD 3(0.79) 41(10.80) 9(2.40) 0 380
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FIGURE 2.13 SHOWING CORRESSPONDING GAIN AND LOSS OF
CHROMOSOME 4 IN FIVE DIFFERENT PATIENTS
HGD HGD
LGC LGD
BE BE
B E BE
BE BE
5 10
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FIGURE 2.14 SHOWING CORRESSPONDING GAIN AND LOSS OF
CHROMOSOME 8 IN FIVE DIFFERENT PATIENTS
HGD
LGD LGD
BE
BE
BE
BE
-2 0 2 4 6 8 10 12 14
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TABLE 2.6 SHOWING TOTAL GAIN AND LOSS OF CHROMOSOME FOUR 
AND EIGHT IN FIVE DIFFERENT PATIENTS
PT.NO HISTOLOGY
CHROMOSOME 4 CHROMOSOME 8
% LOSS % GAIN % LOSS % GAIN
A BE 1.25 13.75 0.75 1.25
B BE .75 10 0.5 1.25
C BE 0.57 8.57 0.86 .29
D LGD 0.5 0.75 0.25 .50
E HGD 1.84 18.68 0.79 13.20
Primary cell lines serve as an excellent tool to study the physiological and 
pathological processes occurring in the cells of their origin. Cultured cells provide the 
advantage of using human cells. The advantage of primary cell culture is that they are 
more representative of the organ under consideration. More importantly, primary cell 
lines from Barrett’s oesophagus could serve as an excellent model to study the 
metaplasia-dysplasia-carcinoma sequence in vivo. Not only would it enable us to 
study the cytogenetic changes but also to evaluate the effects and role of various 
noxious substances (such as acid, pepsin, bile, trypsin) in the pathogenesis of BE and 
oesophageal adenocarcinoma. A review of the literature has shown that very few 
workers from the past have had success with primary culture of Barrett’s oesophagus. 
Most of these studies describe methods of culture of BE.
Our results have been comparable to studies conducted in the past. Like most workers 
in the past we used the explant technique to culture our cells. We were able to obtain 
monolayer culture with an overall success of 34.2% which is comparable to most 
other studies in the past.
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Previous studies have not noted any significant difference in cell growth based on 
histological grade of the specimen and sex of the patients. Similarly we did not record 
any significant difference in the ability of the cells to grow based on their histology. 
However there seemed to be a slightly better success rate in men than in women and 
in younger patients. The former could be because of the small number of women 
included in the study. We noticed a significant difference in the ability of the cells to 
grow based on antibiotic concentration (see fig 2.11). At lower concentrations (of 
antibiotics) there was a significantly high rate of infection. Increasing the 
concentration of antibiotics had a significant effect on decreasing the infection rates 
and improving the culture yield.
We had very limited success at obtaining serial passages. Attempts to sub-culture 
these cells resulted in their senescence except in two samples (which could be 
passaged twice). Despite using the same technique as described in previous studies we 
were unable to obtain serial passages. This clearly shows that the technique is 
unpredictable and not easily reproducible. Most of our positive cultures lasted for 6-8 
weeks. In the early part of the study most of the cultures were lost to senescence as 
they were left for a longer period of time or disaggregated to obtain subcultures. 
Towards the end of the study the cell cultures were trypsinised at an early stage in 
order to obtain cells to perform interphase FISH study. It was not possible to obtain or 
process more samples due to constraints of time and lack of adequate quantity of 
biopsy sample.
The short term primary culture technique could be used for several other studies such 
as interphase FISH. However they would not be suitable for short term toxicity 
studies as they are not easy to obtain in a reproducible manner, which would make it 
difficult to standardize testing conditions.
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Senescence of the cells was one of the major factors affecting the long term survival 
of the Barrett’s cells in vitro. This is probably because the cells undergo terminal 
differentiation. Explantation of the cells itself induces trauma which can shorten the 
life of the cells. The cells explanted from organisms and grown in vitro have a 
relatively brief replicative lifespan compared to the impressively long and robust 
replication they have in vivo. This is possibly due to the fact that tissue organization, 
hormone levels and other homeostatic mechanisms play an important role in growth, 
which are absent in vitro (Rosen 1978; Rubin 1997; Elsasser et al, 1998).
Cell anchorage has been thought to be one of the important factors in survival of the 
cells. Studies have shown that cell anchorage not only provides structural anchorage 
but also mediates pivotal survival signals for the survival of the cell. Survival of most 
normal epithelial cells requires adhesion to the basement membrane. Loss of cell- 
basement membrane contacts results in death of such cells by apoptosis, a 
phenomenon known as anoikis (Meredith et al, 1993; Frisch et al, 1994). Anoikis is 
likely to be one the mechanisms terminating the life of cells in vitro.
One other factor responsible for the limited replicative life span of the cell in culture 
is the absence of the enzyme telomerase which maintains the length of telomeres. The 
absence of this enzyme can lead to critical shortening of the protective ends of 
chromosomes. Studies have shown that cell multiplication is dependent on a minimal 
telomere length. Activation of the telomerase enzyme is one of the methods to 
immortalize cell lies. More recently immortalised Barrett’s cell lines have been 
generated by activation of the telomerase enzyme(Palanca-Wessels et al, 2003).
An increasing number of changes involving oncogenes, tumor suppressor genes 
growth factors, cell cycle related proteins and chromosomal ploidy have been 
described in patients with oesophageal adenocarcinoma and Barrett’s oesophagus.
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To date only a limited number of studies have investigated the cytogenetic changes in 
Barrett’s oesophagus. A number of workers have detected loss and gain of several 
chromosomes using various methods such as flow cytometry, CGH and interphase 
FISH techniques. Increased frequencies of ploidy with progression to dysplasia and 
adenocarcinoma have been described in the past. The results of most of these studies 
have been inconsistent and none of the markers described so far can be reliably used 
to predict the progression of BE to oesophageal adenocarcinoma.
Studies performed by our group using CGH showed that there was amplification of 
chromosome four and chromosome eight in patients with BE (Croft et al, 2002). 
These changes were seen mostly in patients with high grade dysplasia. CGH detects 
changes when present in high proportion of the cells. Changes present in a low 
proportion of cells can easily overlooked by CGH. We therefore used interphase FISH 
technique to see if these changes occurred in the early stages of BE.
Interphase FISH is more sensitive and can detect changes when present in smaller 
proportion of the cells. The initial goal of our study was to obtain metaphase spreads 
from growing cells which would enable us to perform a complete karyotyping (using 
whole chromosome FISH). As it was impossible to obtain metaphase spreads from the 
growing cells, interphase FISH technique was used to analyze the chromosomal 
aberrations.
Our studies did confirm the changes (amplification of chromosome four and 
chromosome eight) previously detected by our CGH studies. These changes 
(hyperploidy of chromosome four) were seen in patients with HGD as well as patients 
with BE. This suggests that aneuploidy could be an early event in tumorigenesis. 
Hyperploidy of chromosome four both in early and late stages of Barrett’s suggests 
that it could be involved in the neoplastic progression of BE. Studies in the past have 
recorded both amplification and loss of chromosome four. It is difficult to make a
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sensible interpretation of the results as the number of samples analyzed in the study 
was too small. A study with larger number and appropriate controls should be more 
conclusive (Doak et al., 2003).
Our study shows that interphase FISH can be reliably used for detection of numerical 
chromosomal aberration in BE. Large numbers of samples could not be obtained in 
this study because of the constraints imposed by cell culture. Although cells can be 
obtained for interphase study by short term cell culture, it is difficult to use because of 
lack of reliability, reproducibility and simplicity. The only published study so far in 
which cell culture was used as method to investigate cytogenetic abnormalities was by 
Garewal et al (Garewal et al., 1992). Although Wessels et al manged to generate long 
term cultures of BE their cytogenetic studies were based mostly on CGH and flow 
cytometry (Palanca-Wessels et al., 1998). Studies by other worker have only 
described techniques to culture BE and no attempts have been made to perform 
cytogenetic analysis at the time of publication or subsequently. Clearly this shows that 
although BE cells can be cultured in short term and possibly long term it is highly 
unreliable and not easily reproducible. Lack of simplicity makes this technique 
unacceptable. Other techniques such as brush cytology and touch prep technique are 
much simple and less time consuming for obtaining cells for FISH analysis. Unlike 
cell culture they can be relied upon and analyzed quickly. In view of the difficulty 
encountered in obtaining a continuous cell line from BE it was not possible achieve 
some of the goals that were originally planned. We decided to use an alternative 
model for our further studies which would be a continuous cell line that would be 
immortal and would replicate with ease and at the same time bear some similarities to 
the tissue of origin. The OE33 cells, which are derived from Barrett’s oesophageal 
adenocarcinoma were selected as they fulfilled our requirements. The next chapter 
briefly describes the OE33 cells and their characterization.
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CHAPTER 3 
CHARACTERISATION OF THE 
OE33 CELL LINES
3.1 INTRODUCTION
Cytogenetic analysis of tumor cells provides essential data regarding the origin, 
biology, behavior and prognosis of the tumor. Not only does it identify the lineage to 
which the cell belongs but also enables monitoring of cell lines for instability and 
variation, and to detect cross contamination (Freshney 1987). The information 
regarding solid tumours and carcinomas is limited owing to the technical difficulties 
in culturing the neoplastic cells and partly due to the karyotypic complexity of some 
of these cells. This chapter deals with the cytogenetic analysis of the OE33 cells 
which were generated by Rockett et al in 1997 from oesophageal adenocarcinoma 
cells(Rockett et al., 1997).
3.2 CHARACTERISATION OF THE CELL LINES
3.21 MORPHOLOGY
This is the simplest and most direct technique to identify cells, although it is not the 
most reliable method. It is usually possible to identify epithelial from fibroblastic cells 
by their appearance. Epithelial cells are regular and polygonal with a clearly defined 
edge. The fibroblasts usually appear as bipolar or multipolar cells with the length 
usually being twice that of the width. Some times it may be difficult to identify the 
epithelial nature of the cells based on the morphology alone. There are certain 
structurally related molecules called cytokeratins which are ubiquitously expressed by 
both normal and experimentally altered epithelial cells. Identification of these 
cytokeratins with immunohistochemical techniques serves as a reliable marker for 
epithelial cells (Moll et al, 1982).
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3.22 CYTOGENETIC ANALYSIS
3.221 CHROMOSOME BANDING
Chromosomal alterations play an important role in neoplasia. A variety of genes like 
the oncogenes, the tumour suppressor genes and genes associated with apoptosis can 
all be affected by chromosomal deletions, translocations or amplifications. 
Identification of recurrent cytogenetic alterations can be of diagnostic and prognostic 
significance. The earliest karyotyping was performed by Hungerford et al in 1959 
from peripheral blood cultures by using relatively crude techniques (Hungerford et al, 
1959). The chromosomal banding itself was first introduced by Caspersson et al in 
1968 (Caspersson et al, 1968). Over the years, cytogenetic techniques have made 
immense progress from simple banding techniques to advanced multicolour FISH (M- 
FISH) and spectral karyotyping (SKY) which are more sensitive and accurate. 
Chromosome banding techniques have facilitated the precise identification of 
individual chromosomes. G-banding obtained by digesting the chromosomes with 
proteolytic trypsin followed by Giemsa staining still remains the the most widely used 
technique for routine chromosome analysis. The Giemsa staining results in a 
characteristic banding pattern which is unique for each chromosome (figure 3.1). 
Based on the size and position of the centromere, and the G-banding pattern, the 
individual chromosomes are identified. The distinctiveness of these banding patterns 
not only enables identification of specific parts of a chromosome but also to locate the 
sites of chromosomal breaks and translocations. The limitation of G-banding is that it 
cannot detect chromosome structural rearrangement involving segments smaller than 
a band (around 10 Mb) or complex structural rearrangements (Heim S 1995). 
Similarly staining with Quinacrine, a fluorescent dye that inserts (intercalates) 
between base pairs in the DNA helix, produces Q bands. Q banding is generally not 
preferred because Q bands tend to fade away with time.
Figure 3.1 A. G banded metaphase B. The same Metaphase after SKY analysis 
[Adapted from Reid et al., 1998].
3.222 FISH
FISH (discussed in detail in chapter 2 section 2.65) has emerged as an important tool 
for the study of chromosome structure and genome mapping. FISH or chromosome 
painting allows the visualization of individual chromosomes in metaphase or 
interphase cells and the identification of both numerical and structural chromosomal 
abnormalities. Newer techniques like M-FISH (Multicolour FISH) and SKY (Spectral 
Karyotyping) enable painting and visualisation of all the 24 chromosomes in one 
experiment. Both M-FISH and SKY involve simultaneous hybridization of multiple 
chromosome painting probes, each tagged with a specific fluorochrome or 
fluorochrome combination resulting in the differential colour display of all the 
chromosomes, i.e. colour karyotyping (see figure 3.1). The advantage of this 
technique over the conventional G-banding include improved accuracy in the 
detection and characterization of translocations and an appreciable shortening of the 
time required for performing chromosome analysis. The major disadvantage is its 
poor sensitivity to detect aberrations like intra-chromosomal deletions, duplications 
and inversions (Le Beau 1996). The battery of G-banding, FISH methods and CGH 
used together can identify numerical alterations on a global basis, localize breakpoints
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of translocations and deletions and help in-complete derivation of complex re­
arrangements.
3.3 MATERIAL AND METHODS
3.31 OE33 CELL LINES
The OE33 cells were purchased from the EACC. The OE33 are oesophageal 
adenocarcinoma cells derived from a 73 year old female patient with poorly 
differentiated Barrett’s adenocarcinoma. These cells which have been characterized 
by Rockett et al., 1997 express epithelial cytokeratins and are tumourigenic in nude 
mice (Rockett et al., 1997).
3.311 CULTURE OF OE33 CELLS
The OE33 cells (described in detail in chapter 3) were cultured in monolayer in 25 
cm tissue culture flasks (Nunclon) using:
• RPMI 1640 without glutamine (in vitro )
• 10%(v/v) Foetal calf serum (Gibco BRL)
• Penicillin lOOIU/ml (Gibco)
• Streptomycin 100pg/ml (Gibco)
• Glutamine lmm/L (Gibco)
The cells were cultured in a humidified atmosphere of 5% CO2 , 95% air at 37°C. The 
cells were sub-cultured once they became confluent every four to six days. Fresh 
culture medium was added to the flask every two to three days. To split the cells the 
culture medium was removed by suction and discarded. About 4-5ml of 2.5% trypsin 
EDTA (Gibco BRL) was added. The fluid was washed around gently and discarded. 
The flask was rinsed again with 4-5ml of trypsin. The trypsin was discarded after 30- 
60 seconds so as to leave enough trypsin to just cover the bottom of the flask. The
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flask was then transferred into the incubator at 37°C and left for about 5-10 minutes. 
The monolayer was examined at frequent intervals under the microscope to see for 
signs of detachment from the surface of the flask, which was indicated by the 
rounding up of the cells. The flask was then gently tapped to aid the detachment of the 
cells. When the cell monolayer was completely detached and evenly dispersed about 
5-10 ml of fresh medium was added. The cells were then split in the ratio of 1:3 or 1:4 
depending on the density of the cells. Fresh culture medium was added to each flask 
to make up the quantity to 10 mis. The flasks were gassed with CO2  and then 
incubated at 37°C in humidified atmosphere and 5% CO2 .
3.312 STORAGE OF OE33 CELLS
Cell stocks were preserved in liquid nitrogen to prevent contamination, and also to 
serve as backup in the event of technical problems such as bacterial infection or 
incubator failure. Cultures that had reached near confluence were trypsinised as 
already described. The cells were then re-suspended in the culture medium and 
centrifuged at 1500 RPM for 8 minutes. The supernatant was discarded and the pellet
(\ 7was re-suspended at approximately 5x10 - 2x10 cells/ml in 90% heat inactivated 
foetal calf serum (HIFCS) and 10% DMSO. DMSO is a cryoprotective agent, which 
prevents physical damage to the cell by ice crystals. The cells (1.5 ml of the 
suspension) were then transferred into sterile cryovials. The vials were labelled dated 
and placed in a bio-freezing (Bicell, Nihon freezer co Ltd) at -20°C overnight and 
then transferred to a cryomed liquid nitrogen freezer the next day.
3.313 THAWING OF CELL STOCK
To thaw a frozen cell stock the ampoule was placed in a 37°C water bath. The cell 
suspension was then transferred to a centrifuge tube containing pre-warmed culture 
medium and centrifuged at 1500RPM for 8 minutes. The supernatant was removed
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and the cells were re-suspended in fresh culture medium. The cell suspension was 
then transferred to a 25cm flask and more culture medium was added to make up the 
total quantity to 10 mis. The flask was then gassed with CO2  and incubated at 37°C in 
humidified atmosphere and 5% CO2.
3.32 GIEMSA BANDING (G-BANDING)
The metaphase spreads were prepared from the OE33 cells as describer in Chapter 2 
section 2.361. The protocol used for G banding was similar to the one described by 
Sumner et al (1971). G banding was performed as follows.
Aged slides (10-14 days) were put in 2 X SSC in a plastic Coplin jar at 60-65°C for 
90 minutes ( 2 X SSC = sodium chloride 17.53g (0.3m) tri-sodium citrate 8.82g 
(0.03M) dissolved in 1 litre of deionised H2 O and made up to lOOmls). The slides 
were removed from the bath and left to cool at room temperature. Thirty minutes 
before cooling 0.4% of trypsin (0.2g dissolved in 50mls saline) solution was made up. 
Once the slides cooled they were taken out of the 2 X SSC and put into normal saline 
(0.9 percent solution of sodium chloride) for 2 minutes. The slides were then drained 
off one by one by touching onto a filter paper, and then placed in a horizontal plane 
and flooded with the 0.4% trypsin for 1 minute. To stop the effect of trypsin, slides 
were put back into the normal saline to dilute it out (5-10 seconds). Slides were then 
transferred from the normal saline into phosphate buffer pH 6.8. They were then 
rinsed in the buffer once (in Coplin jar) and stained whilst the slides were still wet 
with 1 part Giemsa and 9 parts of the Gurr phosphate buffer (pH 6.8 0.005M 
phosphate) for 8 minutes. Finally they were washed with phosphate buffer (pH 6.8) 
and left to dry. The cells were counted under Olympus BH2 microscope with a triple 
band pass filter. About 50 metaphase cells were counted. Karyotyping was attempted 
with the Mac karyotype software.
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3.33 FISH ANALYSIS USING WHOLE CHROMOSOME PROBES
Whole chromosome painting was done using Cambio FISH probes. The protocol used 
was the one supplied by the manufacturers (Cambio). The details of which are 
described in Chapter 2 section 2.362. Whole chromosome probes for all the 
chromosomes except 9, 21, 22 and Y chromosome were used, (due to lack of probes).
3.34 MICROTUBULIN AND CENTROSOME STAINING
The OE33 cells were seeded on a glass slide in a concentration of lx l0 5/mm and were 
grown for over 24 hrs. The slides were washed by rinsing in ice cold PBS .They were 
then fixed with 90% methanol at -20°C for 30 minutes and subsequently in acetone 
at -20°C for 20 seconds. They were then rinsed in PBS/Tween (250 pi in 500 pi 
PBS). The slides were then incubated with primary antibody specific for ytubulin and 
a tubulin as follows.
1. 50 pi of mono-clonal Anti - y-Tubulin( T6557 diluted 1 in 200) was added 
to each slide and covered with plastic cover slips and incubated in a 
humidified chamber at 37°C for 2 hours. It was then rinsed in PBS/Tween at 
37°C
2. Next 50 pi of anti mouse IgG (Fab Specific) TRITC conjugate (T7782 diluted 
1 in 32) was added to the slides and covered with plastic cover slips and 
incubated in a humidified chamber at 37°C for 2 hours. It was then rinsed in 
PBS/Tween at 37°C.
3. 50 pi of monoclonal Anti - a  - Tubulin Conjugate (F2168 diluted 1 in 100) 
was added to the slides and covered with plastic cover slips and incubated in a 
humidified chamber at 37°C for 1 hour. It was then rinsed with PBS/Tween.
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4. The slides were then counterstained with DAPI (lp l DAPI+9plH20+300pl 
vectorshield) and covered with glass cover slips and visualised under the 
microscope.
At least 200 cells were counted for each slide and were examined for 
abnormalities centrosome structure, mitotic spindles and nuclear morphology. The 
cenetrosomes were considered abnormal if the cells contained more than two 
copies per cell or if they were many times larger than the normal centrosome or if 
they were arranged in large patchy aggregates.
3.4 RESULTS AND DISCUSSION
3.41 METAPHASE SPREAD
Analysis for the chromosome number revealed gross polyploidy of the OE33 cell 
lines. Most of the cells had near tetraploid or more than tetraploid number of 
chromosomes. 100 metaphase cells were counted. The mean chromosome number for 
the OE33 cells was 90.27 with a modal karyotype number of 96. Repeat metaphase 
chromosomal counts after a year of initiating the cultures did not reveal any 
significant change in number.
3.42 G BANDING
G banding using the trypsin technique is widely used in cytogenetic studies to identify 
chromosomes in metaphases. Giemsa banding produces a series of light and dark 
bands along the lengths of chromosomes, permitting the identification of 
chromosomes and chromosome regions. G banding of the OE33 cells revealed that 
there were multiple copies of most of the chromosomes (see figure 3.2). Many of the 
chromosomes also had gross structural abnormalities (probably deletions and 
translocations). Owing to gross polyploidy and complex structural abnormalities it
I l l
was virtually impossible to perform a complete Karyotype on these cells. Plate 3.1 
shows G-banding of OE33 cells with attempted karyotyping in plate 3.2.
3.43 WHOLE CHROMOSOME PAINTING
To obtain more detailed information on the structural and numerical chromosomal 
abnormalities, FISH was performed using whole chromosome probes. Whole 
chromosome probes for chromosome 1, 2, 3, 4, 5, 6, 7, 8, 10, 11, 12, 13, 14, 15, 16, 
17, 18, 19, 20 and X (except 9, 21, 22 and Y) were used in different combination. 
Each slide contained a cell suspension with metaphases at both ends. At each end two 
chromosome probes with different colour were used. In total four different 
chromosome probes were used for each slide. 20 metaphases were scored at each end 
of the slide and therefore 40 per slide per cell line. Metaphases were scored for the 
number of each chromosome and for the presence of translocation/ deletion. The 
results of the whole chromosome painting of the OE33 cells have been summarized in 
the table 3.1. Most cells showed multiple copies of the chromosome analyzed with 
complex translocations and possibly deletions.
1 1 2
FIGURE 3.2
METAPHASE COUNT OF OE33 CELL LINES
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PLATE 3.1 Metaphase spreads from two different OE33 cells banded with the 
conventional GTG banding technique.
PLATE 3.2 Karyotyping o f two different metaphase spreads o f OE 33 cells 
using the G-banding technique. Picture demonstrates the difficulty in karyotyping 
due to gross aneuploidy and complex reaarangements o f the chromosomes.
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PLATES 3.3 to 3.15 show the different chromosomes that were analyzed using whole 
chromosome painting labeled with either biotin or FITC and detected with avidin- 
Texas Red or the FITC respectively.
PLATE 3.3 Shows the FISH analysis with whole chromosome probe for chromosome 
one (green) and chromosome sixteen (red). Most of the cells showed four copies of 
chromosome one and four copies of chromosome sixteen. None of the cells showed 
normal copies of either one or sixteen. Frequent deletions and translocations of both 
the chromosomes were also noted.
PLATE 3.4 shows FISH analysis of chromosome two (red) and chromosome 
seventeen (green). The cells in these metaphases revealed a modal population with 
three copies of chromosome two and four copies of chromosome seventeen. Two of 
the cells showed normal copies of chromosome two.
PLATE 3.5 shows FISH analysis of chromosome three (red) and chromosome fifteen 
(green). The probes revealed a modal cell population with three copies for both 
chromosome three and chromosome fifteen. None of the counted cells showed normal 
copies of either chromosome three or fifteen.
PLATE 3.3
Shows the w hole chrom osom e painting o f  chrom osom e one (green) and 
chrom osom e sixteen (red). At least four copies o f  chrom osom e one and four 
copies o f  chrom osom e sixteen are seen with possible deletion and translocations.
PLATE 3.4
Show s the w hole chrom osom e pain ting  o f  chrom osom e tw o ( red) and 
chrom osom e seventeen (green). M ultip le copies o f  chrom osom e seventeen 
and  tw o copies o f  chrom osom e tw o are seen. A lso seen in the p ic tu re  is 
translocation  o f  a fragm ent o f  chrom osom e seventeen (ind ica ted  by an arrow )
on to an ano ther chrom osom e.
PLA TE 3.5
Show s the w hole chrom osom e pain ting  o f  chrom osom e th ree ( red) and 
chrom osom e fifteen (green). T hree norm al copies if  chrom osom e three w ith  a 
fourth  copy w ith  deletion (ind ica ted  by an arrow ) are seen. T here are tw o 
copies o f  chrom osom e fifteen w ith  a deleted /translocated  segm ent
(ind icated  by an arrow ).
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PLATE 3.6 shows FISH analysis of chromosome four (red) and chromosome twelve 
(green). The cells showed a modal population with four copies of chromosome four 
and three copies of chromosome twelve. None of the cells showed normal copies of 
chromosome four. Two cells showed normal copies of chromosome 12 whilst there 
was loss of one copy in one of the cells.
PLATE 3.7 shows the FISH analysis of chromosome five (green) and chromosome 
twenty (red). The cells showed a modal population with three copies of chromosome 
five and four copies of chromosome twenty. None of the cells had normal copies of 
chromosome twenty whilst two cells showed normal copies of chromosome five. 
PLATE 3.8 shows the FISH analysis of chromosome six (green) and chromosome 
seventeen (red). Most cells showed three copies of both chromosome six and 
chromosome seventeen. Normal copies of chromosome six were seen in three of the 
cells.
PLATE 3.9 Shows the FISH analysis of chromosome eight (green) and chromosome 
four (red) using whole chromosome probes.
PLATE 3.10 Shows the FISH analysis of metaphase as well as interphase cell with 
probes for chromosome eight (green) and chromosome four (red). Most of the cells 
had predominantly four copies of chromosome four and chromosome eight. None of 
the cells had normal copies of either of the chromosomes.
PLATE 3.11 shows the FISH analysis of chromosome ten (green) and chromosome 
sixteen (red). The cells showed predominantly four copies of chromosome ten and 
three copies of chromosome sixteen. One of the cells showed loss of one copy of 
chromosome ten.
PLATE 3.6
Shows the w hole chrom osom e painting o f  chrom osom e four ( red) and 
chrom osom e twelve (green). Four copies o f  chrom osom e four and four copies o f  
chrom osom e twelve are seen in the picture.
PLATE 3.7
Show s the w hole chrom osom e pain ting  o f  chrom osom e five (green) and 
chrom osom e tw enty  (red). Three copies o f  chrom osom e five w ith  a 
translocated  segm ent (indicated  by an arrow ) are seen. There are at least four
copies o f  chrom osom e tw enty
*
PLA TE 3.8
Show s the w hole chrom osom e pain ting  o f  chrom osom e six (green) and 
chrom osom e seventeen(red). Two copies o f  copies o f  chrom osom e six are seen 
w ith  a deletion  and translocation  (indicated  by an arrow ) are seen. There are at 
least three copies o f  chrom osom e seventeen.
w
T
PLA TE 3.9
Show s the w hole chrom osom e pain ting  o f  chrom osom e eight (green) and 
chrom osom e four(red). Three copies each  o f  chrom osom e four and eigh t are
seen in the picture.
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PLA TE 3.11
Show s the w hole chrom osom e pain ting  o f  chrom osom e ten (green) and 
chrom osom e six teen (red). F our copies o f  chrom osom e ten and  three copies 
o f  chrom osom e sixteen can  be seen in the picture. F ragm ents o f  
deletion/ translocation  o f  chrom osom e sixteen can also be seen 
(as ind icated  by  the arrow ).
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PLATE 3.12 shows the FISH analysis of chromosome eleven (green) and 
chromosome three (red). Most of the cells showed three copies of both chromosome 
eleven and chromosome three. In addition to this two of the cells had normal copies of 
chromosome eleven.
PLATE 3.13 shows the FISH analysis of chromosome seventeen (green) and 
chromosome four (red). The cells showed predominantly three copies of seventeen 
and four copies of four. There also loss of one copy of chromosome seventeen in two 
of the cells whilst two of the cells showed normal copies of chromosome seventeen.
PLATE 3.14 shows the FISH analysis of X chromosome (green) and chromosome 
twelve (red). The cell populations showed a modal three copies of X chromosome 
four copies of chromosome twelve. Normal copies of X chromosome were seen in 
two of the cells.
PLATE 3.15 Shows the FISH analysis of chromosome X and chromosome fourteen 
(green) and chromosome sixteen (red). Most of the cells showed three copies of both 
the chromosomes. Two of the cells showed normal copies of chromosome sixteen.
PLA TE 3.12
Show s the w hole ch rom osom e pain ting  o f  ch rom osom e eleven (green) and 
ch rom osom e th ree(red). T hree cop ies each o f  chrom osom e three and eleven
can be seen in the picture .
PLA TE 3.13
Show s the w hole chrom osom e pain ting  o f  chrom osom e seventeen (green) and 
chrom osom e four (red). Three copies o f  seventeen and three copies o f  four 
w ith translocation  to  ano ther chrom osom e can be seen 
(as indicated  by  the arrow ).
PLA TE 3.14
Show s the w hole chrom osom e pain ting  o f  X chrom osom e (green) and 
chrom osom e tw elve (red). M ultip le copies o f  chrom osom e tw elve (six) and  at 
least th ree copies o f  X chrom osom e are seen. T ranslocation  o f  the 
X  chrom osom e is also seen (as indicated  by the arrow ).
PLA TE 3.15
Show s the w hole chrom osom e pain ting  o f  chrom osom e fourteen  (green) and 
chrom osom e six teen(red). M ore then  three copies o f  both  chrom osom e 
fourteen and  six teen are seen in the picture.
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Table 3.1 Showing the results of the whole chromosome FISH analysis of the OE33 
cells with probes for different chromosomes
CHROMOSOME ONE AND SIXTEEN (SEE PLATE 3.3 ) 
CHROMOSOME NO OF COPIES TOTAL
0 1 2 3 4 4+ CELLSCOUNTED
CH ONE 0 0 0 7 10 3 20
CH SIXTEEN 0 0 0 6 12 2 20
CHROMOSOME TWO AND SEVENTEEN (SEE PLATE 3.4 )
CH TWO 0 0 2 10 7 1 20
CH SEVENTEEN 0 0 0 7 8 5 20
CHROMOSOME THREE AND FIFTEEN (SEE PLATE 3.5)
CH THREE 0 0 0 6 11 1 18
CH FIFTEEN 0 0 0 5 9 4 18
CHROMOSOME FOUR AND TWELVE (SEE PLATE 3.6)
CH FOUR 0 0 0 6 10 2 18
CH TWELVE 0 1 2 10 5 0 18
CHROMOSOME FIVE AND TWENTY (SEE PLATE 3.7)
CH FIVE 0 0 2 12 4 2 20
CH TWENTY 0 4 11 5 20
CHROMOSOME (SEE PLATE 3.8)
CH SIX 0 0 3 12 3 2 20
CH SEVENTEEN 0 0 0 14 4 2 20
CHROMOSOME FOUR AND EIGHT (SEE PLATE 3.9)
CH FOUR 0 0 0 7 8 5 20
CH EIGHT 0 0 0 5 9 6 20
CHROMOSOME FOUR AND EIGHT (SEE PLATE 3.10) CEP PROBE 
CH FOUR 0 0 0 3 10 7 20
CH EIGHT 0 0 0 8 9 3 20
CHROMOSOME TEN AND SIXTEEN (SEE PLATE 3.11)
CH TEN 0 1 0 4 9 3 17
CH SIXTEEN 0 0 0 8 6 3 17
CHROMOSOME ELEVEN AND THREE (SEE PLATE 3.12)
CH ELEVEN 0 0 2 8 6 2 20
CH THREE 0 0 0 10 8 2 20
CHROMOSOME SEVENTEEN AND FOUR (SEE PLATE 3.13 )
CH SEVENTEEN 0 2 2 10 4 2 20
CH FOUR 0 0 0 8 10 2 20
CHROMOSOME X AND TWELVE (SEE PLATE 3.14)
CH X 0 0 2 9 7 2  20
CH TWELVE 0 0 0 6 10 4 20
CHROMOSOME FOURTEEN AND SIXTEEN (SEE PLATE 3.15)
CH FOURTEEN 0 1 0 12 3 1 17
CH SIXTEEN 0 0 2 10 2 3 17
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In addition to the changes described above all the chromosomes showed frequent 
deletions and translocation which were impossible to characterize given the vast 
number of total abnormalities.
3.44 MICROTUBULE AND CENTROSOMES
The centrosomes can be visualized immunocytochemically with antibodies directed 
against y tubulin (Oakley et al 1990).
y tubulin is normally visualized as a dot on the nucleus or at the periphery of the 
nucleus. In the metaphase cells they are usually located at the two spindle poles on 
which the mitotic MTs spindles converge or nucleate. Although normal controls were 
not used (owing to inability to culture cells from normal oesophagus) in this 
experiment, most normal cells which are about to divide tend to contain one or two 
centrosomes per cell. The OE33 cells on the other hand the revealed gross 
abnormalities in both centrosome number and structure as revealed by y tubulin 
staining. About 21% of the cells contained more than two centrosomes (table 3.2). 
They were heterogeneous in their shape and size. Large centrosomes, multiple 
centrosomes arranged in large patchy aggregates and centrosomes detached and lying 
outside the nucleus were frequently seen (plate 3.16). To demonstrate abnormalities in 
the spindle assembly during mitosis the cells were stained with y tubulin. The OE33 
cells showed abnormal spindles and spindles with poorly focused poles or multiple 
poles. Multipolar spindles were seen in about 17% of the cells (200 cells were 
counted) (plate 3.17). Some of the telophase cells showed abnormal multipolar 
divisions with the chromosomes segregating unequally into more than two daughter 
cells. These observations suggest that defects in centrosomes, spindle structure and 
chromosome segregation often occur together in cancer cells.
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The centrosomes are tiny organelle composed of a pair of centrioles and surrounded 
by pericentiolar material (Rieder et al, 2001). The centrosomes play a major role in 
the balanced chromosomal segregation during mitosis. Loss of centrosome function 
and regulation can lead to formation of abnormal spindles and chromosomal mis- 
seggregation. Structural and functional abnormality of centrosomes has been 
described in a number of different cancers (Pihan et al, 1998). Aneuploidy which is a 
common feature in most cancers could be induced by a number of factors (discussed 
in chapter 4 in detail). Segregation errors leading to aneupoidy can be caused by 
mutation of mitotic check points or due to defects in cellular structures involved in 
chromosome segregation and mitosis. Owing to the major role played by the 
centrosomes in cell segregation, any defect in the structure and function of 
centrosomes could lead to aneuploidy. The centrosome abnormalities in our study did 
show a strong correlation with the degree of numerical chromosomal abnormality. 
This could partly explain many of the genetic changes and karyotypic abnormalities 
seen in the OE33 cells.
Table 3.2 Showing the results of centrosome and microtubule analysis
CELL
LINE
ABNOR
MAL
CENTRO
SOMES
(%)
MULTIPOLAR
SPINDLES
CHROMOSOMAL
ABERRATION
Biaster
(%)
Multiaster
(%)
Numerical
(%)
Structural (%)
OE 33 21 83 17 I o o
ooI
3.5 CONCLUSION
One of the hall marks of cancer cells is their genetic instability (Nowell 1976; Heim et 
al., 1998). It is believed that cancer cells are monoclonal in origin (arise from a single
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cell). Though most cancers are clonal they are found to be heterogeneous i.e., 
different chromosome patterns are found within individual tumors and among 
phenotypically similar tumors (Sandberg et al., 1990; Mitelman F 1994; Heim S 
1995; Johansson et al, 1996; Mitelman F 1997). This heterogeneity could be in the 
form of alteration in the number and structure of the chromosomes. Cytogenetic 
analysis of the OE33 cells with G-banding and FISH has clearly demonstrated this 
fact. Studies have shown that cells lines undergo karyotypic changes with serial 
passages and have an increasing tendency to be polyploid. The OE 33 cells have a 
modal chromosomal number of 4n. Our cytogenetic analysis has shown that these 
cells have a high rate of ongoing structural and numerical chromosomal instability. 
Although there were several structurally altered chromosomes (or marker 
chromosomes) and centrosomal abnormalities, there was no common marker or 
unique chromosomal breakage common to all the cells. The high level of karyotypic 
complexity made the systematic characterization of the chromosome pattern difficult 
in this cell line.
The genetic instability of the cancer cells can be explained either by the genetic 
mutation theory (Nowell 1976) or the aneuploidy- genetic instability theory 
(Duesberg et al, 1998). Studies have shown that the Karyotypic instability of the cell 
lines in vivo is directly proportional to the the degree of aneuploidy of the cell lines. 
As already observed (from both our studies and studies conducted by others) 
aneuploidy has been seen both in early and late stages of BE and OADC. Aneuploidy 
alone could explain genetic instability and the resulting karyotypic and phenotypic 
heterogeneity of cancer cells. The resulting heterogeneity in turn may permit selection 
and increase of aberrant cells that are responsible for tumour progression and 
metastasis.
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CHAPTER FOUR 
EVALUATION OF CYTOTOXICITY AND GENOTOXICITY
OF THE BILE ACIDS
4.1 CHEMICAL CARCINOGENS
Carcinogenesis is a multi-step process. During this multi-step process a normal cell 
progressively acquires phenotypes which contribute to malignancy (Foulds 1954). 
The fact that cancer is caused by multiple genetic changes in a somatic cell is 
compatible with the view that many carcinogens induce mutation (Yamasaki et al, 
1995). It has been known for several hundreds of years that exposure to particular 
chemicals and mixtures can lead to cancers (Luch 2005). Paracelsus who described 
“wasting disease of miners” in 1567 was among the first to consider a chemical 
compound as an occupational carcinogen. In 1700 Ramazzini described the first 
example of occupational cancer. He noted that there was a high incidence of breast 
cancer in nuns, which he attributed to their celibate life. Later in the same century, the 
two English physicians John Hill and Percivall Pott described the occurrence of 
cancerous alterations in the nasal mucosa and at the skin of the scrotum in a few 
patients, and traced it to the local long-term exposure to snuff (Hill 1761) and to 
repetitive local contamination by soot, (Pott 1775) respectively. The Japanese 
pathologist Katsusaburo Yamagiwa and his assistant Koichi Ichikawa were the first to 
produce malignant epithelial tumours by application of coal tar to the ears of rabbits 
in 1915 (Yamagiwa 1915). The field of chemical mutagenesis has rapidly expanded 
and a great diversity of compounds have been discovered which are carcinogenic in 
humans.
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The evidence to show that chemicals can damage DNA leading to mutation has been 
accumulating over the years (Bridges 1976; Russell et ah, 1985). The need to detect 
mutagenic chemicals has been well recognized due to the risk that these chemicals 
pose to the germ and somatic cells in man (Oshimura et ah, 1986).
4.12 CLASSIFICATION OF CHEMICAL CARCINOGENS
In an early approach chemical carcinogens were classified as initiators, promoters or 
complete carcinogens (Pitot 1986). This was based on the fact that the process of 
chemical carcinogenesis involved two stages, namely, initiation and promotion 
(Clayson et ah, 1991). Initiation is a relatively rapid and irreversible stage in which 
normal cells are converted to cells with the potential to become malignant. Promotion 
is a long lasting and partially reversible stage in which the initiated normal cells are 
encouraged to become tumours (Clayson et al, 1991). However the distinction 
between these categories became increasingly blurred with increasing insight into the 
process of carcinogenesis (Butterworth et ah, 1995). A more useful and practical 
classification is the one suggested by Cohen and Ellwein which is based on the 
biological activity of the carcinogens (Cohen et ah, 1990). According to this 
classification the chemical carcinogens are divided into two broad categories; namely 
genotoxic and non-genotoxic carcinogens (see table 4.1). This distinction is of 
profound importance in developing short term tests (Clayson et ah, 1996).
4.121 GENOTOXIC CARCINOGENS
The term “genotoxic substances” was first used by Herman Druckrey in 1973. 
Druckrey defined genotoxic substances as “any agent which, by virtue of its physical 
or chemical properties, can induce or produce heritable changes in those parts of the 
genetic apparatus that exercise homeostatic control over somatic cells, thereby 
determining their malignant transformation” (Weisburger 1999). Genotoxic (or
139
genotoxicity) refers to agents which interact with the DNA and/or the cellular 
apparatus which regulates the fidelity of the genome, e.g. the spindle apparatus, and 
enzymes such as the topoisomerases. It is a broad term that includes mutation as well 
as damage to DNA or the production of DNA adducts, by the chemical itself or its 
metabolites (Parry 2000).
TABLE 4.1: Classification chemical carcinogens (Adapted from Butterworth et al., 
1995).
CLASSIFICATION OF CARCINOGENS ACCORDING TO MODE OF 
ACTION
GENOTOXIC CARCINOGENS
DNA reactive or DNA reactive metabolites
Direct interaction to alter chromosome structure or number
May also be cytotoxic
Regenerative cell proliferation will enhance mutagenic/carcinogenic activity. 
May also be mitogenic
Induced cell proliferation will enhance mutagenic/carcinogenic property. 
NON-GENOTOXIC CARCINOGENS
CYTOTOXICANTS
Not DNA reactive 
Cytolethal at carcinogenic Doses 
Induce regenerative growth
Mutations may occur secondary to regenerative cell proliferation 
Accompanying critical effect may occur as inflammation.
Circulating growth factors may cause preferential growth of pre­
neoplastic cells
MITOGENS
Not DNA reactive
Not cytolethal at carcinogenic doses
Mitogenic stimulation of growth
May be acting through a specific receptor
Mutations occur secondary to cell proliferation
May stimulate preferential growth of pre-neoplastic cells
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Chemical carcinogens can induce mutation at three different levels (Bridges et al., 
1989) namely,
1. At the gene level
2. At the individual chromosome level (Clastogenicity)
3. At the level of chromosomal set (Aneuploidy)
Clearly information at these three different levels of mutation, namely gene, 
clastogenicity (i.e. structural chromosome aberrations) and aneuploidy (i.e. numerical 
chromosomal aberrations), is necessary to provide comprehensive coverage of the 
mutagenic potential of a substance (Parry et al, 2002). This is also required for 
assessing the carcinogenic potential of a substance, since all three types of mutation 
have been shown to be associated with the activation and expression of oncogenes, 
and loss or inactivation of tumour suppressor genes and other classes of genes 
implicated in carcinogenesis (Parry et al, 2002).
4.1211 GENE MUTATION
Mutations involving single genes may be a consequence of effects on single DNA 
bases (point mutations) or of larger changes, including deletions, insertions and 
rearrangements of DNA (Pihan et al, 2003). Point mutations can be in the form of 
transitions, transversions or ffameshift mutations. The gene mutation assays are of 
two categories, those which detect forward mutations and those which detect 
reversion (Parry 2000). Forward mutations alter a wild type gene, and inactivation of 
the gene results in a detectable change in the phenotype. A reversion on the other 
hand restores gene function in a mutant and thus brings about a return to the wild 
phenotype. The Ames test is a good example for reverse mutation assay. The test uses 
strains of salamonella typhimurium which cannot synthesis amino acid histidine and 
therefore will fail to grow in histidine deficient medium. However a reversion of
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mutation (due to exposure to a mutagen) restores the functional capability of the 
bacteria to synthesise histidine, therby allowing the bacteria to grow in colonies in 
histidine deficient medium (Mortelmans et al, 2000).
The mouse lymphoma assay (MLA) is a good example for forward mutation assay. 
The MLA assay uses the L5178Y tk+/~ mouse lymphoma cells which have one 
functional copy of the gene that codes for thymidine kinase (TK). Forward mutation 
of this cells (from tk+l- to tk v') leads to formation of mutant cells deficient in TK. 
Cells deficient in TK are resistant to the cytotoxic effect of pyrimidine analogues such 
as trifluorothymidine (TFT) and therefore survive and form colonies, while cells 
without mutation have their growth totally arrested. The mutagenicity of the test 
agents is indicated by the increase in the number of colonies after treatment (Clements 
2000).
4.1212 CHROMOSOMAL ABERRATIONS
Damage to individual chromosome leads to chromosomal breakage. This could be in 
the form of translocations (reciprocal translocation, Robertsonian translocation) 
inversions or deletions (Bridges 1989). An agent, which induces chromosomal 
aberration, is called clastogen (Oshimura et al, 1986). Structural chromosomal 
aberrations result from A. direct DNA breakage; B. replication on a damaged DNA 
template; C inhibition of DNA synthesis and other mechanisms (e.g., topoisomerase- 
II inhibitors) (Aardema et al, 1998). Structural and numerical chromosomal 
aberrations play an important role in carcinogenesis (Tucker et al, 1996; Duesberg et 
al, 1998). Increased frequency of structural chromosomal aberrations in peripheral 
blood lymphocytes has been shown to be associated with an increased overall risk for 
cancer.
Chromosome aberrations involve gross alteration of genetic material which can be 
detected by light microscopy in a metaphase spread. Analysis of chromosomal
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aberration is mostly performed in the CHO cells or cultured lymphocytes. Structural 
and numerical chromosomal aberrations are most commonly scored in proliferating 
cells arrested at metaphase using a tubulin polymerisation inhibitor e.g. Colcemid, 
colchicines. Chromosomal aberrations can also be detected in metaphase or 
interphase-cells using fluorescence in-situ hybridisation FISH. This technique 
provides increased efficiency and specificity for identifying certain kinds of 
chromosomal aberrations (i.e. chromosome-type structural rearrangements, stable 
symmetrical rearrangements derived from chromatid-type chromosome aberrations, 
hyperploidy) induced in-vivo. However, the drawback with FISH technique is that 
only hyperploid events are scored due to the potential for technical artifacts resulting 
in the loss of a hybridisation signal (Aardema et al., 1998).
The evaluation of chromosome aberration by classical metaphase preparations is time 
consuming and labour intensive. An easier and equally efficient method to detect 
clastogens and aneugens is the in-vitro micronucleus assay. The in-vitro micronucleus 
test is the only test which is able to detect both numerical and structural chromosomal 
aberrations (Marzin 1997). In fact it has been proposed as an alternative to the 
metaphase analysis for the biological risk assessment of chemicals (Miller et al., 
1995). The in-vitro micronucleus test will be described in detail further in this chapter.
4.1213 ANEUPLOIDY
The third type of mutation which involves the chromosomal set is aneuploidy. 
Aneuploidy refers to change in chromosome number from the normal diploid or 
haploid number for the species (Aardema et al., 1998). Of the different classes of 
chromosome abnormality, aneuploidy is by far the most common and, clinically, the 
most important (Hassold et al., 1996). Aneuploidy in germ cells leads to spontaneous 
abortions, infant deaths and congenital malformations (Hassold et al, 1996). 
Aneuploidy in somatic cells is associated with the development of several cancers
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(Fearon et al., 1990; Cavenee et al., 1991). Aneuploidy has been seen in both early 
and late stages of cancer (Aardema et al., 1998). In fact many believe that aneuploidy 
could be the somatic mutation that causes cancer (Brinkley et al., 1998; Duesberg et 
al., 1998; Duesberg et al., 1999; Rasnick et al, 1999; Li et al, 2000). Studies have 
shown that a large number of aneugens are inducers of malignant transformation in 
Syrian hamster cells in-vitro ((Oshimura et al., 1986; Parry et al., 1993; Gibson et al., 
1995). Aneuploidy can result from damage to a variety of structures such as tubulins, 
centromeres/kinetocores, centrioles/centrosomes, microtubule associated proteins and 
regulatory molecules (Liang et al, 1985; Oshimura et al, 1986). The different 
mechanisms by which chemicals can induce aneuploidy are summarized in table 4.2. 
There are a number of methods to detect the induction of aneuploidy. Some assays are 
restricted to specific targets, such as mitotic spindle in an assay for effects on the 
polymerisation of tubulin in-vitro (Parry JM 1993).
Table 4.2: MECHANISMS BY W HICH CHEMICALS CAN INDUCE 
ANEUPLOIDY (Adapted from Oshimura et al., 1986)
Damage to essential elements for chromosome function (centromeres, origins of 
replication, and telomeres)
Reduction in chromosome pairing
Induction in chromosome interchanges
Effects on chromosome condensation
Persistence of the nucleolus in mitosis or meiosis
Increased chromosome stickiness
Effects on microtubules
Damage to centrioles or kinetochores
Impairment of chromosome alignment
Alterations in ion concentration in mitosis
Damage to nuclear membrane
Physical disruption of chromosome segregation
Others, such as chromosome counting in a metaphase spread, detection of micronuclei 
that contain kinetochores (Natarajan et al., 1993) and gross examination for abnormal 
spindles and spindle-chromosome associations in cells in which spindles and
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chromosomes have been differently stained (Warr et al, 1993) tend to detect 
aneuploidy itself.
Chromosomes can be studied directly by observing and counting aberrations in 
metaphases (Natarajan et al, 1982). This approach provides the most detailed 
analysis, but the major drawback is complexity and laboriousness of enumerating 
aberrations in metaphase and the confounding effect of artefactual loss of 
chromosomes from metaphase preparations.
The major drawback of counting chromosomes in a metaphase spread is that it is time 
consuming and limited to evaluation of hyperploidy because decreases are frequently 
due to artefacts of slide preparation. As described earlier in this section, this problem 
can be overcome by using the FISH technique and the in-vitro micronucleus assay 
(T uckers al, 1996).
4.122 NON GENOTOXIC CHEMICALS
As already described, non-genotoxic compounds are those that lack DNA reactivity or 
direct chromosome altering activity as a primary biological effect (Butterworth et al, 
1995). Unlike genotoxic substances which can be detected by a range of in-vitro 
assays, non-genotoxic chemical detection depends principally upon 2 year rodent 
bioassays. Molecular targets of non-genotoxic carcinogens can include all cellular and 
extra-cellular constituents of various organs, except the DNA. Owing to the diversity 
of their mechanism of action it is difficult to define one or two endpoints by which 
non-genotoxic carcinogenesis can be studied (Yamasaki 1995). Epigenetic 
carcinogens can induce transformation by increasing intracellular reactive species 
(reactive oxygen species, nitric oxide and lipid peroxidation products) that have a 
potential to modify DNA, by stimulation of cell proliferation (can enhance 
spontaneous mutations) or by inhibition of apoptosis (Williams 2001). Various 
markers have been used as a basis of tests for non-genotoxic carcinogens. These
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include inhibition of intercellular gap junctional intercellular communications, 
inhibition of tubulin polymerisation, and inhibition of apoptosis and induction of cell 
proliferation (Combes 2000). Most risk assessments however use genotoxicity as a 
qualitative hazard because most human carcinogens belong to this category (Williams 
et al, 1988; Weisburger 1999). However, many of the mutagenic agents also have 
non-mutagenic epigenetic mechanisms which are important to their carcinogenic 
activity. One such example is nickel. The mechanism of nickel induced 
carcinogenesis is likely to involve both genetic and epigenetic routes. High 
concentrations of nickel can induce DNA damage by generation of reactive oxygen 
species (ROS) and inhibiting DNA repair. The epigenetic effects of nickel include 
alteration gene expression resulting from DNA hypermethylation and histone 
hypoacetylation, as well as activation or silencing of certain genes and transcription 
factors, especially those involved in cellular response to hypoxia (Kasprzak et al,
2003).
4.14 THE MICRONUCLEUS ASSAY
4.121 HISTORICAL ASPECTS OF MICRONUCLEUS ASSAYS
The description of micronuclei dates back to as early as 1930s and 1940s. Induction of 
micronuclei was observed by a number of different cytogeneticists who were studying 
the effects of x-ray irradiation on diverse materials, such as grasshopper neuroblasts, 
onion root tip meristems (Sax 1941) and tradescantia pollen grains (Koller 1943). 
The micronucleus assay was used for the first time in-vitro in radiation experiments 
with roots of vicia faba by Evans et al in 1959 (Evans et al, 1959). This was the first 
realistic attempt to use micronucleus assay to measure the chromosome damaging 
effects of mutagenic agents. Later on in 1973 Schmid et al and Heddle independently 
described the use of micronucleus assay in vivo experiments, for the first time for 
detection of chromosome damage, induced in animals following exposure to
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mutagens (Heddle 1973; Schmid 1973). A large number of studies have been 
conducted since, both in-vitro and in-vivo using a variety of mutagens and a range of 
different cell types.
In the original method proposed by Countryman and Heddle (Countryman et al, 
1976) MN were scored in dividing cells without discriminating between cells that had 
completed nuclear division and those that had completed nuclear division following 
exposure to the mutagen. It was realised that this method under estimated the 
frequency of MN when nuclear division was inhibited or when the cells divided more 
than once (Fenech et al, 1985). In the former case the MN frequency is reduced 
because MN are formed only in dividing cells and in the latter case the MN frequency 
is reduced because of the loss of MN from micro-nucleated cells and/or dilution of 
micro-nucleated cells that divide once by non-micro-nucleated cells that have divided 
more than once (Fenech 2000). This major problem was however overcome with the 
introduction of cytokinesis blocked micronucleus assay by Michael Fenech and Alec 
Morley in 1985. They used Cytochlasin B to inhibit cytokinesis without blocking 
mitosis. This enabled them to score MN in cells which had divided once only. Since 
then the MN assay has been adopted worldwide as a sensitive and reliable method for 
assessing chromosomal damage.
4.122 DEFINITION
Micronuclei are chromatin containing structures in the cytoplasm surrounded by a 
membrane without any detectable link to the cell nucleus (Schifftnann et al, 1991). 
Micronuclei are formed in actively dividing cells. These micronuclei originate from 
acentric fragments (chromosome fragments lacking a centromere) or whole 
chromosomes which are unable to migrate to spindle poles during mitosis. These 
lagging chromosome and fragments acquire a nuclear envelope during telophase and 
assume the morphology of a nucleus, except that they are smaller in size than the
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actual nucleus (Fenech 1997). In the cytokinesis blocked MN assay cells which have 
completed only one nuclear division are counted.
4.123 CYTOKINESIS BLOCKED MN ASSAY; A MULTI ENDPOINT ASSAY
The CBMN assay is a multi-endpoint assay which enables simultaneously to detect 
mitotic delay, necrosis, apoptosis, chromosome loss, chromosome breakage and non­
disjunction (Kirsch-Volders M 1997). It provides information on cell cycle 
progression and chromosome / genome mutation at the same time. Thus, MN provide 
a measure of both chromosome breakage and chromosome loss and it has been shown 
to be as sensitive an indicator of chromosome damage as classical metaphase 
chromosome analysis (Matsuoka et al, 1993; Miller et al, 1995).
The key advantage of the MN assay is
1. The relative ease of scoring and the statistical power obtained from scoring 
larger numbers of cells than are typically used for metaphase analysis.
2. Frequencies of cytokinesis blocked bi-nucleated cells (and poly-nucleated 
cells) are considered as reliable estimators of the mitotic rate.
3. Based on morphological criterias necrotic and apoptotic cells can be 
differentiated from viable cells.
4. Combination of micronucleus scoring and FISH with centromeric, 
pericentromeric or telomeric probes allows the discrimination between 
aneugens and clastogens.
5. Use of appropriate FISH probes also enables to distinguish between 
chromosome loss and non-dysj unction.
4.124 DETECTION OF ANEUGENS AND CLASTOGENS
There are various ways by which an aneugen can be distinguished from clastogen in 
the in vitro micronucleus assay.
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A quick, simple, inexpensive but less reliable way of detection is based on 
morphology of the micronuclei (Matsuoka et al, 1999). A number of studies have 
shown that the size and morphology of the micronucleus can be used to distinguish an 
aneugen from clastogen (Yamamoto et al, 1980; Hogstedt et al, 1985). It has been 
observed that the relationship between an average chromosome and an average 
fragment is 4:1. Hence a larger micronucleus is suggestive of a whole chromosome 
rather than a fragment (Kirsch-Volders 1997). This can however lead to erroneous 
results because large MN may contain more than one acentric fragment. Acentric 
fragments of a large chromosome may have a size and DNA content exceeding that of 
MN containing entire small chromosomes and DNA replication and hence, increase of 
DNA content may occur in MN (Schuler et al, 1997). Matsuoka et al suggested a 
method to distinguish aneugen from clastogen based on the frequency of polynuclear 
cells (PN) and mitotic cells (M). They found that aneugens induced more than 200 PN 
cells/1000 cells while clastogens usually induced less than 100 PN cells/1000 cells. 
The aneugens were found to induce a higher frequency of M cells (Matsuoka et al, 
1999). A high ratio of large MN to total micronucleated cells is more suggestive of an 
aneugen than clastogen.
A more reliable technique is the use of immunofluorscent staining with anti- 
kinetochore antibody (Eastmond et al, 1989; Fenech et al, 1989). This technique was 
first employed by Vig and Sweamgin in 1986. They used serum from CREST patients 
(Calcinosis, Raynaud phenomenon, Oesophageal dysmotility, sclerodactyly and 
telangiectasia) to detect the kinetochores. The CREST serum contains antibodies to a 
specific protein of the kinetochore region of the chromosomes (Kirsch-Volders 1997). 
The centromere kinetochore complex is located at the primary constriction of the 
mitotic mammalian chromosomes and is responsible for the proper segregation of the 
replicated sister chromatids to the daughter cells (Warburton 2001). Kinetochores
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form when specialized proteins bind to specific centromeric DNA sequences (Ault et 
al., 1994). The kinetochore of higher eukaryotes usually appears as a tri-laminar 
structure (see figure 4.1) consisting of a well defined outer plate that is separated 
from, but connected to, a poorly defined inner plate intimately associated with the 
chromosome (Ault et al., 1994). The antibodies in the CREST serum bind to 
kinetochores of mammalian cells in general. One of the major disadvantages with 
kinetochore staining is that, it visualizes the kinetochore proteins rather than the 
centromeric DNA itself. Hence aneuploidy induced by an agent (eg: Mitomycin c and 
5-azacytidine) which inactivate or inhibit the formation of kinetochore proteins cannot 
be visualised (Kirsch-Volders 1997). With the advances in in-situ hybridisation 
technique more accurate methods have been developed to distinguish a clastogen from 
an aneugen. Centromeric probes can be used to accurately detect the whole 
chromosomes. The centromeric probe detects highly repeated alpha or classical 
satellite sequences located on specific chromosomes. The centromeric probes could be 
either pancentromeric probes or chromosome specific centromeric probes. 
Chromosome specific centromeric probes enable the detection of non-dysj unction and 
chromosome lagging thereby providing more information about the mechanism of 
action of the chemical. All of these techniques, although accurate, are more expensive 
and labour intensive.
4.125 NECROSIS AND APOPTOSIS
DNA damage, induction of necrosis and apoptosis are closely interrelated. Induction 
of necrosis can result in the release of degradable enzymes which can lead to partial 
digestion of DNA during early stages of necrosis. DNA damage by a genotoxic 
compound can lead to apoptosis. Inhibition of apoptosis may allow cells that have 
undergone DNA damage to proceed through the cell cycle and survive as mutated / 
micro-neucleated cells. Therefore in order to get a complete picture of a Genotoxic
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ability of an agent necrosis and apoptosis have to be measured concurrently. One of 
the unique advantages of CBMN assay is that it allows parallel estimation of mitotic 
delay apoptosis, necrosis and chromosomal aberration. Apoptotic cells can be 
detected as small cytoplasm condensed dark violet cells which show nueclei with 
different degrees of chromatin condensation and fragmentation depending on the 
stage of apoptosis. Necrosis is characterised by a loss of membrane integrity and 
release of toxic cytoplasmic enzymes into the surrounding tissue. Apoptosis, on the 
other hand, is characterised by preservation of the plasma membrane until late in the 
process without the leakage of intracellular complex.
4.13 BILE ACIDS
4.131 BILE ACIDS SYNTHESIS, STRUCTURE, FUNCTION AND
4.132 METABOLISM
The two principal bile acids formed in the liver are cholic acid and chenodeoxycholic 
acid. These are called the primary bile acids and are formed in the pericentral 
hepatocytes from cholesterol by a multi-enzyme process. In the synthesis of C24 bile 
acids the side chain of cholesterol undergoes oxidative cleavage resulting in the 
conversion of an iso-octane moiety into an iso-pentanoic acid moiety. One or two 
hydroxy groups are added to the nucleus (see figure 4.2 and table 4.3). The 
hydroxylation is always on one face of the molecule, and the final product invariably 
has a hydrophobic face and a hydrophilic face resulting in amphipathic molecule 
(Hofmann 1999). All bile acids are conjugated with either glycine or taurine resulting 
in glycocholic acid or taurocholic acid. Conjugation increases aqueous solubility at 
acidic pH, increases resistance to precipitation by Ca+, and renders bile acids 
impermeable to cell membranes.
Figure 4.1. Showing the putative location and possible function of reported 
kinetochore proteins. Modified from Rieder et al 1998
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In the colon, bacteria convert (by the action of 7-dehydrogenase enzyme) cholic acid 
to deoxycholic acid and chenodeoxycholic acid to lithocholic acid (Ganong 1989; 
Hofmann 1999). These bile acids, namely deoxycholic acid and lithocholic acid are 
called secondary bile acids.
4.133 FUNCTIONS
The bile acids play an important role in the digestion and absorption of fat in the 
body. The bile acids reduce the surface tension and, in conjunction with phospholipids 
and monoglycerides, are responsible for the emulsification of fat preparatory to its 
digestion and absorption in the small intestine. The bile acids because of their 
amphipathic nature (i.e. they have both hydrophobic and hydrophilic domains) tend to 
form cylindrical disks called micelles, with hydrophilic surfaces facing out and the 
hydrophobic surfaces facing in. The micelles play an important role in keeping lipids 
in solution and transporting it to the intestinal brush border where they are absorbed 
(Ganong 1989).
Table 4.3: The Human Bile Acids (adapted from Ganong WF, 1997). The numbers 
refer to the position in the steroid ring
BILE ACIDS Group at 
3
Group at 
7
Group at 
12
% in human 
bile
Cholic acid OH OH OH 50
Chenodeoxycholic
acid
OH OH H 30
Deoxy cholic acid OH H OH 15
Lithocholic acid OH H H 5
4.134 TRANSPORT
90-95% the bile salts are absorbed from the small intestine. The remaining 5-10% of 
the bile salts that enter the colon are converted to the salts of deoxycholic acid and
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lithocholic acid. Lithocholate is relatively insoluble and is mostly excreted in the 
stools. Deoxycholate on the other hand is absorbed. The absorbed bile salts are 
transported back to the liver and re-excreted in the bile (enterohepatic circulation). 
The total bile salt pool is approximately 3.5 g and the entire pool recycles about six to 
eight times a day (Ganong 1989).
4.14 BILE ACIDS AND CARCINOGENICITY
Cook and Kennaway had proposed the role of bile acids in carcinogenesis as early as 
1932. They noticed that the bile acids had structural resemblance to carcinogenic 
polycyclic aromatic hydrocarbons. This was confirmed by the finding that 
subcutaneous injection of DC A in mice can lead to “malignant spindle celled 
tumours” (Cook et al., 1940). Bile acids have long been implicated in the aetiology of 
colon cancer (Aries et al., 1969; Wynder 1969; Hill et al., 1971). Studies have shown 
that bile acids are either mutagenic or carcinogenic in experimental models. The bile 
acids have been implicated in carcinogenic process as mutagens or carcinogens. 
Several bile acids have been tested in Ames mutagenicity assay with negative results 
(Silverman et al, 1977; McKillop et al, 1983). Kulkami et al showed tht lithocholic 
acid induces single strand breaks in L11210 cells (Kulkami et al, 1980). Watanabe et 
al showed that several bile acids were mutagenic to Salmonella using a fluctuation 
test (Watabe et al, 1985). More recently, DCA and LCA have been shown to induce 
DNA damage in the alkaline comet assay. This genotoxic effect was significantly 
increased after treatment with endonuclease III, an enzyme that nicks DNA at sites of 
oxidized pyrimidines, and thus indicates the induction of oxidative base damage 
(Venturi et a l, 1997).
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Recent studies using comet assay has shown that the bile acids induce DNA damage 
and apoptosis in cells in-vitro (Powolny et al, 2001; Glinghammar et al, 2002; Jolly 
et al, 2004). Although there is growing evidence for DNA damaging ability of DC A 
there are reports that suggest that bile acids may not be genotoxic( (Mori et al, 1991; 
Venturi et al, 1997; Fein et al, 2000). Scates et al have shown that bile acids do not 
form DNA adducts. Studies have shown that bile acids do not damage DNA directly 
but require key cell based intermediates (Scates et al, 1996; Glinghammar et al, 
2002). It has been shown DCA can cause damage by generating ROS (reactive 
oxygen speices) (Patel et al, 1997; Fang et al, 2004). The ROS intum can cause 
oxidative DNA damage which could explain the mechanism of genotoxicity of DCA 
(Bernstein et al, 2005).
4.141 MECHANISM OF CYTOTOXICITY
The exact mechanism of injury by bile acids is not known. There are two possible 
hypotheses.
• According to one hypothesis bile acid induced cell damage is probably due to 
their detergent property and solubilisation of mucosal lipid membranes. This 
theory is supported by studies in gastric mucosa where bile acid induced 
mucosal injury correlated with the release of phospholipids and cholesterol into 
the lumen. Experiment with rabbit mucosa has shown that bile acids cause 
disruption at a concentration which is much lower than the one required for 
phospholipid solublisation. Therefore this is a less likely mechanism of bile acid 
induced cell injury (Vaezi MF 2001; Bernstein et al, 2005).
• The second and more favoured mechanism is that bile acids enter the mucosa 
due to their lipophilic nature causing intra-mucosal damage by disorganizing
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membrane structures or interfering with cellular function (Vaezi MF 2000 Oct; 
Bernstein et al, 2005). This model is supported by studies conducted by Batzri 
et al and Schweitzer et al who demonstrated that bile acids penetrated the 
mucosal barrier and were trapped inside the cells due to intracellular ionisation 
thus increasing the intracellular concentration of bile acids by several folds 
(Batzri et al, 1991). Studies conducted by Schweitzer et al have correlated bile 
acid entry and mucosal accumulation with bile acid mediated mucosal damage 
(Schweitzer et al, 1987).
4.142 MECHANISM OF CARCINOGENICITY (PROMOTER / GENOTOXIC 
ACTION)
There has been conflicting opinion about the direct genotoxic effect of bile acids. 
Their exact role in the process of carcinogenesis is not clear. Epidemiological and 
animal studies have suggested that bile acids act as tumour promoters in the 
gastrointestinal tract (see section 4.182). The exact mechanism of their action is 
however not very clear. They probably act by affecting intracellular signalling and 
gene expression which leads to alteration in cell proliferation and cell death 
(Debruyne et al, 2001; Qiao et al, 2002; Bernstein et al, 2005).
PROTEIN KINASE C AND AP-1 PATHWAY
Bile acids are known to cause increased cell proliferation and apoptosis in cell lines 
depending on the concentration of the bile acids. The mechanism by which they 
induce these changes is probably by the activation of PK-C (Huang et al, 1992; 
Pongracz et al, 1995; Hirano et al, 1996; Rao et al, 1997; LaRue et al, 2000). 
Protein Kinase C comprises of a group of more than 11 phospholipid dependent 
ser/thr kinases. The PKC’s are divided into three broad categories namely, 
conventional PKC’s, novel PKC’s and atypical PKC’s depending on their need for
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calcium and DAG (Diacyl glycerol) for activation. PKC are activated by a number of 
extra-cellular signals and play a critical role in many signal transducing pathways in 
the cell [Reviewed by (Koivunen et al., 2005)]. They are involved in a variety of cell 
regulatory pathways, including mitogenesis, cell adhesion, apoptosis, angiogenesis, 
invasion and metastasis (Di Mari et al, 2005). The classical PKC are activated by 
DAG and calcium in the presence of phosphatidyl serine. DAG and inositol 1-4-5- 
triphosphate (IP3) are generated from plasma membrane associated 
phosphatidylinosito 1-4-5-diphosphate (PIP2) by the activation of phospholipase C 
(PLC). Ca ++ is released from an intracellular storage pool stimulated by IP3. Phorbol 
ester (plant derived diterpenes) mimics the action of DAG, but its action is sustained 
leading to long term activation of PKC (Musashi et al, 2000). The bile acids probably 
stimulate PKC’s in a phorbol ester like manner (see figure 4.3) by mimicking the 
action of DAG (de Kok et al, 2000; Debruyne et al, 2001). The bile acids may 
increase PKC activity by facilitating its association with phospholipids or by 
stimulating PI-PLC and thereby increasing the formation of DAG (Debruyne et al, 
2001). Bile acids also stimulate activator protein-1 (AP-1) which is probably mediated 
by stimulation of PKC and ERK (Extracellular signal Related Kinases) (Song et al, 
2005; Bemt et al, 2006). Activator protein-1 (AP-1) is a collective term for dimeric 
transcription factors composed of Jun, Fos or ATF (Activating Transcription Factor) 
proteins, c-fos is required for the viability, proliferation and differentiation of cells, 
particularly bone and neuronal cells (Ameyar et al, 2003; Eferl et al, 2003). The jun 
components are essential for growth and proliferation. The AP-1 complex activated 
by bile acids consists of Jun D, Fra-1 and c-fos. Studies suggest that these proteins are 
involved in tumorigenesis (Eferl et al, 2003). Hence this could be an important step 
in the tumorigenesis. COX-2 gene could be one of the important targets and 
mechanism of action of the bile acids (see figure 4.4). Increased expression of COX-2
1 5 8
Figure 4.3 Possible pathways involved in bile acid signalling [adapted and 
modified from (Debruyne et al., 2001)]
PIP2
PI-PLC
BILE ACIDS / 
PHORBOL
ESTERS
1P3
DAG
♦ ♦♦ ♦
Ca ■ •  *
PKC
RAF
ERK
M EK
AP-1
I
 ,
TRANSCRIPTIO N, COX-2 
OTHERS
* 
■ 
*
159
is seen in a variety of cancers (colonic cancer, gastric cancer and oesophageal cancer). 
Although COX-2 is constitutively expressed in the normal oesophageal and duodenal 
mucosa, studies have shown that it is over expressed as an early event in the 
neoplastic transformation of BE (Shirvani et al, 2000; Zhang et al, 2001).
The induction of COX-2 by bile acids has been shown to be mediated via PKC 
dependent mechanism (Zhang et al, 1998; Kaur et al, 2002)). Li et al showed that 
bile acids could induce COX-2 in various oesophageal cell lines leading to an 
increased production of prostaglandin E 2. studies have shown that COX-2 inhibitors 
could act as chemopreventive agent in oesophageal cancer (Li et al, 2000; Altorki
2004).
Cyclo-oxygenase is the key enzyme required for the conversion of arachidonic acid to 
prostaglandins. The COX pathway consists of two different iso-enzymes, COX-1 and 
COX-2. The recently identified COX-3 is a splice variant of the COX-1 gene the 
exact function of this in humans remains to be elucidated (Tuynman et al, 2004). 
COX-1 is expressed constitutively in most tissues and is responsible for the house 
keeping functions. COX-2 on the other hand is usually not detectable in most of the 
normal tissues but is induced by oncogenes, growth factors, carcinogens and tumour 
promoters. Both COX-1 and COX-2 are similar with only minor differences in their 
catalytic activity. COX-2 activation leads to enhanced synthesis of prostaglandins. 
The prostaglandins can promote angiogenesis, inhibit immune surveillance and 
increase cell proliferation. COX-2 over expression also inhibits apoptosis and 
increases the invasiveness of the malignant cells. The other mechanism by which 
COX-2 may function is lowering the level of arachidonic acid. High concentration of 
arachidonic acid can promote apoptosis. COX-2 catalysis pathway may simply
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FIGURE 4.4: Mechanism of action of COX-2. Arachidonic acid is released from membrane 
phospholipids by phospholipase-A2 (PLA2) and is metabolized by cyclooxygenase (COX) to 
prostaglandin H2 (PGH2) in two steps. PGH2 is converted to a variety of eicosanoids by specific 
isomerases (Abbreviation: TXA2, thromboxaneA2). Adapted from (Subbaramaiah et al., 2003)
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deplete the apoptotic signal by depleting the concentration of arachidonic acid 
(Simmons et ah, 2004).
4.17 BILE ACIDS IN BARRETTS OESOPHAGUS
The exact aetiology of BE is still unknown. However it is clear that BE is associated 
with longstanding reflux of acid, bile and pancreatic secretions compared to normal 
patients. The exact role of individual constituents of the refluxate in the development 
of BE is unknown. There is increasing evidence to show that bile acids play an 
important role in the pathogenesis of BE and its progression to adenocarcinoma. If 
acid reflux alone induces BE then acid suppressive therapy should potentially reverse 
BE. Studies have shown that 25-35% of the patients on recommended dose of PPI’s 
develop recurrent or progressive disease (Sontag 1992; Champion et ah, 1994; 
Jankowski et ah, 2000). None of the studies so far have shown complete regression or 
reversal of BE inspite of acid suppression therapy (Neumann et ah, 1995). 
Oesophagitis has been seen in achlorhydric patients with pernicious anaemia (Palmer 
1960; Orlando 1973). It has also been documented in patients with gastrectomy and 
oesophago-jejunostomy (Nakayama 1956; Meyer et ah, 1979). Neoplastic progression 
of BE has been seen in patients who have had bile reflux without any pathological 
acid reflux (Jankowski et al, 1993). Bile acids are also involved in the promotion of 
goblet cell metaplasia in other gastrointestinal epithelium such as stomach duodenum, 
intestine and bile ducts. All of these factors suggest that bile acids alone could be 
highly important in the pathogenesis of BE and its complications.
I
I
i;
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4.15 DGER
Duodenogastric reflux was first observed and assessed by Beaumont in 1833. In the 
last few decades DGER has been associated with a number of pathologic conditions 
of the foregut such as gastric ulcer, gastritis gastric cancer and dyspepsia (Ritchie 
1980; Schumpelick 1983; Du Plessis DJ 1962). Recent experimental and clinical 
evidence indicates that DGER plays a significant role in the development of Barrett’s 
oesophagus and adenocarcinoma of the distal oesophagus (Johnson 1986; Ireland 
1996; Pera 1998). The evidence for association of GERD and Barrett’s oesophagus is 
over-whelming. However, the role of individual constituents of the refluxate in the 
development of BE and its complications (ulcer, strictures, dysplasia or 
adenocarcinoma) is not known. DGER is retrograde reflux of duodenal contents (bile 
and pancreatic fluid) into the stomach with subsequent reflux into the oesophagus. 
DGER occurs in normal individuals, particularly postprandially (Muller-Lissner 1983; 
Mackie 1986; King 1987) and at night (Gotley 1991; Nehra et al, 1999). Terms such 
as ‘Bile reflux’ and ‘alkaline reflux’, which have been used in the past, are no longer 
appropriate. The term bile reflux is in-appropriate because duodenal contents contain 
more then just bile. The term alkaline reflux is a misnomer because recent studies 
have shown that DGER can occur at neutral as well as acidic pH (Nehra et al, 1999). 
Further-more rise in pH does not predict the presence of bile, as oesophageal pH > 7 
could be due to presence of saliva, secretions from the sub mucosal oesophageal 
glands, food or oral infection (Singh 1993). Studies have also shown that 70-91% of 
the DGER episodes occur in an acidic environment (Johnson 1997).
4.151 MEASUREMENT OF DGER
Extrapolating the results regarding the injurious effect of DGER from the animal data 
into humans has been hampered for a long time due to lack of “gold standards” for
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detecting DGER in humans. A number of different methods have been described to 
asses DGER (see table 4.4). Some of the earlier methods used for measuring DGER 
sucl as endoscopy, aspiration studies (both gastric and oesophageal), scintigraphy and 
amhilatory pH monitoring have technical difficulties and are imprecise.
Encbscopic observation of bile pool in humans is a poor marker of bile induced 
oesophageal disease (Katz 2000; Vaezi 2001). Aspiration of gastric contents for 
measurement of bile acid and trypsin concentration, although helpful, represents only 
a sk>rt-term assessment of reflux of duodenal contents into the stomach occurring in a 
24-lour period (Katz 2000; Richter 2001; Vaezi 2001). Scintigraphic evaluation for 
DGER is stationary and results in radioactive exposure to patients, and has conflicting 
resiits (Stein et al., 1999; Katz 2000). Using pH > 7 (“alkaline reflux”) as a marker 
for esophageal exposure to duodenal contents (DGER) has recently been shown to be 
an iiaccurate means of detecting DGER for the reasons already discussed above.
The e has been a renewed interest in DGER and role of bile in BE with the advent of 
the Bilitec 2000. Bilitec is a new fibreoptic spectrophotometric system which 
measures DGER independent of the pH. It utilizes the optical property of bilirubin the 
mos: common bile pigment. Studies indicate very good correlation between Bilitec 
readng and bile acid concentration as measured by duodenogastric aspiration studies 
(Vaezi 1995). However Bilitec 2000 tends to under-estimate bile reflux by almost 
30°A in an acidic medium i.e. at pH < 3.5. Furthermore the readings can be modified 
by tie presence of some dietary substances (Vaezi 1995; Barrett et al, 2000). Despite 
its Imitations Bilitec 2000 is an invaluable device in the assessment of DGER.
4.152 ANIMAL STUDIES
Earl/ studies by Cross and Wangensteen suggested a role for bile acids in 
oescphageal mucosal damage. Moffat and Berkas used a dog model with biliary 
diversion and a jejunal conduit anastomosing directly to the oesophagus to show that
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canine bile was capable of producing various degrees of erosive oesophagitis, thereby 
confirming the earlier studies by Cross and Wangensteen (Vaezi et al, 2000). 
Shafie-Shirazi et al showed that bile acid combined with HC1 was more damaging 
than HC1 or bile acid alone (Safie-Shirazi 1975). More recent studies show that 
oesophageal mucosal damage by bile acids is dependent on the conjugation state of 
the bile acids and pH of the refluxate. Harmon et al showed that conjugated bile acids 
were more injurious to oesophageal mucosa at acidic pH, whereas un-conjugated bile 
acids were more harmful at pH 5-8 (Harmon et al., 1981).
TABLE 4.4: SHOWING THE VARIOUS METHODS AVAILABLE FOR THE 
ASESSMENT OF DGER WITH THEIR RELATIVE ADVANTAGES AND 
DIS- ADVANTAGES
METHOD ADVANTAGES DISADVANTAGES
Endoscopy Easy visualization poor sensitivity/specificity/po
sitive predictive value 
Requires sedation 
High cost
Aspiration
Studies
Easy visualization of bile 
No sedation required 
Low cost
Short duration of study 
Requires familiarity with 
enzymatic assay for bile acid
Scintigraphy Noninvasive Semiquantitative at best 
Radiation exposure 
High cost
pH monitoring Easy to perform 
Relatively noninvasive 
Prolonged monitoring
pH >7 not a marker for DGER 
Nonspecific for DGER
Bilirubin 
Monitoring 
(Bilitec 200)
easy to perform 
relatively noninvasive 
prolonged monitoring 
good correlation with 
gastric bile acid 
concentrations.
Current design under 
estimates DGER by 
about 30% in acidic 
medium(pH 3.50) 
Requires modified diet
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The pH dependent damage caused by conjugated and un-conjugated bile acids was 
further confirmed by Kivilaasko et al using rabbit oesophageal perfusion studies 
(Kivilaakso 1980).
Lillemoe et al compared the injurious effects of various duodenal components on 
rabbit oesophageal mucosa at pH 2. At this acidic pH trypsin had no effect on the net 
flux of ions across the oesophageal mucosa, as it is inactive at pH <4. At neutral pH 
taurocholate showed no effect, but in an acidic medium there was mucosal disruption. 
There was also evidence of synergism between pepsin and HC1 as well as between 
HC1 and conjugated bile acids in causing oesophageal mucosal damage(Lillemoe 
1982). Table 4.5 summarizes some of the animal studies conducted so far. A number 
of experimental animal models have been used to study the effects of DGER. Studies 
in rat have shown that reflux of duodenal contents, produced by means of 
oesophagojejunal anastomosis, exerts a co- carcinogenic effect with 2,6 -dimethyl 
nitrosomorphine (2,6-DMNM) (Pera M 1989; Attwood et al., 1992). Goldstein et al 
surgically induced DGER by oesophagoduodenostomy in Sprague Dawley. They 
found that DGER induced changes similar to BE and adenocarcinoma in the rats 
(Goldstein et al, 1997).
Melo et al studied the effect of gastro-oesophageal reflux and DGER in female wistar 
rats by performing cardioplasty and oesophagoduodenostomy. They found that DGER 
in isolation behaved as an oesophageal carcinogen by inducing oesophagitis, BE and 
oesophageal adenocarcinoma in the rats. Oesophageal carcinogenesis induced by 
DGER was potentiated by DEN (diethyl nitrosamine) but DEN in isolation failed to 
induce carcinoma (Melo 1999).
Fein et al studied the effects of artificially induced DGER in rats. In their study 
DGER induced cancers in the rat oesophagus, but the duodenal fluid from the rats
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failed to show any genotoxicity in the mouse lymphoma micronucleus assay. All their 
samples showed cytotoxic effect but none of them had any genotoxic effect (Fein et 
al., 2000). They concluded that EAC in the experimental model was due to chronic 
inflammation rather than due to presence of any specific carcinogen.
Table 4.5 EFFECTS OF COMPONENTS OF DUODENAL REFLUXATE 
AND SURGICAL PROCEDURE IN ANIMAL MODELS
Authors Animal/ Procedure Component
Evaluated
Damaging effects/ 
Outcome
Safaie-Shirazi 
et al. 1975
Rabbit Bile, HC1
Bile acid plus HC1 is 
more damaging than 
HC1 or bile
acid alone.
Kivilaakso 
et al. 1981
Rabbit Conjugated or 
un
unconjugated 
bile acids, 
pepsin, 
lysolecithin
Conjugated bile acids 
and pepsin at pH 3.5;
uncon-jugated bile 
acids at pH 7; lysole­
cithin and trypsin at pH 
7.
Harmon et al. 
1981
Rabbit Conjugated bile 
acids,
unconjugated 
bile acids or 
HC1
HC1 alone damages 
only at pH 1; 
conjugated bile acids at 
pH 2; unconjugated 
bile acids at pH 7.
Lillemoe et al. 
1982
Rabbit Pepsin,
conjugated bile 
acid,
trypsin, HC1
At pH 2, pepsin > 
conjugated bile acid > 
trypsin > HC1.
Salo and
Kivilaakso
1984
Rabbit Trypsin, 
unconjugated 
bile acid
At pH 2, trypsin plus 
unconjugated bile acid 
>trypsin > conjugated 
bile acid.
Pera et a l , 
1989
Sprague Dawley rats; 
oesophago-j ej unostomy
DGER +
DMNM(a
nitrosamine)
Induced EAC in 24% 
of the rats
Miwa et al 
,1996
Wistar rats; esophago- 
jej unostomy
DGER 92-100% BE, 
75% EAC
Goldstein et al, 
1997
Sprague Dawley rats 
Oesophago­
duodenostomy
DGER BE and EAC
Fein et al, 2000 Sprague Dawley rats 
Oesophago­
duodenostomy
DGER BE and EAC
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More recently similar experiments performed by Pera et al showed that duodenal 
reflux alone in rats can induce metaplastic changes and oesophageal cancers (Pera M 
2000). These tumours could range from squamous carcinoma to adenosquamous 
carcinoma to adenocarcinoma. Based on their experiments proposed that chronic 
duodenal reflux induces the development of metaplastic cells, which in turn can 
progress to adenocarcinoma. CDCA an unconjugated bile acid was shown to promote 
duodenal tumours in an animal model of familial adenomatous polyposis (Mahmoud 
etal., 1999).
4.153 HUMAN STUDIES
As already described various methods have been used to detect bile reflux in the 
oesophagus. With the use of Bilitec 2000 it has been possible to monitor bile reflux in 
an ambulatory setting, independent of the pH over a 24 hr period. Using Bilitec 2000 
Kauer et al found that patients with Barrett’s had more acid and bile reflux than 
normal patients (Kauer et al, 1995). Champion et al observed a graded increase in 
bile reflux and acid reflux from controls to patients with reflux oesophagitis with the 
highest values observed in patients with Barrett’s oesophagus (Champion et al, 
1994).
Subsequent studies by Vaezi et al and Richter et al have supported the graded 
increase in bile reflux. Not only did the patients with Barrett’s have increasing and 
acid reflux, but also had episodes of acid reflux which paralleled episodes of bile 
reflux (Vaezi et al, 1996; Richter 2001). Bilitec 2000 is qualitative rather than a 
quantitative test for bile acids. Bilitec cannot distinguish between the different bile 
acids nor can it distinguish between conjugated and unconjugated bile acids.
Gotley et al tried to measure the concentration of bile acids in patients with DGER. 
They performed continuous aspiration studies. They found that the refluxate contained
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predominantly conjugated bile acids and the bile reflux was particularly severe during 
the nocturnal periods. More than 24% of their patients with reflux oesophagitis had a 
total bile reflux of >200pmol/L during the nocturnal period (Gotley et al, 1988). 
Iftikhar et al measured the concentration of the various bile acids in patients with BE 
(Iftikhar et al, 1993). Their studies showed that patients with BE had a higher bile 
reflux and the most predominant bile acids were glycocholic and taurocholic acids. In 
patients with BE, the bile acids were found in a concentration ranging from 0- 
14000pmol/L.
More recently Nehra et al studied the concentration of various bile acids in patients 
with reflux oesophagitis and in patients with Barrett’s oesophagus by continuous 
aspiration of the bile acids over a period of 15 hours. They found that bile acids 
refluxed concurrently with acid in most instances. Patients with BE and reflux 
oesophagitis had increasing bile reflux compared to normal patients. They also found 
that in 20% of the patients with BE bile reflux occurred independently without any 
acid reflux. They found that patients with BE had an average bile reflux of 180pmol/l 
and a maximum of about 800- lOOOpmol /l. More than 50% of their patients with BE 
had a bile reflux exceeding 200pmol/l (Nehra et al, 1999). The predominant bile 
acids detected in the patient groups consisted of primary bile acids, cholic acid, 
taurocholic acid and glycocholic acid. A significant proportion of patients with 
extensive mucosal injury had increased taurodeoxycholic acid, cholic acid and 
deoxycholic acid (Nehra et al, 1999). Kauer et al showed that majority of the 
duodenal reflux occurs at a pH range of 4 to 7 (Kauer et al, 1997).
A number of in vitro experiments have been conducted to study the effects of bile 
acids on Barrett’s epithelium. Bachir et al studied the effect of conjugated bile acids 
on oesophageal tissue in organ culture. They used taurine and glycine conjugated bile 
salts in concentrations ranging from lmmol/L up to 3mmol/L. They found that
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concentrations of bile acids over 3mmol had a generalized cytotoxic effect where as 
concentrations of l-2mmol had a milder cytotoxic effect seen in the form of 
progressive and consecutive shedding of the superficial layers of the epithelium 
(Bachir et al., 1982). As already described Shirvani et al have showed that pulses of 
acid and bile increased the expression of COX-2 in BE explants (Shirvani et al, 
2000). More recently Kaur et al showed that exposure of BE explants to pulses of bile 
salts increases the proliferation, whereas exposure to a combination of bile salts and 
acid together inhibits proliferation (Kaur et al, 2000). They used glycine and taurine 
conjugated cholic and chenodeoxycholic acid in the final concentration of lmmol/L. 
The cell proliferation was associated with increased level of PKC (Kaur et al, 2000). 
Dixon et al studied biopsies (both gastric and oesophageal) from patient with BE and 
reflux oesophagitis for reflux gastritis score (RGS) and bile reflux index (BRI). Based 
on these parameters they showed that patients with BE had more evidence of bile 
gastritis than patients with uncomplicated GORD suggesting that bile could be an 
important factor in the development of BE and dysplasia (Dixon et al, 2001).
AIMS:
The aim of this chapter was to evaluate the cytotoxic and genotoxic effects of various 
bile acids commonly seen in patients with BE. The effects of these bile acids were 
evaluated in concentration which was physiologically relevant.
4.2 MATERIALS AND METHODS
4.21 CULTURE OF OE33 CELLS
The OE33 cells were cultured in monolayer in 25 cm2 tissue culture flasks (Nunclon). 
The techniques of culture, storage and thawing of these cells have been described in 
detail in Chapter 3 section 3.31.
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4.22 IN VITRO MICRONUCLEUS ASSAY WITH OE33 CELLS
Flasks with confluent growth were selected (50 cm or 75 cm ) for the initiation of 
fresh culture. The culture flasks were split with trypsin EDTA as described in the 
earlier section. The cells were seeded in a concentration of 1-2 x 105 cells /ml into 
several 25 cm flasks to make the final quantity of the culture medium to lOmls in 
each flask. Flasks were gassed and returned to the incubator at 37°C. Twenty four 
hours after the initiation of the culture chemical treatments were added (l%v/v, 100ml 
/10ml culture). Cytochalasin-B was added to the culture flasks in a final concentration 
of 4pg/ml (ie.40Mg/10ml) 44 hours after the initiation of culture. The cells were 
harvested at 72 hrs from the time of initiation of cultures (figure 4.5).
The toxic culture medium from each flask was discarded into appropriately labelled 
universals. The cells were then split with trypsin EDTA as described previously. The 
trypsin washes were discarded into the respective labelled universals. After the final 
trypsin wash all the detached cells were transferred into the respective universals and 
centrifuged at 1500RPM for about 8 minutes. The supernatant was discarded and the 
pellets were re-suspended in RPMI 1640 with 5% foetal calf serum.
4.221 SLIDE PREPARATION
The slides were prepared in a similar manner for all the experiments. The detached 
cells were washed and re-suspended in RPMI 1640 and 5% FCS in a concentration of 
about 1-2 x 105 cells/ml. Aliquots of 100-200pl were centrifuged in the cytospin 
(Shandon) for 8 minutes at 1200RPM. The quality of the slides was checked under the 
simple microscope. The slides were then air dried for a brief period and then fixed 
with 90% methanol at -20°C for 10 minutes. 6-8 slides were prepared for each 
replicate. After fixing the cells were air dried. Slides for Giemsa staining were stored 
at room temperature while slides for kinetochore labelling were stored at -20°C.
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4.222 STAINING OF THE SLIDES (GIEMSA STAINING)
The slides for Giemsa staining were fixed with methanol at -20°C, dried and stored at 
room temperature. These slides were first immersed in xylene (Fisher Scientific Ltd 
UK) for about ten seconds and then allowed to dry. These slides were then stained 
with 10% Giemsa (Gurr BDH) in phosphate buffer at pH 6.8. The phosphate buffer 
was prepared by dissolving a phosphate tablet (BDH) in one litre of deionised water. 
The slides were immersed in the 20% Giemsa solution for eight minutes. The slides 
were then washed a few times with the phosphate buffer and water to wash off the 
excess of the stain. Once dry, the slides were mounted with a few drops of DPX 
mounting medium (BDH) and covered with glass cover slips. They were then left for 
a few hours to dry. The slides were then visualised and scored under an Olympus BH2 
(Dixon et al., 2001)
4.223 KINETOCHORE LABELLING
Slides were prepared and stored at -20 °C as described in the previous section. The 
kinetochores were detected by immunofluorescence method. This method enables the 
detection of chromosome loss. The protocol employed was similar to the one 
described by Ellard et al in 1991 with minor modifications. The slides were removed 
from -20°C and re-hydrated in PBS at room temperature in a coplin jar for about a 
minute. The slides were then placed in 0.5pg/ml primulin (Sigma) in deiodinised 
water for about 30 seconds. The anti-kinetochore antibody (Antibodies Incorporated) 
was prepared by diluting with PBS in a 1:1 ratio. 50pl of the antikinetochore antibody 
was added to each slide and covered with half size plastic cover slip. The slides were 
then incubated at 37°C for 45 minutes. After incubation for 45 minutes three washes 
were made for 3 min each in bovine albumin serum solution (1% solution prepared in
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PBS) + PBS followed by three washes of three minute each in PBS at room 
temperature. The second antibody was prepared by diluting lp l of Antihuman IgG 
Fluorescein Isothiocyanate (FITC) conjugate (Sigma) in 99pl of PBS. The slides were 
drained briefly, the dot was located and 50pl of the second antibody was added to 
each slide. The slides were covered with half coverslips and incubated at 37°C for 45 
minutes. After that three washes were made for 3 min each in bovine albumin serum 
solution followed by three washes fort 3 minutes each in PBS. The slides were air 
dried and stored in the dark at 4°C. 20pl of DAPI was added to each slide before 
scoring. DAPI was prepared as follows:- lp l DAPI + 9pl d H2 O + 990pl mounting 
medium (Vectashield Vector). The slides were left in the dark for 10 minutes before 
they were ready to be scored.
4.23 CHEMICALS
4.231 MITOMYCIN C
Mitomycin C is a genotoxic antineoplastic agent derived from streptomyces 
caespitosus.
It is used as a primary chemotherapy agent for anal, lung and superficial bladder 
cancers and as a secondary agent in breast, colon, gastric and pancreatic cancers 
(Verweij et al, 1990). MMC is a potent mutagen and has been shown to be a 
predominantly clastogenic agent (Rudd et al., 1991; Nesti et al, 2000) MMC was 
used a positive control in all the experiments. MMC was used in the concentration of 
about 10-100pg/l. Mitomycin C was purchased from Sigma. Stock solutions of MMC 
were prepared by dissolving in distilled water.
4.232 BILE ACIDS
Six different bile acids were used in this study namely:
• Cholic Acid Sodium Hydrate (Sigma Aldrich Co Ltd. Dorset, UK)
Molecular formula: C24H39NNa05
Molecular weight: 430.6
• Deoxycholic Acid (Sigma Aldrich Co Ltd. Dorset, UK)
Molecular formula: C24H39Na04
Molecular weight: 432.6
• Glycocholic Acid sodium (Sigma Aldrich Co Ltd. Dorset, UK)
Molecular formula: C26H42NNa06
Molecular weight: 487.6
• Taurocholic Acid, Sodium Salt Hydrate (Fisher Scientific UK)
Molecular formula: C26H44NNa07S
Molecular weight: 537.7
• Glycodeoxycholic Acid Sodium (Sigma Aldrich Co Ltd. Dorset, UK) 
Molecular formula: C26H42NNa05
Molecular weight: 471.6
• Taurodeoxycholic Acid (Sigma Aldrich Co Ltd. Dorset, UK)
Molecular formula: C26H4406SNa
Molecular weight: 521.7 
Stock solutions of all the bile acids were prepared by dissolving in distilled water. 
Dilutions were made as needed to add no more than 100 pi to each flask containing 
10ml of the medium. Untreated cultures were used as negative controls. All 
compounds were tested in two different experiments.
The experiments were conducted in two different culture conditions, at pH 7.3 
(physiological) and at pH 5.5 (acidic). To obtain the acidic culture medium, RPMI 
1640 was titrated with filtered 1M HCL to achieve a pH of 5.5 (measured with pH 
strips). A pH below 5 was found to be deleterious to the cells. The above bile acids
175
were used in our study as they are most commonly encountered in patients with reflux 
oesophagitis and BE (Gillen et al, 1988; Iftikhar et al, 1993; Nehra et al, 1999; Stein 
et al, 1999). The bile acid concentration 50pmol -  lm  mol was selected as it 
represented the near physiological concentration of bile acids seen in patients with 
BE. All of the bile acids remained in solution and the solubility was not affected by 
the pH of the medium. Distilled water was used as a vehicle for dissolving the bile 
acids and Mitomycin C.
4.24 SCORING OF SLIDES
4.241 SCORING OF GIEMSA SLIDES FOR MICRONUCLEI
All the slides including the positive and negative controls were independently coded 
before scoring. 500 bi-nuecleated cells were counted per dose for each experiment. 
Two separate experiments were conducted for each dose (1000 cells per dose). This 
was followed for all experiments with bile acids (except GDCA) at neutral pH. For 
experiments with GDCA and all the other bile acids at acidic pH microneucli were 
scorred in a total of 1000 bi-nuecleate cells per culture (2000 cells per dose). The 
slides were scored in an Olympus BH2 microscope. Tri-nucleate, tetra-nucleate and 
multinucleate cells were also counted at the same time. Criteria described by M 
Fenech (2000) were used to identify binucleate cells and micronuclei.
4.242 CRITERIA FOR SELECTING BINUCLEATED CELLS
The bi-nucleated cells in the cytokinesis-blocked assay were scored based on the 
following criteria:
• The two nuclei in a bi-nucleated cell should have intact nuclear membranes 
and be situated within the same cytoplasmic boundary;
• The two nuclei in a bi-nucleated cell should be approximately equal in size, 
staining pattern and staining intensity;
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• The two nuclei within a BN cell may be attached by a fine nucleoplasmic 
bridge which is no wider than l/4th of the largest nuclear diameter.
• The two main nuclei in a BN cell may touch but ideally should not overlap 
each other. A cell with two overlapping nuclei can be scored only if the 
nuclear boundaries of each nucleus are distinguishable.
• The cytoplasmic boundary or membrane of a bi-nucleated cell should be intact 
and clearly distinguishable from the cytoplasmic boundary of adjacent cells.
4.243 CRITERIA FOR SCORING MICRONUCLEI (MN)
MN are morphologically identical to but smaller than nuclei (figure 4.6). They also 
have the following characteristics:
• The diameter of MN should be no greater than a third of that of the main 
nuclei.
• MN are non-refractile and they can therefore be readily distinguished from 
artefact such as staining particles;
• MN are not linked or connected to the main nuclei;
• MN may touch but not overlap the main nuclei and the micro-nuclear 
boundary should be distinguishable from the nuclear boundary;
• MN usually have the same staining intensity as the main nuclei but 
occasionally staining may be more intense.
4.244 SCORING OF APOPTOTIC AND NECROTIC CELLS
Apoptosis and necrosis were scored based on the criteria described by M Fenech et al 
(1999). Five hundred cells were counted and scored as either mono-nucleate, bi- 
nucleate, tri-nucleate, tetra-nucleate, apoptotic or necrotic and the ratio for these types 
of cells were calculated. Apoptotic and necrotic cells were identified based on the 
following features (figure 4.7).
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Cells with chromatin condensation and intact cytoplasmic and nuclear boundaries 
(“early” apoptotic cells) or cells exhibiting nuclear fragmentation into smaller nuclear 
bodies within an intact cytoplasm/cytoplasmic membrane (“late” apoptotic cells) were 
counted as apoptotic cells.
Cells exhibiting a pale cytoplasm with numerous vacuoles (mainly in the cytoplasm 
and some in the nucleus) and damaged cytoplasmic membrane with a fairly intact 
nucleus (“early” necrotic cells) or cells exhibiting loss of cytoplasm and 
damaged/irregular nuclear membrane with only a partially intact nuclear structure 
(“late necrotic cells) were scored as necrotic cells.
4.245 SCORING OF KINETOCHORE LABELLED SLIDES
Slides were labelled for kinetochore as described in the previous section. The slides 
were examined under fluorescence microscope using the filter for blue spectra in 
order to locate bi-nucleated cells containing MN. Upon location of an MN, switching 
filters to either the triple band pass filter or the single band filter for green spectra 
allowed the presence or absence of the green kinetochore signal to be detected. 
Scoring of kinetochore in a micronucleus was restricted to those cells which had good 
kinetochore signals (>20 in each nucleus) in their nuclei (figure 4.8). A minimum of 
100 micronuclei were counted for either presence or absence of signals.
4.25 STATISTICAL EVALUATION OF THE DATA
The statistical difference between controls and each treated sample were identified 
with the one tailed X2 test (Lovell 1989). The levels for statistical significance were 
P< 0.05, P< 0.01 and P 0.001.
FIGURE 4. 6 : SHOWING MONONUCLEATED CELL WITH MICRONUCLEUS 
SHOWING BINUCLEATED CELL WITH MICRONUCLEUS
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4.3 RESULTS
The induction of micronuclei in the OE33 cells by the various bile acids were 
measured using the Cytokinesis Blocked Micronucleus Assay. The experiments with 
all the bile acids were performed in two different pH conditions (pH 7.3 and pH5.5). 
This was to mimic the in-vivo conditions as closely as possible. Although the 
physiological pH in the lower oesophagus in patients with GERD can vary from 4 to 7 
(Kauer et al., 1997), a pH lower than 5.5 was found to have a marked cytotoxic effect 
on the cell lines.
The bile acids were tested over a dose range of lOpmol to 3mmol. This range was 
selected based on the findings of Nehra et al., 1999 and Iftikhar et al, 1993 who found 
that the concentration of various bile acids could vary in the range of ranging from 
50pmol -  3mmol in patients with oesophageal reflux and Barrett’s oesophagus. 
Deoxycholic and cholic acid were used in the range of lOpmol to 500pmol as 
concentrations of greater than 500pmol were found to be toxic to the cell lines.
4.31 MICRONUCLEI INDUCTION AT pH 7.3
Results of the OE33 Micronucleus assay with different bile acids at pH 7.3 are shown 
in the tables (For raw data vide appendix). Each table depicts the mean percentage of 
mononucleates, binucleates, multinucleates and MN in binucleate cells induced by 
different bile acids.
4.311 TAUROCHOLIC ACID
Data from this assay are presented in both tabular and graphical format (table 4.6 and 
figure 4.9). Taurocholic acid was used in the strength ranging from lOOpmol to 
3mmol. Concentrations above 3mmol were found to be extremely cytotoxic as seen
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by complete necrosis and loss of integrity of the cells on slides. This prevented 
scoring of the cells.
Taurocholic acid induced a dose dependent reduction in the levels of binucleated 
cells. The percentage of the binucleate cell gradually decreased with increasing dose 
from 39.70% at lOOpmol to 20.80% at 3mmol. Statistically significant reduction 
(PO.OOl) in the proportion of the binucleate cells was seen at a concentration of 
lOOpmol and above.
TCA did not show any statistically significant increases in Mn induction in 
binucleated cells. Maximum level of MN induction in binucleates of 1.16% was seen 
at concentration of 300pmol compared to 0.70% with control sample. There was no 
significant increase in the levels of multinucleated cells.
Table 4.7 and figure 4.10 show the results of apoptosis and necrosis. There was a 
progressive increase in the dose of the necrotic cells with increasing dose of TCA. 
The number of necrotic cells increased from 2.21% at lOOpmol to 16.36% at 
3000pmol. Statistically significant necrosis (PO.OOl) was seen at the dose of 
700mmol. There was no statistically significant change in the level of apoptosis in 
comparision with the control.
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Table 4.6: Data for MN induction for Taurocholic acid treated OE33 cells
Dose in iimol/1 %Mono %Binucleate %Multinucleate %MN Bn
00 54.29 44.80 0.94 0.70
100 59.50 39.70*" 0.78 0.59
200 61.50 38.00*** 0.53 0.99
300 66.60 32.80*** 0.60 1.16
400 68.12 31.33*** 0.56 0.79
500 64.66 34.70*** 0.64 0.70
600 70.62 28.90*** 0.49 0.50
700 67.32 32.00 0.67 0.79
800 70.58 28.95*** 0.47 0.45
900 71.00 28.43*** 0.57 0.60
1000 76.45 23.00*** 0.55 0.90
2000 76.17 23.33*** 0.50 0.73
3000 78.57 20.80*** 0.65 0.70
*P<0.05 **P<0.01 ***P<0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency of cells containing more than 2 nuclei
%MNBn- frequency of binucleated cells containing micronuclei
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Table 4.7: Data for induction apoptosis and necrosis by Taurocholic acid
Dose in 
|Liniol/l
%Mono %Binu %Multi %Apoptosis % Necrosis
000 54.17 42.25 0.68 0.51 2.39
100 56.72 40.52 0.92 0.37 2.21
300 54.03 41.05 1.05 0.70 3.16
500 58.95 36.32 0.88 0.35 3.5
700 58.05 33.97 1.08 0.71 7.1 8***
1000 66.32 17.49 0.70 0.87 14.14*"
2000 67.63 16.70 0.52 0.51 14.65***
3000 65.26 17.03 0.67 0.67 16.36***
P<0.05 PO.Ol PO.OOl 
%Mono- frequency of mononucleated cells 
%Binucleate- frequency of binucleated cells 
%Multinucleate- frequency of cells containing more than 2 nuclei 
%apoptosis- frequency of apoptotic cells 
%necrosis- frequency of necrotic cells
Figure 4.10: Induction of apoptosis and necrosis by taurocholic acid 
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4.312 GLYCOCHOLIC ACID
The results of MN induction in the OE33 cell lines by glycocholic acid, is shown in 
the table 4.8 and figure 4.11 and multinucleates along with micronucleated binucleate 
cells.
Glycocholic acid was used at concentration ranging from lOOpmol to 3mmol. 
Concentrations above 3mmol were found to be extremely cytotoxic as seen by 
extensive necrosis.
There was dose dependent increase the levels of binucleated cells. The percentage of 
the binucleate cell gradually decreased from 43.30% at lOOpmol to 20.61% at 3mmol 
while the proportion of mononucleated cells increased from 55.69% at lOOpmol to 
78.80% at 3mmol. A statistically significant decrease (P<0.001) in the level of 
binucleate cells was found at concentration of lOOpmol and greater. The number of 
multinucleate cells did not show any statistically significant difference in comparision 
to the control.
The induction of MN in binucleate cells did not show any statistically significant 
increase with increasing dose of GCA. The MN induction in binucleate cells was 
0.80% in the control samples whereas a maximum of 1.24% was observed at 
2000mmol.
Table 4.9 and figure 4.14 show the results of apoptosis and necrosis. There was a dose 
dependent increase in the number of necrotic cells. The level of necrotic cells 
increased from 2.95% at lOOpmol to 16.13% at 3000pmol. Statistically significant 
necrosis (p=0.05) was seen at the dose of 500pmol and above.
A maximum level of apoptosis of 1.1% was seen at doses of 1 and 2 mmol compared 
to a level of 0.70% in the control samples. There was no statistically significant 
increase in the level of apoptosis.
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Table 4.8: Data for MN induction for Glycocholic acid treated OE33 cells
Dose in 
^mol/1
%Mono %Binuc %MultinucIeate %MN BN
00 49.0 50.0 0.99 0.80
100 55.69 43.30*** 1.03 0.60
200 64.99 34.40*** 0.59 1.20
300 66.52 32.83*** 0.65 1.10
400 64.74 34.50*** 0.58 0.93
500 70.20 29.11*** 0.69 0.98
600 67.35 32.00*** 0.65 0.69
700 68.43 31.00*** 0.57 0.80
800 71.59 27.73*** 0.69 0.79
900 67.98 31.50*** 0.54 0.90
1000 69.64 29.77*** 0.59 0.80
2000 76.35 23.05*** 0.59 1.24
3000 78.80 20.61*** 0.58 0.85
*P<0.05 **P<0.01 ***P<0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency of cells containing more than 2 nuclei
%MNBn- frequency of binucleated cells containing micronuclei
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Table 4.9: Data for induction apoptosis and necrosis by glycocholic acid
Dose in pmol/1 % M ono % Binu % M uIti % Apoptosis % N ecrosis
000 46.51 49.02 0.72 0.70 3.04
100 50.92 45.20 0.55 0.37 2.95
300 45.05 49.47 083 0.88 3.71
500 51.71 41.44 0.72 0.36 5.76*
700 58.08 34.30 0.91 0.54 6.17’
1000 68.46 20.41 0.92 1.1 9.27’”
2000 62.55 23.43 0.55 1.1 12.36’”
3000 57.99 24.35 0.77 0.76 16.13’”
P<0.05 P<0.01 ” P<0.001
%Mono- frequency of mononucleated cells 
%Binucleate- frequency of binucleated cells 
%Multinucleate- frequency of cells containing more than 2 nuclei 
%apoptosis- frequency of apoptotic cells 
%necrosis- frequency of necrotic cells
Figure 4.12: Induction of apoptosis and necrosis by glycocholic acid 
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4.313 TAURODEOXYCHOLIC ACID
Table 4.10 (for raw data see appendix ) shows the results of MN induction in the OE33 
cell lines by taurodeoxycholic acid. The means of frequencies of mono-, bi- and 
multinucleates along with micronucleated binucleate cells are shown in the table. 
Taurodeoxycholic acid was used in the highest concentration of 2mmol/l. Concentration 
greater than 2mmol/l induced extensive cytotoxicity.
TDCA induced cytotoxicity in a dose dependent manner. There was a progressive 
decrease in the level of binucleated cells with increasing dose of TDCA (figure 4.13). 
The percentage of the binucleate cells decreased from 45.89% at lOOjimol to 22.10% at 
2mmol while the proportion of mononucleated cells increased from 53.24% at lOOpmol 
to 77.52% at 2mmol. A statistically significant decrease (P<0.001) in the level of 
binucleate cells was found at concentration of 600pmol and above. There was no 
statistically significant difference in the number of multinucleate cells between the 
various doses and the control.
The induction of MN was the maximum at doses between 400 to 700pmol/l with a level 
of 1.1% compared to 0.79% with the control. None of the doses of TDCA showed 
statistically significant induction of MN in the binucleate cells.
The results of apoptosis and necrosis are shown in the table 4.11 and figure 4.14. 
Necrosis induced by TDCA was dose dependent. The level of necrotic cells increased 
from 1.54% at 100pmol/l to 20.82% at 1000mmol/l (figure 4.14). Statistically significant 
necrosis (p<0.05) was seen at the dose of 300pmol and above.
A maximum level of apoptosis of 1.50% was seen at 700pmol/l compared to a level of 
0.83% in the control samples. TDCA did not show statistically significant induction of 
apoptosis at the various tested doses.
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Table 4.10: Data for MN induction for Taurodeoxycholic acid treated OE33 cells
Dose in 
limol/1
%Mono %Binuc %Multinucleate %MN BN
00 53.96 45.28 0.76 0.79
100 53.24 45.89 0.92 0.70
200 54.27 45.10 0.66 0.49
300 50.09 49.16 0.74 0.70
400 56.06 43.2 0.78 1.10
500 54.15 44.90 0.99 1.01
600 64.22 35.28*** 0.45 0.91
700 59.19 40.10*** 0.75 1.10
800 66.57 33.00*** 0.46 0.70
900 70.22 29.21*** 0.57 0.69
1000 68.50 30.60*** 0.896 0.81
2000 77.52 22.10*** 0.39 0.58
><0.05 *><0.01 **><0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency of cells containing more than 2 nuclei
%MNBn- frequency of binucleated cells containing micronuclei
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Table 4.11: Data for induction apoptosis and necrosis by Taurodeoxycholic acid
Dose in 
jamol/l
% M ono %Binu % M ulti %Apoptosis %Necrosis
000 49.84 46.87 0.66 0.83 1.82
100 51.15 45.77 0.77 0.77 1.54
300 51.29 43.20 0.69 0.52 4.30*
500 53.33 34.33 1.00 0.67 10.7***
700 56.72 32.84 00.90 1.50 8.10***
1000 60.04 35.46 1.50 0.94
♦ * *
20.82
*P<0.05 **P<0.01 "><0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency of cells containing more than 2 nuclei
%apoptosis- frequency of apoptotic cells
%necrosis- frequency of necrotic cells
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4.14: Induction Of Apoptosis And Necrosis By Taurodeoxycholic Acid 
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4.314 GLYCODEOXYCHOLIC ACID
The results of MN analysis with GDC A are shown in the table 4.12 and figure 4.15 (for 
raw data see appendix). GDCA was used in the concentration ranging from lOOpmol to 
2000pmol/l. Concentrations of greater than 2000pmol induced extensive necrosis as seen 
by the loss of integrity of the cells under simple microscope.
Induction of cytotoxicity by GDCA was dependent on the dose. There was a gradual 
reduction of the binucleate cells with the increasing dose of GDCA.
The percentage of the binucleate cells decreased from 47.96% at lOOpmol/L to 30.60% at 
2000pmol/L. Similarly the level of mononucleated cells increased from 51.08% at 
lOOpmol/L to 69.10% at 2000pmol/ml. A statistically significant decrease (PO.OOl) in 
the level of binucleate cells was found at concentration of 200pmol/L. The number of 
multinucleate cells seemed to decrease at high dose of GDCA though this was not 
statistically significant.
The induction of MN in binucleate cells by GDCA was not much different from that 
observed in the control samples. None of the doses of the GDCA showed significant 
induction of MN.
The results of apoptosis and necrosis are shown in the table 4.13 and figure 4.16. GDCA 
induced necrosis in a dose dependent manner. The level of necrotic cells increased from 
1.93% at lOOpmol/L to 17.67% at lOOOpmol/L. Statistically significant necrosis 
(pO.OOl) was seen at the dose of 500pmol and above. A maximum level of apoptosis of 
1.73% was seen at 500pmol/l compared to a level of 0.94% in the control samples. 
Induction of apoptosis by various doses of GDCA was not found to be statistically 
significant.
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Table 4.12: Data for MN induction for Glycodeoxycholic acid treated OE3 3 cells
Dose in 
limol/1
%Mono %Binuc %Multinucleate %MN BN
00 51.72 47.29 0.99 0.83
100 51.08 47.96 0.96 0.63
200 58.77 40.77*** 0.46 0.62
300 57.95 41.77*** 0.30 0.71
400 60.68 38.97*** 0.35 0.70
500 60.91 38.79*** 0.31 0.69
600 62.50 37.14*** 0.37 0.59
800 63.50 36.09*** 0.42 0.84
1000 69.20 30.50’** 0.30 0.59
2000 69.10 30.60**’ 0.28 0.71
*P<0.05 **P<0.01 ***P<0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency of cells containing more than 2 nuclei
%MNBn- frequency of binucleated cells containing micronuclei
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Table 4.13 Data for induction apoptosis and necrosis by Glycodeoxycholic acid
Dose in 
pmol/1
% M ono %Binu % M ulti %Apoptosis %  Necrosis
000 47.08 44.82 0.75 0.94 3.01
100 48.36 47.58 0.97 1.16 1.93
300 51.52 42.25 0.71 0.53 4.99
500 51.12 38.00 0.86 1.73 8.29’"
700 51.38 34.31 1.1 1.10 1 2 . 1  r*+
1000 50.47 29.97 0.95 0.95 17.67’"
*P<0.05 P<0.01 PO.OOl
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%MultinucIeate- frequency of cells containing more than 2 nuclei
%apoptosis- frequency of apoptotic cells
%necrosis- frequency of necrotic cells
FIGURE 4.16: Induction Of Apoptosis And Necrosis By Glycodeoxycholic Acid
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4.315 DEOXYCHOLIC ACID
The results of MN analysis with DC A are shown in the table 4.14 and figure 4.17 (for 
raw data see appendix). The concentrations tested were 10, 25, 50, 100, 200, 300 and 
40Qpmol/l. Unlike the conjugated bile acids concentrations of 500pmol and above 
showed extensive cytotoxicity as seen by complete necrosis of the cells under light 
microscopy.
Table figure 4.17 shows that DC A induced cytotoxicity in a dose dependent manner. The 
proportion of binucleate cells gradually decreased from 36% at lOpmol to 11% at the 
highest dose of 400pmol/L. The decrease in proportion of the binucleate cells was 
statistically significant (P<0.001) at concentrations of lOpmol and above. The level of 
multinucleate cells did not vary significantly in comparison with the control.
At concentrations of 50, 100 and 200 there was a statistically significant (p<0.05) 
increase in the induction of MN in binucleated cells. At concentration of 100, 200 and 
400pmol the the frequency of MN induction was more than three times the control value. 
In order to further investigate the content and of MN and the mechanism of induction of 
MN by DCA, CREST analysis was performed. The CREST analysis was performed 
using the concentrations (50, 100 and 200pmol) which induced statistically significant 
number of micronuclei in binucleate cells. The results of kinetochore analysis are 
presented in the table 4.15 and figure 4.18.
The kinetochore analysis showed that the MN were predominantly kinetochore negative 
i.e, most of the micronuclei did not exhibit a fluorescence signal. The proportion of 
kinetochore positive MN in the DCA treated slides was much lower than that seen in the 
control indicating a clastogenic effect. The proportion of kinetochore negative 
micronuclei increased with increasing concentration of DCA (67% at 50pmol to 76% at 
200pmol). Hence the mechanism of induction of MN by DCA was mostly clastogenic.
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Table 4.16 and figure 4.19 show the results of apoptosis and necrosis induced by DCA. 
DCA induced necrosis in a dose dependent manner. The level of necrotic cells increased 
from 2.63% at lOpmol/L to 15.98% at lOOOpmol/L. Statistically significant necrosis 
(p<0.001) was seen at the dose of 50pmol and above. The induction of apoptosis by 
DCA was the highest at the concentrations between 50 and 300pmol/L. At concentrations 
of lOOpmol/L the level of induction of apoptosis was almost six times the control. The 
induction of apoptosis by DCA was found to be statistically significant.
Table 4.14: Data for MN Induction for Deoxycholic Acid treated OE3 3 Cells
Dose in 
pmol/1
%Mono %Binuc %Multinucleate %MN BN
00 55.61 43.66 0.74 0.65
10 63.36 36.00*" 0.67 0.97
25 59.69 39.65*" 0.67 1.19
50 65.46 33.70*** 0.84 00 o *
100 69.89 29.44*** 0.67 2.10"
200 79.22 20.0*** 0.76 2.02*
300 81.60 17.90*** 0.49 1.52
400 88.85 11.00*** 0.56 2.2*
*P<0.05 **P<0.01 "><0.001
%Mono- frequency of mononucleated cells 
%Binucleate- frequency of binucleated cells 
%Multinucleate- frequency of cells containing more than 2 nuclei 
%MNBn- frequency of binucleated cells containing micronuclei
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Table 4.17: Data for MN Induction for Cholic Acid treated Oe33 Cells
Dose in 
p.mol/1
%Mono %Binuc %Multinucleate %MN BN
00 49.81 49.50 0.73 0.79
10 52.04 47.00 0.99 0.60
25 59.43 40.00 0.55 0.99
50 59.70 39.70*** 0.64 0.71
100 55.94 43.42*** 0.64 0.69
200 63.99 35.30*** 0.71 1.00
300 66.19 33.20*** 0.66 1.20
400 74.79 24.65*** 0.55 0.67
500 82.36 17.00*** 0.67 0.79
><0.05 **P<0.01 ***P<0.001
jMono- frequency of mononucleated cells
>Bi nucleate- frequency of binucleated cells
jMultinucleate- frequency of cells containing more than 2 nuclei
jMNBn- frequency of binucleated cells containing micronuclei
s||90  pa^eapnuouoiAi jo  %
s||30  p a jea p n m g  jo  %
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Table4.18: Data for Induction Apoptosis and Necrosis by Cholic Acid
Dose in 
pmol/1
%Mono %Binu %MuIti %Apoptosis %Necrosis
000 46.77 48.80 0.55 0.74 3.14
10 45.86 49.72 0.92 0.74 2.76
25 49.90 45.49 1.15 0.97 2.50
50 51.09 43.82 1.09 0.36 3.64
100 50.18 40.26 1.47 1.47 6.62’
200 54.81 35.93 0.73 1.82 "  6.72**"
300 71.57 19.80 1.18 0.98 6.47*
400 61.97 23.94 1.01 0.88 12.32*"
500 67.19 20.73 0.69 0.52 '1 0 .8 8 * "  ~
P<0.05 PO.Ol P<0.001 
%Mono- frequency of mononucleated cells 
%Binucleate- frequency of binucleated cells 
%Multinucleate- frequency of cells containing more than 2 nuclei 
%apoptosis- frequency of apoptotic cells 
%necrosis- frequency of necrotic cells
Figure 4.21: Induction Of Apoptosis And Necrosis By Cholic Acid 
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4.317 MITOMYCIN C
Mitomycin C was used as a positive control. Mitomycin C is a known clastogen. MMC 
both alklylates and cross links DNA, which leads to breakage of DNA. MMC was used in 
the concentration 10, 30, 50, 70 and 100 pmols/L.
The data of MN induction by various concentrations of MMC is shown in the table 4.19 and 
figure 4.22. MMC induced cytotoxicity which was indicated by a decrease in the level of 
binucleate cells with an increasing concentration. The proportion of bineucletate cells 
decreased from 50.10% at lOpmol/L to 33.53% at 100pmol/L. The highest level of 
microneucleus was induced at concentrations 70 pmol/L and lOOpmol/L with 4.17% and 
3.70% respectively compared to 0.73% with control.
To further evaluate the mechanism of induction of microneuclei kinetocore staining 
(CREST analysis) was performed table 4.20 and figure 4.23 show the results of CREST 
analysis of mitomycin C using concentrations of 30, 50 and 70 pmol/L. The kinetocore 
analysis showed that the microneulei were predominantly kinetocore negative. The 
proportion of k- to k+ was greater with mitomycin C compared to the control. At 
concentrations of 50pmol/L and 70pmol/L greater than 75% of the microneuclei were 
kinetocore negative. Table 4.21 and figure 4.24 show the results of induction of apoptosis 
and necrosis by mitomycin C in the OE33 cells. The level of necrosis increased from 2.76 
at concentration of lOpmol/L to 6.62% at lOOpmol/L. The highest level of apoptosis was 
induced at lOOpmol/L which was almost twice the level seen in control (1.47% versus 
0.74%). The induction of apoptosis by mitomycin C was not found to be statistically 
significant.
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Table 4.19: Data for MN induction for Mitomycin C treated OE33 cells
Dose in 
^mol/1
%Mono %Binuc %Multinucleate %MN BN
00 51.88 47.64 0.48 .73
10 49.19 50.10** 0.74 1.08
30 56.35 42.90*** 0.80 2.15*
50 61.49 37.82** 0.69 3.95***
70 55.37 44.91* 0.60 4.17***
100 65.96 
*** ' _ '
***
33.53 0.51 3.70*’*
P<0.05 PO.Ol ” 'P<0.001 
%Mono- frequency of mononucleated cells 
%Binucleate- frequency of binucleated cells 
%Multinucleate- frequency of cells containing more than 2 nuclei 
%MNBn- frequency of binucleated cells containing micronuclei
Figure 4.22: MICRONUCLEUS INDUCTION BY MITOMYCIN C
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TABLE 4.20: SHOWING PROPORTION OF KINETOCHORE POSITIVE 
AND KINETOCHORE NEGATIVE MICRONUCLEI INDUCED BY
MITOMYCIN C
Dose K+ K- Total Proportion Proportion %MN %Mnbn %Mnbn
ilg/ml Mn Mn Mn Of
K+
Of
K-
Bn K+ K-
00 24 40 64 0.37 0.63 .73 0.27 0.46
30 28 58 86 0.33 0.67 2.15 0.71 1.44
50 23 77 100 0.23 0.77 3.95 0.91 3.04
70 19 81 100 0.19 0.81 4.17 0.79 3.38
|J%MNBn K+ and %MNBn K- calculated by multiplying %MNBn by proportion 
of MN K+ or K-
Figure 4.23: FREQUENCIES OF KINETOCHORE POSITIVE AND 
KINETOCHORE NEGATIVE MICRONUCLEI IN BINUCLEATE CELLS
INDUCED BY MITOMYCIN C
30 50
Dose in ng/MI
□  %MNBn □  %MNBnK+ □  %MNBnK-
210
Table 4.21: Data for Induction Apoptosis and Necrosis by Mitomycin C
Dose in 
pmol/1
%Mono %Binu % Multi %Apoptosis %Necrosis
00 46.77 48.80 0.55 0.74 3.14
10 45.86 49.72 0.92 0.74 2.76
50 49.90 45.49 1.15 0.97 2.50
70 51.09 43.82 1.09 0.36 3.64
100 50.18 40.26 1.47 1.47 6.62’
><0.05 *><0.01 **><0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency o f cells containing more than 2 nuclei
%apoptosis- frequency o f apoptotic cells
%necrosis- frequency of necrotic cells
Figure 4.24: Induction Of Apoptosis And Necrosis By Mitomycin C
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4.32 M ICRONUCLEI INDUCTION AT PH 5.5
The second experiment evaluated the effect of bile acids at pH 5.5. Treatment with 
bile acids, cytochalasin-B and harvesting of the cells were all performed in a similar 
manner as previous experiments. The results of various treatments with bile acids at 
pH 5.5 are shown in the table from 4.22 to table 4.33 (For raw data vide appendix). 
Each table depicts the mean percentage of mono-nucleates, binucleates, 
multinucleates and MN in binucleate cells induced by different bile acids.
TCA, GCA, TDCA and GDCA were used in the concentrations of 100, 500 and 
lOOOpmol/L. DCA was used in the concentration of 50, 100 and 200 pmol/L, while 
CA was used in the concentration of 50, 100, 200 and 500pmol/L.
Treatments with all bile acids induced a greater degree of cytotoxicity in comparision 
to similar strengths at neutral pH. Concentrations of TCA, GCA, TDCA and GDCA 
of greater than 1000 pmol/L induced generalized cytotoxicity. DCA induced 
generalized cytotoxocity at concentrations above 200pmol/L whilst CA induced 
generalized cytotoxicity at concentrations greater than 500pmol/L. With all bile acids 
there was a greater dose related decrease in percentage of bineucleate cells at pH 5.5 
compared to pH 7.3.
Figures 4.25, 4.27, 4.29 and 4.31 show the data from MN analysis of TCA, GCA, 
TDCA and GDCA. The proportion of binucleate cells decreased with increasing dose 
of bile acids, the highest proportion of binucleates being seen at lOOpmol and the 
least at lOOOpmol. The proportion of binucleates in acidic control (pH 5.5) was much 
lower than that of neutral control (pH 7.3) indicating a greater degree cytotoxicity and 
inhibition of cellular division. The overall induction of MN in the binucleates with all 
the four bile acids (TCA, GCA, TDCA and GDCA) was relatively higher at acidic pH 
than at neutral pH. The difference was not statistically significant. Similarly the 
degree of apoptosis and necrosis was higher at pH 5.5 for all strengths of bile acids.
2 1 2
The difference in the level of necrosis at the two different pH conditions was found to 
be statistically significant. Though there was relatively increased apoptosis in the 
acidic medium the difference was not statistically significant (see table 4.23, 4.25, 
4.27, 4.29 and figure 4.26,4.28,4.30 and 4.32).
Table 4.30 and figure 4.33 show the data from MN analysis of DCA at pH 5.5.
DCA induced a higher degree of cytotoxicity at acidic pH. Concentration of greater 
than 200pmol induced extensive necrosis. There was rapid fall in the proportion of 
binucleate cells from 36.82% with control to 10.19 at concentrations of 200pmol. The 
level of induction of MN in binucleates increased to almost three times the levels of 
control at concentrations of 200pmol/L (2.88% vs 0.96). Due to greater degree of 
cytotoxicity at concentrations of 100 and 200mmol the number of binucleate cells 
counted were relatively small (around 500 binucleate cells were counted). Though 
there is increase in the number of micronuclei this has to be interpreted with caution 
due to the high degree of cytotoxicity at these concentrations.
Table 4.31 and figure 4.34 shows the induction of apoptosis and necrosis by DCA at 
pH of 5.5 at concentrations of 100 and 200mmol the proportion of necrotic cells was 
greater than 30% and more than 40% of the remaining cells were mononucleate. The 
degree of apoptosis induced by DCA was almost three times the control level at the 
two highest concentrations (2.97 and 2.70 vs 1.18).
Table 4.32 and figure 4.35 show the data from MN analysis of CA at pH 5.5. CA was 
used in the concentration of 50 -  500pmol/L. The proportionate of binucleate cells 
fell from 32.49% at 50pmol to 8.9% at 500pmol/L. The induction of MN was highest 
at 500pmol/L (nearly twice the control level). Due to extensive degree of cytotoxicity 
at this concentration the number of binucleated cells counted was around 500.
2 1 3
At higher concentrations the level of apoptosis induced by CA was almost twice the 
control levels (2.18% vs 1.38%) although this was not found to be statistically 
significant (table 4.33 and figure 4.36).
Table 4.22: Data for MN induction for Taurocholic acid treated OE3 3 cells at pH
5.5
Dose in 
pmol/1
%Mono %Binucleate %Multinucleate %MN Bn
00 65.679 34.03 0.29 0.95
100 64.89 34.81 0.30 0.80
500 73.43
_ , _ _ *** 
26.32 0.25 1.00
1000 84.21 15.61"’ 0.18 1.26
Control 54.60 45.13’" 0.27 0.60
%Mono- frequency of mononucleated cells 
%Binucleate- frequency of binucleated cells 
%Multinucleate- frequency of cells containing more than 2 nuclei 
%MNBn- frequency of binucleated cells containing micronuclei
Figure 4.25: MICRONUCLEUS INDUCTION BY TAUROCHOLIC ACID AT
pH 5.5
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Table 4.23 Mean data for induction apoptosis and necrosis by Taurocholic acid at pH5.5
Dose in 
pmol/I
%Mono %Binu %Multi %Apoptosis %Necrosis
000 51.59 36.71 1.19 0.99 9.52
100 48.68 32.64 0.76 1.69 16.22"
500 55.66 13.52 0.99 1.59 28.23*"
1000 46.73 16.24 0.99 2.38 33.66"*
P<0.05 PO.Ol PO.OOl 
%Mono- frequency of mononucleated cells 
%Binucleate- frequency of binucleated cells 
%Multinucleate- frequency o f cells containing more than 2 nuclei 
%apoptosis- frequency of apoptotic cells 
%necrosis- frequency of necrotic cells
Figure 4.26 Induction of apoptosis and necrosis by taurocholic acid at pH 5.5 
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Table 4.24: Data for MN induction for Glycocholic acid treated OE33 cells at pH 5.5
Dose in 
pmol/1
%Mono %Binuc %Multinucleate %MN BN
00 63.46 36.29 0.24 0.98
100 66.57 33.21*** 0.22 0.72
500 74.24 25.51*’* 0.25 0.71
1000 85.22
***
14.58 0.20 1.07
Control 
pH 7.4
51.98
***
47.73 0.29 0.70
*P<0.05 **P<0.01 ***P<0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency o f cells containing more than 2 nuclei
%MNBn- frequency of binucleated cells containing micronuclei
Figure 4.27: MICRONUCLEUS INDUCTION BY GLYCOCHOLIC ACID AT
pH 5.5
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Table 4.25: Data for Induction apoptosis and necrosis by Glycocholic acid at pH 5.5
Dose in 
prnol/l
%Mono %Binu %Multi %Apoptosis %Necrosis
000 58.45 31.26 0.97 1.36 12.04
100 59.20 16.51 0.95 2.09 21.52'** '
500 52.02 14.26 0.77 1.54 ■i . ; i "
1000 55.42 10.85 0.79 1.76 31.16***
*P<0.05 **P<0.01 ***P<0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%MultinucIeate- frequency of cells containing more than 2 nuclei
%apoptosis- frequency of apoptotic cells
%necrosis- frequency of necrotic cells
Figure 4.28: Induction of apoptosis and necrosis by glycocholic acid at pH 5.5
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Figure 4.26: Data for MN induction for Taurodeoxycholic acid treated OE33 cells
Dose in 
pmol/1
% M ono %Binuc %M ultinucleate % M N  BN
00 57.41 32.35 0.36 1.04
100 69.12 30.48 0.31 0.88
500 80.61 19.04*** 0.32 1.35
1000 85.46 14.25*** 0.29 1.15
NORMAL
CONTROL
50.02 48.98*** 0.50 0.81
*P<0.05 *><0.01 **><0.001
%Mono- frequency of mononucleated cells 
%BinucIeate- frequency of binucleated cells 
%Multinucleate- frequency of cells containing more than 2 nuclei 
%MNBn- frequency of binucleated cells containing micronuclei
Figure 4.29: M ICRONUCLEUS INDUCTION BY TAURODEOXYCHOLIC ACID
AT pH 5.5
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Table 4.27: Data for Induction Apoptosis and necrosis by Taurodeoxycholic acid
Dose in 
pinol/1
%M ono %Binu %MuIti %  Apoptosis %  Necrosis
000 58.26 31.03 0.91 1.63 8.17
100 56.83 26.20 0.92 1.29 14.76***
500 41.96 18.43 0.78 1.57 37.25***
1000 49.61 18.90 0.98 1.18 29.53***
*P<0.05 *><0.01 **><0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency of cells containing more than 2 nuclei
%apoptosis- frequency of apoptotic cells
%necrosis- frequency of necrotic cells
Figure 4.30: Induction of apoptosis and necrosis by taurodeoxycholic acid
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Table 4.28: Data for MN induction for Glycodeoxycholic acid treated OE33 cells
Dose in 
pniol/1
% M ono %Binuc %Multinucleate % M N  BN
00 67.68 32.06 0.26 1.05
100 72.07 27.68*** 0.25 0.95
500 85.82 13.79*** 0.38 1.47
1000 92.72 6.89*** 0.30 1.67
NORMAL
CONTROL
52.59 46.76*** 0.65 0.89
><0.05 *><0.01 "><0.001
%Mono- frequency of mononucleated cells 
%Binucleate- frequency of binucleated cells 
%Multinucleate- frequency of cells containing more than 2 nuclei 
%MNBn- frequency of binucleated cells containing micronuclei
Figure 4.31: M ICRONUCLEUS INDUCTION BY G LY COD EO X YCH O LIC ACID
AT pH 5.5
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Table 4.29: Data for Induction Apoptosis and necrosis by Glycodeoxycholic acid
Dose in 
jiimol/l
%Mono %Binu % M ulti %Apoptosis %Necrosis
000 55.15 32.25 1.34 0.95 10.31
100 55.34 28.57 0.72 1.45 13.74
500 50.85 15.94 0.57 2.28 30.36***
1000 47.06 17.65 1.10 1.47 32.72***
><0.05 *><0.01 **><0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency of cells containing more than 2 nuclei
%apoptosis- frequency of apoptotic cells
%necrosis- frequency of necrotic cells
Figure 4.32: Induction of Apoptosis and Necrosis by Glycodeoxycholic Acid 
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Table 4.30: Data for MN Induction for Deoxycholic Acid treated OE33 Cells
Dose in 
pmol/l
% M ono %Binuc %Multinucleate % M N  BN
00 62.96 36.82 0.30 0.96
50 78.044 21.70*** 0.25 1.53
100 86.23 13.59*** 0.173 2.68**
200 89.61 10.19*** 0.19 2.88**
><0.05 **P<0.01 **><0.001
%Mono- frequency of mononucleated cells 
%Binucleate- frequency of binucleated cells 
%Multinucleate- frequency of cells containing more than 2 nuclei 
%MNBn- frequency of binucleated cells containing micronuclei
Figure 4.33: M ICRONUCLEUS INDUCTION BY DEOXYCHOLIC ACID AT pH
5.5
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Table 4.31: Data for Induction Apoptosis and Necrosis by Deoxycholic Acid
Dose in 
fimol/l
%Mono %Binu % M ulti %Apoptosis %  Necrosis
000 46.85 42.52 1.18 1.18 8.27
50 46.66 29.71 1.14 2.29 20.19***
100 42.67 20.87 0.74 2.97* 32.84"'
200 50.97 15.06 0.77 2.70 30.50"'
><0.05 *><0.01 **><0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency of cells containing more than 2 nuclei
%apoptosis- frequency of apoptotic cells
%necrosis- frequency of necrotic cells
Figure 4.34: Induction Of Apoptosis And Necrosis By Deoxycholic Acid 
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Table 4.32: Data for MN Induction for Cholic Acid treated OE33 Cells
Dose in 
pmol/l
%Mono %Binuc %MuItinucleate % M N
BN
00 64.78 35.02 0.20 0.72
50 63.72
* **
32.49 0.19 0.76
100 75.15
_ . _*** 
24.7 0.19 0.76
200 84.99 14.81*** 0.20 1.09
500 90.94 08.90*** 0.17 1.36
><0.05 *><0.01 **><0.001
%Mono- frequency of mononucleated cells 
%Binucleate- frequency of binucleated cells 
%Multinucleate- frequency of cells containing more than 2 nuclei 
%MNBn- frequency of binucleated cells containing micronuclei
Figure 4.35: MICRONUCLEUS INDUCTION BY CH O LIC ACIDAT pH 5.5
PERCENTAGE OF BINUCLEATED CELLS AND  
MICRONUCLEATED CELLS
35 --
30 --
25 --
20 - -
15 --
-- 0
10 - -
5 --
50050 100 2000
D ose in micro mol
% B N  % MN 5.5 —SK—%MN 7.3
224
Table 4.33: Data for Induction Apoptosis and Necrosis by Cholic Acid
Dose in 
pmol/1
%Mono %Binu %Multi %Apoptosis %Necrosis
000 48.42 37.55 0.99 1.38 11.66
50 50.88 28.38 0.98 0.98 18.79"
100 40.27 28.79 1.36 1.56 28.02*"
200 44.36 26.93 0.99 2.18 25.55""
500 43.38 18.62 0.96 1.15 35.89""
*P<0.05 **P<0.01 ***P<0.001
%Mono- frequency of mononucleated cells
%Binucleate- frequency of binucleated cells
%Multinucleate- frequency of cells containing more than 2 nuclei
%apoptosis- frequency of apoptotic cells
%necrosis- frequency of necrotic cells
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Figure 4.36: Induction of Apoptosis and Necrosis by Cholic Acid 
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4.4 DISCUSSION 
BARRETT’S OESOPHAGUS
There has been an increasing interest in Barrett’s oesophagus in the last few years. 
This is because of its strong association with oesophageal adenocarcinoma, the 
incidence of which has been rapidly increasing in the last few decades. Surgical 
resection remains the standard treatment for early localised cancers. Despite 
improvements in surgical techniques, radiation and chemotherapy, the prognosis of 
this cancer remains poor (less than 25% of patients live for 5 years after 
oesophagectomy) (Ilson 2003; Wu et al, 2003). The cause of the increasing incidence 
of this cancer is not known. A proper understanding of the aetiology and molecular 
events that characterize the transition to carcinoma is important for early detection 
and development of new preventive strategies to improve the prognosis for this grave 
disease. Although BE is a well recognised precursor of oesophageal adenocarcinoma, 
the aetiology, pathogenesis, prevalence and malignant risk of this lesion are still not 
clear. BE is an acquired condition which results from chronic DGER. Studies show 
that reflux of gastric and duodenal content are the most important factors in the 
development of this condition. Almost 10% of patients with GERD symptoms have 
BE (Spechler 2000).
Patients with BE have been shown to have increased reflux of acid and bile. BE 
possibly results from a complex interaction between acid exposure, bile, 
environmental factors and genetic susceptibility. More recently a number of studies 
have shown that bile acids may be one of the important factors involved in the 
pathogenesis of BE.
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Several studies have evaluated the effects of bile acids (mostly DCA) on colonic cell 
lines, hepatocytes and pancreatic cancer cell lines and oesophageal cell lines.
No studies have been performed in the past to establish the genotoxic and cytotoxic 
potential of various bile acids on oesophageal cells in concentrations which are 
physiologically relevant to patients with BE. Knowledge about the genotoxic and 
cytotoxic potential of the various bile acids is limited. This is because most of the 
available data focus mostly on the effects of DCA on cell lines. The aim of our study 
was to fully evaluate the genotoxic and cytotoxic effects of the various bile acids on 
oesophageal cell lines. We therefore investigated the genotoxicity and cytotoxicity of 
the six different bile acids commonly encountered in patients with BE using 
oesophageal cell culture model. Six bile acids namely TCA, GCA, TDCA, GDCA, 
DCA and CA were used in the concentration range normally found in patients with 
BE and GERD. The maximum concentration was limited by the toxicity of the 
individual bile acids.
MN ASSAY
The cytokinesis-blocked micronucleus assay (CBMN) was used to evaluate the 
cytotoxic and genotoxic effects of the bile acids. The CKMB has been widely used as 
a sensitive screening test for the detection of chromosomal aberration and has 
emerged as one of the preferred methods for assessing chromosomal damage. Not 
only is it simpler and quicker than the traditional chromosome analysis it is also found 
to be equally effective. The combination of cytokinesis blocked Micronucleus assay 
and CREST (kinetochore) staining provides a rapid and simple means of analysing the 
induction of numerical chromosomal aberration. This technique can detect both
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clastogenic agents which cause chromosomal breaks as well as aneugens which 
induce aneuploidy.
CYTOTOXICITY
All the bile acids were found to have cytotoxic and growth inhibitory effect as 
demonstrated by the decrease in proportion of the bi-nucleate cells. The decline in the 
frequency of bi-nucleated cells was accompanied with an accumulation of mono­
nucleated cells.
The cytotoxic effect of DCA was greater than CA. The un-conjugated bile acids DCA 
and CA had a greater cytotoxic effect than the conjugated bile acids (TCA, GCA, 
TDCA and GDCA). All of the conjugated bile acids demonstrated a similar range of 
cytotoxicity. The cytotoxic effect of all the bile acids had a linear relationship to the 
dose. The cytotoxic effect of the bile acids (both the conjugated and un-conjugated 
bile acids) was found to be markedly increased in acidic pH.
Cytotoxicity of the bile acids in-vitro has been demonstrated by a number of studies 
(Salo JA et al., 1984, Hopwood D et al., 1981, Kivilaakso E et al, 1980, Bachir et al., 
1982, Latta RK 1993). Bachir et al 1982 showed that conjugated bile acids in the 
range of l-3mmol/l had a significant cytotoxic effect on oesophageal organ culture at 
neutral pH. Our findings are in agreement with this, and in addition we have shown 
that relatively small concentrations of bile acids (DCA 50 -  lOOfimol and conjugated 
bile acids >500pmol) can induce cytotoxic effects. This finding has an implication 
because even a relatively small quantity of bile reflux can cause damage in patients 
with BE. Furthermore, the cytotoxic effect of the bile acids was found to be dose 
dependent.
Kivilaakso E et al., (1980) and Salo et al, (1980) found that the cell damage induced 
by bile acids was pH dependent. They found that conjugated BA (TCA) exerted their
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cytotoxic effect at pH 3. 5 whilst un-conjugated BA (CA and DCA) exerted their 
cytotoxic effect at pH 7.4. Our findings do not agree with this, although it has to be 
noted that our experiments were conducted at a slightly higher pH (pH5.5 versus 
pH3.5). Our outcome was consistent with that of Hopwood et al (1981) who found 
that high and moderate concentration of all the common bile acids damaged the 
oesophagus irrespective of the pH. We found that lowering the pH of the medium 
increased the cytotoxic effect of all the tested bile acids in general. This shows that 
bile acids and low pH have a synergistic effect on inducing cell damage in 
oesophageal cells. Therefore bile acids in combination with acid can cause more 
damage compared to bile or acid alone.
GENOTOXICITY
The information regarding genotoxicity of various bile acids is limited. Most of the 
available data relates to the effects of DCA. In our study all the bile acids except DCA 
failed to induce statistically significant micronuclei. The degree of micronucleus 
induction remained constant irrespective of the dose and the degree of cytotoxicity. 
The induction of micronuclei with these bile acids was found to be slightly higher at 
acidic pH though this was not found to be statistically significant. There is no 
comparable data available in the literature about the genotoxicity of the conjugated 
bile acids.
Our results show the DCA induced statistically significant induction of micronuclei in 
the OE33 cells. The induction of micronucli was found to be at a maximum at doses 
between 100 and 200pmol. A further increase in the dose resulted in an increase in the 
percentage of MN although the number of bi-nucleate cells counted decreased 
profoundly due to increased cytotoxicity. Further evaluation of the mechanism of MN
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induction by DCA using kinetochore staining showed that the micronuclei were 
predominantly kinetochore negative. This indicates that DCA has a predominantly 
clastogenic effect.
Unlike most other bile acids DCA has been extensively studied in the past. There is 
increasing evidence to show that DCA acts as a tumour promoter (Debruyne et al.,
2001) DCA has been shown to act as a tumour promoter by influencing cell signaling 
gene expression. DCA has been shown to increase cox-2 expression in oesophageal 
cells (Shirvani et al., 2000, Zhang et al., 1999). Studies have shown that the tumour 
promoting activity of DCA is closely related to activation of protein kinase C and AP- 
1 (Qiao et al., 2000; Qiao et al, 2002).
Despite extensive studies on the effects of DCA the information regarding its 
genotoxic activity is very limited and contradictory. Very few studies have 
demonstrated the DNA damaging effects of DCA. The earliest reports about DNA 
damaging effects of DCA was reported by Kandell et al., and Cheah et a l ., (Cheah 
et al., 1990; Kandell et al., 1991). They showed that bile acids, DCA in particular, 
could damage DNA in both bacterial and mammalian cells. More recently Venturi et 
al (1997), Powolny et al (2001) and Glinghammar et al (2002) have shown that DCA 
can induce DNA damage in colon cancer cells using comet assay. So far there are no 
studies which have demonstrated genotoxic effect of DCA on oesophageal cell lines. 
Our findings agree with the above studies. We found that concentrations of DCA 
similar to the ones observed in the above studies (100-300pmol) had a significant 
genotoxic effect. We also found that similar concentrations induced significant 
apoptosis of the OE33 cells. This data supports the findings of previous studies 
(LaRue et al., 2000; Powell et al., 2001; Powolny et al, 2001; Milovic et al, 2002).
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As observed in previous studies the induction of apoptosis by DCA was at a 
maximum between 100 and 200pmol. At higher concentration DCA induced cell 
death was increasingly due to necrosis rather than apoptosis. The level of apoptosis 
remained constant with the other bile acids.
There is accumulating evidence that DCA can induce apoptosis. Apoptosis, or 
programmed cell death, is a mechanism that allows a cell to destroy itself when 
stimulated by an appropriate trigger (Wyllie et al., 1980; Barr et al., 1994; Schwartz 
et al., 1995; Ellis et al., 1996). This can be triggered by various stimuli, one of which 
is DNA damage secondary to exposure to genotoxic agents.
Mammalian cells respond to DNA-damaging agents by activating cell cycle 
checkpoints. This can lead to cell cycle arrest, apoptotic cell death, and transcriptional 
induction of genes involved in DNA repair. Arrest of cell cycle enables the cell tor 
repair the defective DNA. Repair of damaged DNA enables the cell to cycle to 
resume. On the other hand if  the damage is too extensive, the cell will undergo 
apoptosis. Genotoxic DNA damaging agents may activate both membrane death 
receptors and the endogenous mitochondrial damage pathway leading to cell death via 
apoptosis.
Our studies showed that the proportion of apoptotic cells increased with the dose of 
DCA and was accompanied by induction of DNA breakage in the OE33 cells. We 
therefore assume that apoptosis in the OE33 was induced by DNA damage secondary 
to exposure to genotoxic concentrations of DCA. These studies indicate that the 
cytotoxic effects of DCA are partly mediated by the inhibition of DNA synthesis, 
induction of DNA damage and apoptosis.
On the other hand no significant apoptosis or DNA damage was observed with the 
other bile acids indicating that the cytotoxicity mediated by these bile acids was
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possibly due to their direct destruction of cell membrane secondary to their 
detergent/lipid peroxidation effect. The experiments were repeated in acidic pH to 
mimic the normal in-vivo environment and to evaluate the influence of acid on the 
cytotoxicity and genotoxicity of the bile acids. In acidic medium (pH 5.5) the 
proportion of bi-nucleate cells was lower and the proportion of micro-nucleated bi- 
nucleate cells was higher than at neutral pH. There was also an increase in the 
proportion of necrotic cells at acidic pH. Although the induction of MN by the bile 
acids in the acidic pH was slightly higher than at neutral pH, it was not found to be 
statistically significant. DCA in particular showed a greater induction of MN at acidic 
pH. This has to be interpreted with caution as studies have shown low pH itself can be 
clastogenic to certain cell lines (Scott et al., 1991; Morita et al, 1992). The 
clastogenicity seen with low pH can vary with the type of cell lines and be associated 
with different degree of cytotoxicity. It has been shown that clastogenicity evaluated 
at low pH can be unreliable when the degree of cytotoxicity is greater than 50%. The 
overall data indicates that the bile acids are cytototoxic and that DCA exerts 
significant genotoxicity on oesophageal cell lines at relatively low concentrations. 
These findings are important because it is well documented that chromosome damage 
is strongly and positively associated with cancer risk (Mitelman et al, 1990).
The in-vitro effect of DCA on the cell toxicity and DNA damage requires further 
detailed investigation. These findings, however, provide further evidence for the 
involvement of bile acids in the malignant transformation of BE and development of 
oesophageal adenocarcinoma. We therefore conclude that bile acids may play a 
significant in the pathogenesis of BE and its progression to adenocarcinoma.
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CHAPTER FIVE 
GENERAL DISCUSSION
Our work has focused on the various aspects of Barrett’s oesophagus. The main 
objective of this study was to use molecular and cellular approaches to understand the 
mechanism of the development of Barrett’s oesophagus and the progression of BE to 
OADC. Understanding these mechanisms will ultimately help in designing effective 
strategies for the management and treatment of Barrett's Oesophagus. Identification of 
a biomarker which could predict the progression of BE to OADC would help in the 
early detection and management of this dreadful condition which has a very poor 
prognosis. The general discussion highlights the findings described in the previous 
chapters of this thesis.
5.1. DEVELOPMENT OF AN IN-VITRO MODEL
One of the aims of this work was to develop an in-vitro model of cell culture to study 
the molecular aspects of BE (chapter two). In-vitro models play an invaluable role in 
understanding tumour biology providing some very important insights into the genesis 
of cancer. They also provide a well defined environment for cancer research in 
contrast to the complex host environment of an in-vivo model. Primary Barrett’s cell 
culture would serve as an ideal model to study the transition of BE to OADC. Such a 
model would not only enable us to study the mechanism involved in neoplastic 
progression but would also allow us to detect biomarkers which could reliably predict 
the progression of BE to OADC. Very few studies have been performed in the past in 
developing a cell culture model from the pre-malignant Barrett’s cells. Most studies 
have had very limited success with few having used this technique subsequently for 
cytogenetic studies. Despite successful attempts to obtain long-term culture by some 
workers the widespread use of this method for cytogenetic analysis has been limited.
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This is because of several reasons including lack of easy reproducibility, infection and 
overgrowth of fibroblasts and limited life span of these cells. Unlike cancer cells, BE 
cells lack clonogenicity and therefore have finite life span. To date none of the 
workers have been able to achieve immortal cell lines from BE cells. We were able to 
achieve long term culture although the success rate was very poor. Although these 
cells survived more than 8 weeks it was extremely difficult to subculture them or 
obtain metaphase spreads. In our opinion use of long term culture for FISH studies is 
difficult and labour intensive. It offers no unique advantage over other quick and easy 
methods such as brush cytology or short term culture. At the beginning of the study 
we aimed to obtain cell lines from patients with BE in the hope of evaluating the early 
cytogenetic changes and obtaining a long term cell cultures from BE cells. Although a 
few studies have described success with long term culture of BE, continuous 
oesophageal cell lines are yet to be obtained. Despite the failure to obtain continuous 
cell lines we managed to obtain and optimise the technique for short term culture of 
BE cells. This technique was found to be relatively easier, reproducible and had the 
unique advantage of being more accurate in representing the changes seen in the 
tissue of origin.
5.2 FISH STUDIES
Our study also aimed at analysing in detail some of the changes that were previously 
analysed in our laboratory using CGH. We had previously found that amplification of 
chromosome four and eight was seen in patients with HGD and OADC (Croft et al., 
2002). The aim of our study was to see if these changes were seen in early stages of 
BE. The latter part of chapter two, deals with interphase FISH analysis of Barrett’s 
cells. Although we were successful in analysing the changes with FISH, our work was 
limited owing to difficulty in obtaining cells for the studies. During the initial part of
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the study most of the cells were lost (senescence or infection) owing to our attempts to 
obtain long term culture. All the samples for FISH analysis were obtained from short 
term culture which we were able to optimize towards the end of the study.
5.21 CHROMOSOME FOUR HYPERPLOIDY
Interphase FISH was performed on cultured cells using CEP probes to look for 
aneuploidy of chromosome four and eight. Cell samples for interphase FISH can be 
obtained by several means including cell culture, touch imprint technique, brush 
cytology or even by using paraffin sections. Touch imprint technique has been used in 
the analysis of solid tumours (prostate, kidney) and has been found to be a relatively 
simple, rapid, and reliable method for detecting chromosome abnormalities. Data is 
however lacking for use of this technique in mucosal lesions like BE, although studies 
from our own laboratory show that it is fairly reliable (Croft et al., 2002). Use of 
paraffin fixed material is possible although it is more difficult to process and interpret 
the results than the conventional methods. Brush cytology on the other hand is very 
easy, quick and reliable compared to cell culture, although short term culture has the 
advantage of providing increased number of cells for cytogenetic studies.
Our previous observation of hyperploidy of chromosome four and eight were based 
on CGH studies which can detect changes when present in large proportion of cells. 
The aim of our study was to see if these changes were seen in relatively early stages 
of BE. We used interphase FISH technique, which is sensitive and can detect changes 
found in smaller proportion of the cells. We found that amplification of chromosome 
four and eight was common in the early stages of BE. Owing to the small number of 
samples analysed it would be difficult to make sensible conclusions from these results 
alone. However, these findings have been confirmed in larger numbers of patients by
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using interphase FISH and brush cytology by Doak et al (2003). We can therefore 
conclude that interphase FISH is a reliable, accurate and sensitive technique for 
detecting numerical chromosomal abnormalities in patients with BE. We have shown 
that these alterations occur early during the neoplastic transformation of Barretf s 
mucosa. These regions may harbour candidate genes involved in the pathogenesis of 
this malignancy.
5.3 CHARACTERISATION OF OE33 CELL LINES
Chapter 3 deals with the characterization of OE33 cells. The genomic re­
arrangements of only a few oesophageal cell lines have been completely 
characterized. The aim of this study was to identify chromosome regions that may 
contain genes important for the development of oesophageal carcinomas and to 
identify genetic markers associated with tumour progression. We analyzed the OE33 
cells using a combination of G-banding and FISH techniques. The G-banding analysis 
revealed a very complex karyotype with gross polyploidy and presence of additional 
material of unknown origin. Owing to the complex karyotypic arrangements seen with 
G-banding, we used chromosome-specific probes to better characterize the 
abnormalities. The use of these FISH-based screening techniques allowed us to detect 
several complex chromosomal changes. Uncertainties seen with G-banding were 
removed only after hybridization with chromosome-specific probes. The combined 
analysis revealed a near tetraploid karyotype with almost all the chromosomes 
demonstrating structural rearrangements. Our study confirms the high frequency of 
chromosomal structural and numerical aberrations in the OE33 oesophageal cell lines. 
We provide a detailed description of chromosomal translocations in the OE33 cells
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although they are complex and difficult to interpret. Some of these changes may be 
useful to direct future intensive investigation of these chromosomal regions.
The findings of G-banding and FISH confirm the chromosomal instability of OE33 
cells. Chromosomal instability is a hall mark of cancer cells the mechanism of which 
is poorly understood. The centrosomes which are involved in segregation of 
chromosomes play an important role in the development of aneuploidy. Centrosome 
and microtubule analysis was performed using immunofluorescence labelling 
technique. Our studies showed that there were striking defects in centrosomes number 
and size in the OE33 cells. The centrosomal abnormalities correlated well with 
chromosomal instability. Presence of centrosome imbalance and aneuploidy together 
suggests that mitotic error and faulty segregation could have resulted in the 
chromosomal instability. It has been suggested that centrosome amplification could be 
an early feature in neoplastic progression which could be followed by clonal selection 
of viable progenitor cells (Brinkley et al., 1998). It would be useful to see if these 
changes are seen in early stages of BE.
5.4 ROLE OF BILE
Until today, the aetiology and pathogenesis of Barrett’s oesophagus is poorly 
understood. Damage of the epithelial cells by various noxious agents seems to be the 
initial process in the pathogenesis of Barrett’s oesophagus. Reflux of duodenal 
contents plays an important role in the genesis of BE and its progression to BE. The 
role of acid reflux in the genesis oesophagitis has been well recognised and was first 
elaborated by Winkelstein (Winkelstien 1935). Despite the fact that acid plays an 
important role in the pathogenesis of BE there seems to be factors other than acid 
which play an equally important role. This is based on the observation that BE and
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OADC have been seen in patients following total gastrectomy. Oesophagitis has been 
noticed in patients following subtotal gastrectomy. Regression of oesophagitis has 
been seen in these patients following surgery for duodenal diversion. From studies in 
experimental models it is clear that bile acids alone can induce BE and oesophageal 
adenocarcinoma in rats. Several studies have shown that bile reflux is common in 
patients with BE. The composition of bile in these patients has been evaluated by 
several workers, and was found to be composed of both conjugated and un-conjugated 
BA. Studies have also shown that 10-25% of the patients with erosive oesophagitis 
have normal pH studies (Masclee et al, 1990). 25-35% of the patients on 
recommended dose of PPI develop recurrent or progressive disease. All this shows 
that duodenal reflux does play a role in the genesis of BE and OADC.
5.41 CYTOTOXICITY AND GENOTOXICITY OF BILE ACIDS
We hypothesized that bile acids play a role in the damage of epithelial cells and are 
possibly involved in inducing DNA damage. While it is generally accepted that bile 
acids can damage cells the ability of different bile acids (particulary TCA, GCA, 
GDCA, TDCA, CA and DCA) to damage oesophageal cells has not been 
demonstrated in the past.
The in vitro MN assay was used to assess the cytotoxic and genotoxic potential of the 
bile acids on oesophageal cell lines. The in vitro MN assay was found to be an easy 
and reliable method to evaluate the mutagenic potential of the various bile acids. The 
MN assay has been well validated and the results have been found to be comparable 
to metaphase analysis. The CBMN assay is in fact a multi endpoint assay which 
simultaneously detects genotoxicity and cytoxicity, chromosmal breakage, 
chromosome loss, cell division inhibition, necrosis and apoptosis (Kirch-Volders et
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al., 1997, Fenech, 2000). Use of CREST analysis further enables to distinguish 
between clastogens and aneugens.
Bile salts are essential components required for the absorption of fat. However their 
detergent property makes them potential cytotoxic agents. In chapter 4, we have 
examined the potential ability of the various bile acids to induce cell damage and 
DNA damage in oesophageal cell lines. Patho-physiologically relevant concentrations 
of the bile salts were found to induce dose-dependent cell toxicity and necrosis. Of all 
the bile acids DCA was found to be the most potent cytotoxic agents. The un- 
conjugated bile acids were found to be more potent than the conjugated bile acids in 
inducing cell damage. DCA and CA induced cytotoxicity at concentrations as low as 
lOOpmol. All the conjugated bile acids had a similar range of cytotoxicity.
Our study has shown that relatively low concentrations of BA can induce cell damage. 
All the bile acids remained in solution both at pH 5.5 and 7.4. The cytotoxicity of all 
the bile acids was found to be significantly higher at pH 5.5 compared to pH 7.45. 
Different studies in the past have demonstrated that DCA interacts directly at the 
DNA level resulting in disruption of genomic function. Studies have shown that DCA 
can induce DNA strand breaks in cells lines.and can lead to the formation of DNA 
adducts. There is evidence to show that DCA may act as a tumour promoter. Our 
study showed that all bile acids (except DCA) failed to induce micronuclei and hence 
lacked any significant genotoxicity in vitro. DCA on the other hand induced 
statistically significant micronuclei in the OE33 cells. The induction of micronuclei 
by DCA was at a maximum at doses between 100 and 200p mol. Kinetochore staining 
revealed that DCA was predominantly clastogen in nature. DCA induced apoptosis in 
dose dependent manner in the OE33 cells. DCA induced apoptosis was possibly
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secondary to DNA damage. These findings may have important implications in the 
pathogenesis and management of BA.
5.5 FINAL CONCLUSION
The work described in this thesis has contributed to a better understanding of the 
several factors relating to in-vitro models of BE and the effects of commonly seen 
bile acids on oesophageal cell lines. The increase in incidence of BE together with the 
poor prognosis of OADC makes this condition extremely important. This increase, 
together with the dismal 5-year survival of patients with this cancer, has focused 
attention on its risk factors.
The initial aim of this study was to understand the early genetic changes in BE which 
could serve as a biomarker in identifying patients who could progress to OADC. This 
aim was to be achieved by obtaining short or long term in-vitro cell culture model of 
Barrett’s. The entire success of the project was based on obtaining an in vitro-model 
of BE. We were partly successful in obtaining short term cultures although it was 
extremely difficult and labour intensive with inconsistent results and poor 
reproducibility. Our studies have also shown that long term cultures are difficult to 
obtain due to lack of clonogenicity of Barrett’s cells. With limited success that was 
obtained from short term cultures we were able to perform cytogenetic studies on a 
small number of samples. Owing to an extreamly small number of samples studied it 
would be over-ambitious to draw a definite conclusion, although the findings were 
consitent with observations made by Doak et al (2003). Our two initial goals, namely 
obtaining an in vitro model and studying the early cytogenetic changes, were therefore 
not fulfilled. The study however shows that in the presence of adequate cells it is 
possible to perform interphase cytogenetic studies.
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The subsequent aim of this study was to evaluate the role of bile acids in the 
pathogenesis of BE. Owing to inconsistency and difficulty in obtaining an in-vitro 
model from BE an alternate but stable and closely representative model was used 
(Barrett’s adenocarcinoma cells- OE33 cells). The in vitro micronucleus assay a 
multi-end point assay, was used to evaluate the cytotoxicity and genotoxicity of bile 
acids. This study has clearly shown that both conjugated and un-conjuagated bile 
acids are cytotoxic at relativily low concentrations. However it is clear from our study 
that most of the bile acids lack genotoxic effect except for DCA. The study has 
answered our initial questions, and does suggest that DCA is the only candidate which 
would need further evaluation regarding its genotoxicity and carcinogenicity.
A number of conclusions can be drawn from our work the most important which have 
been enumerated below:
• Both short and long term cultures of BE difficult to obtain, labour intensive 
and is not easily reproducible. Although it is possible to obtain cells from 
short term cultures it is not a reliable technique to obtain material for 
cytogenetic studies. Not only are the results inconsistent but are also diffuclt 
to reproduce.
• Interphase FISH can be reliably used in the cultured cells to detect numerical 
chromosomal aberration.
• Chromosomal aberrations and centrosome abnormality are common in 
oesophageal adenocarcinoma cells, and that centrosome abnormalities 
correlates with the degree of aneuploidy.
• The cytokinesis blocked micronucleus assay has been successfully applied to 
evaluate the genotoxic and cytotoxic potential of the bile acids.
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• Our results derived from in-vitro MN assay indicate that bile acids are 
cytotoxic at relatively low concentrations which are relevant to patients with 
BE. Un-conjugated bile acids were found to be more cytotoxic than 
conjugated bile acids. In general the cytotoxicity of the bile acids was 
exaggerated by lowering the pH of the medium.
• Our study demonstrates that DCA does exert significant genotoxic effect in 
oesophageal cell lines at concentrations as low as 100-200pmol/l. CREST 
anaylsis showed that DCA was clastogenic in action. The DNA damaging 
effect of DCA therefore needs further evaluation.
• None of the other bile acids (TCA, GCA, TDCA, GDCA and CA) produced 
any genotoxic effects in vitro.
Together the above findings support the hypothesis that bile acids can cause damage 
to the oesophageal epithelial cells in vitro.
5.6 CLINICAL IMPLICATIONS OF BILE REFLUX
Most authors believe that suppression of acid with PPI s can control bile reflux by 
reducing the volume gastric fluid. Studies have shown that treatment with adequate 
doses of PPI fails to suppress acid and bile reflux completely ((Marshall et al, 1998; 
Manifold et al, 2000; Sarela et al, 2004). Suppression of acid with a Proton pump 
inhibitor in turn results in a high prevalence of gastric bacterial overgrowth. The 
presence o f bacterial overgrowth markedly increases the concentration of 
unconjugated bile acids (Theisen et al, 2000). This could lead to continued mucosal 
injury despite suppression of acid reflux. Hence prevention of both acid and bile 
reflux is important in patients with BE. Studies have shown that standard anti-reflux 
procedures are effective in preventing acid and bile reflux (Stein et a\., 1998). More
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recently Gurski et al showed that more than one-third of patients with visible 
segments of Barrett's oesophagus undergo histologic regression after anti-reflux 
surgery (Gurski et al, 2003). Csendes et al (2002) showed that the rate of failure of 
the standard anti-reflux procedure (Nissen fundoplication or Hill's posterior 
gastropexy) was higher in the patients with BE than in those with reflux oesophagitis 
owing to the persistence of duodenal reflux into the oesophagus (Csendes et al,
2002). They treated their patients with aggressive surgery to prevent both acid and 
bile reflux. They performed anti-reflux surgery plus either a duodenal switch 
procedure or a partial distal gastrectomy with Roux-en-Y gastrojejunal anastomosis in 
patients with BE (Csendes et al, 2002). They found that following surgery there was 
a significant decrease in acid reflux, and that duodenal reflux was completely 
abolished in almost all patients. None of these patients progressed to high-grade 
dysplasia or adenocarcinoma. It is therefore important to monitor bile reflux in 
patients with BE. In patients with advanced and persistent bile reflux, surgical options 
should be considered as treatment with PPI alone is insufficient to prevent bile reflux.
5.7 FUTURE PERSPECTIVES
The results of this research strongly support the role of bile acids in oesophageal 
injury and transformation of BE to oesophageal adenocarcinoma. Although the data 
suggests the possible role of BA in the pathogenesis of BE and OADC more studies 
are needed to confirm these findings. Our studies were conducted using commercial 
preparations of bile acids which although is not ideal, gives a good representation of 
the natural situation. A better model would be to use gastric aspirates from patient 
with GERD and BE. Studies in the past have shown that bile acids can be precipitated 
at low pH rendering them harmless at low pH. Use of natural bile acids from the 
aspirate obtained from patients can allow the naturally occurring interaction between
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alkaline and acid components. This could also provide insight into the presence of any 
other genotoxic agents which could be of importance.
There are not many studies which have measured the exact composition and 
concentrations of bile acids in patients with GERD and BE. The currently utilised 
Bilitec technique, although sensitive in detecting presence of bile reflux is semi- 
quantitative at best. Hence more studies are required to study the exact composition. 
Characterisation of the oesophageal cancer cells did show that centrosome defects 
were common and that they correlated well with aneuploidy. It will be interesting to 
see if centrosomal defects are seen in patients with early BE. Although our studies did 
not show any association between BA and induction of aneuploidy it would be worth 
investigating if naturally occurring duodenal contents can induce aneuploidy and 
centrosomal defects.
2 4 4
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APPENDICES
Appendix A: Outcome Of Barrett’s Cell Culture.
Table A2.1 Showing the details of the outcome of Barrett’s cell culture
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Appendix D: Raw data from necrosis and apoptosis at pH 7.4
Table A4.14 NECROSIS / APOPTOSIS: TAUROCHOLIC ACID AT pH 7.4
DOSE MONON , BINU 3 r 4 4 | NEC %NEC ! APOP i %AP
UC C j : + ! R R | T iI
OOOpmol 318 248
_ i  t  3
0 14 2.39 3.." ..... 0.51
lOOpmol 304 2 2 0 2  j 2 1 1 1 2 2 . 2 1 1 2 j~ 0.37
300pmol 308 234 4 ! 1 1 | 18 3.16 j 4 |  0.70
500pmol 336 | 207 j 1 2 2 [ 2 0 3.5 ! 2  i z | 0.35
700pmol j 323 189 |2  4 0 | 40
iioo 4 |  0.71
lmmol 380 103 i 1 i 3 o I 81 14.14 | 5 | 0.87
2 mmol 397 vo 
i 
0
° j 1 2  ! 0 T 8 6 1A65 ! 3 j 0.51
3 mmol 391 1 0 2 I 1 1 2 l 1 98 16.36 ! 4 1 0.67
Table A4.15 NECROSIS / APOPTOSIS: GLYCOCHOLIC ACID AT pH 7.4 j
DOSE MONON BINU : 3 ; 4~ ■ 4 NEC %NEC APOP %APOP
UC C ; + R ! R ! T |
OOOpmol 260 274
1
0 [ 3 17 3.04 4 0.70
lOOpmol 276 245 1 0 16 2.95 'T ‘2 r0.37
300pmol 255 280 1 1 '3 2 1 3.71 ' 5 70 . 8 8
500pmol 287 230 2 2 o ; 32 5.76 i 2 ' 0.36
700pmol 320 189 1 4 0 34 6717 3 [ 0.54
lmmol 369 1 1 0 1 : 2 1 50 9.27 ' 6  : 1 . 1 0
2 mmol 339 127 2 o \ \ " |6 7 j 12.36 6  i 1 . 1 0
3mmol 381 160 3 0 106 16.13 I 5 ; 0.76
Table A4.16 NECROSIS / APOPTOSIS: DEOXYCHOLIC ACID AT pH 7.4
DOSE MONON BINU 3 ! 4 [ 4 ~! NEC I %NEC ! APOP 1%APOP
UC C ; + |  R : R ! t  ;
OOOpmol 280 230 1 3 : 0 ~ 1 1  ..... 2 . 1 0 "  [3 . .  r 0.57
1 Opmol 270 241 1 0 \ T 14 ” 2.64 " [ 4 " “ '. . . i " 0.75
25pmol 291 219 | 2 1 0 r  22 4.051 '  8  ! 1 47
50pmol 245 243 [  1 ; 3 ! 2 42 ' 7.7 i i  r 2 . 0 1
lOOpmol 285 189 1 ! 2 0 I 82i 14.13 " P i — 1
3.62
2 0 0 pmol 356 2 0 2 2 1 '■ 3 8 6 12.90 ; i s 2.70
300pmol 441 1 1 0 3 0 1 ' ; 73 11.38 13 72.028
400pmol 473 6 8 ' 2 1
io5
15.98 7 [ 1.06
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Table A4.17 NECROSIS/APOPTOSIS: CHOLIC ACID AT pH 7.4
MONON BINU [TIT 4 NEC %NEC APOP %APOP
UC i c ! + R R T
OOpmol 253 ; 264 1 0 12 17 3.14 4 0.74
1Opmol ! 249 | 270 1 3 ! 1 15 2.76 4 0.74
25pmol 260 j 237 3 0 ! 3 13 2.50 5 0.97
50pmol 281 241 4 0 1 2 20 3.64 1 0.36
lOOpmol 273 | 219 3 3 12 36 6.62 8 1.47
200pmol 302 | 198 1 0 13 37 6.72 10 1.82
3 OOpmol 365 [ 101 3 1 2 33 6.47 5 0.98
400pmol 352 I 136! 1 3 1 70 12.32 5 0.88
5 OOpmol 389 | 120 3 1 1 ° 63 10.88 3 0.52
Table A4.18NECROSIS/APOPTOSIS: GDCA AT pH 7.4
DOSE MONONUC BINUC 3 4 [ 4 +” NECR %NECR j APOPT j %APOP
OOOpmol 268 j 238 2 1 | 1 16 3.01 I 5 ; 0.94
1 OOpmol 250 246 3 2 0 10 1.93 6 1.16
300pmol 289 237 ~ 0 '2 \ 2 ~ i 28 4.99 3 0.53
500pmol 296 220 : 3 \2 0 ; 48 8.29 10 ' 1.73
700pmol 280 187 ' [ ' i “ 3 \2 ! 66 12.11 6 1.10
lmmol : 320 ; 190 ! 1 2. ;' 3" “ 112 17.67 ~ i 6 0.95
_ .  _
Table A4.19 NECROSIS / APOPTOSIS: TDCA AT pH 7.4
DOSE MONONUC j BINUC [ T ]  4 f 4~ NECR %NECR APOPT %AP
; i + i i OP
000 3C)2 284 1" 1 \ ~2 i i ” S 11 | 1.82 5 0.83
lOOpmol 266 238
... ^
! 8 ! 1.54 4 ; 0 . 7 7
300pmol 298 : 251 0  "|T IT ' 25 4.30 3 0.52
500pmol 320 206 [“ 3  \ Y 1 0 64 | 10.7 4 0.67
700pmol j 380 220 ! 1 ! 41 > ! 1 54 8.10 10 1.50
lmmol 1 320 189 iTT5. 111 20.82 5 0.94
Table A4.20 NECROSIS / APOPTOSIS: MITOMYCIN j
DOSE MONONUC BINUC 3 4 :4+  NECR %NECR APOPT j  %APO j
nmol 1 ; P
00 253 264 \T ' \  0 2 17 3.14 \4  0.74 j
308
30 249 270 1 3 1 15 2.76 |4 : 0.74
50 260 237 3 0 3 13 2.50 " 5 0.97
70 281 241 4 0 ; 2 ' i 20 ! 3.64 2 I 0.36
100 273 219 3 1 3 1 2 ; 36 6.62 8 ; 1.47
Appendix E: Raw data from necrosis and apoptosis at pH 5.5
Table A4.21 NECROSIS / APOPTOSIS: TAUROCHOLIC ACID AT pH 5.5
DOSE
OOOpmol 
lOOpmol 
500pmol 
1 OOOpmol 236
MONON BINU 3 4 4 NEC %NEC ” APOP %APOP
UC C + R ! R ; T
260 185 2 3
1
48 9.52 5 .... 0.99
258 173 1 2 1 86 16.22 9 ; 1.69
280 68 1 1 3 142 28.23 8 1.59
82 2 2 1 170 33.66 12 ; 2.38
Table A4.22 NECROSIS / APOPTOSIS: GLYCOCHOLIC ACID AT pH 5.5
DOSE MONONU BINU 3 4 4 NEC %NEC APOP %APOP
C C + R R T
OOOpmol 301 140 2 2 1 62 12.04 7 1.36
lOOpmol 312 87 1 3 1 112 21.52 i i 2.09
500pmol 270 74 1 1 2 163 31.41 8 1.54
1 OOOpmo 281 55 1 3 0 158 31.16 9 1.76
Table A4.23 NECROSIS / APOPTOSIS: DEOXYCHOLIC ACID AT pH 5.5
DOSE MONONU BINU 3 4 4 ; NEC : %NEC APOP %APOP
C C + R R T
OOOpmol 238 216 1 4 1 42 8.27 6 1.18
5 Opmol 245 156 2 3 1 106 20.19 12 2.29
1 OOpmol 230 112 1 0 3 177 ; 32.84 16 2.97
200pmol 264 78 1 1 2 158 30.50 14 2.70
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Table A4.24 NECROSIS / APOPTOSIS: CHOLIC ACID AT pH 5.5 j
DOSE MONONUC BINUC ; 3 14 4+ NECR ! %NECR APOPT j %APOP j
OOpmol
1! in 
! (N 190 0 59 ! 11.66
j _  -
1.38
50jamol : 2601 145 I 1 ! 3
1 96 \ 18.79
i
! 5i ! .0.98i
lOOpmol j 207 148 ! 3 | 1 3 144 | 28.02 ! 8 | 1.56
200|amol | 224 136 \2 \ 3 0 129 j 25.55 ! 11 ;  2.18
5 OOpmol |  226 97 ” T 3 “ n r 1 187 f 35.89i 1 1.15
Table A4.25 NECROSIS / APOPTOSIS: TDCA AT Ph 5.5
DOSE ! MONONU BINU ; 3 [ 4 i 4 NEC i %NEC \ APOP %APOP
C ; C ; | ! + ! R R | T j
000 I 321 171 ; 3 0 j 45 8.17 ! 9 ! 1.63
lOOpmol' 308 142 ;T!T \ 2 ~  80 14.76 [ 7 j 1.29
5 OOpmol 214 94 ! 3 0 190 37.25 8 1.57
lOOOpmo 252 96 j l  2 1 | 150 29.53 6 1.18
1 ' ! 1 i ! ! 1
Table A4.26 NECROSIS /APOPTOSIS: GDCA AT pH 5.5
DOSE MONONUC BINUC 3 4 4+ NECR %NECR APOPT j %APOP
000 289 169 ; 3 2 ! 2 r 54 10.31 5 | 0.95
lOOfimol 306 158 " j l " \ 2 " j ’l 76 13.74 8 j 1.45
500jimol 268 84 ■ 1 2 0 160 30.36 12 2.28
1 OOOpmol 256 96 2 3 1 178 32.72 8 L47
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